UCHL1 Data Analysis

HGNC Gene Name
ubiquitin C-terminal hydrolase L1
HGNC Gene Symbol
UCHL1
Identifiers
hgnc:12513 NCBIGene:7345 uniprot:P09936
Orthologs
mgi:103149 rgd:3928
INDRA Statements
deubiquitinations all statements
Pathway Commons
Search for UCHL1
Number of Papers
2298 retrieved on 2023-02-19

DepMap Analysis

The Dependency Map (DepMap) is a genome-wide pooled CRISPR-Cas9 knockout proliferation screen conducted in more than 700 cancer cell lines spanning many different tumor lineages. Each cell line in the DepMap contains a unique barcode, and each gene knockout is assigned a “dependency score” on a per cell-line basis which quantifies the rate of CRISPR-Cas9 guide drop. It has been found that proteins with similar DepMap scores across cell lines, a phenomenon known as co-dependent genes, have closely related biological functions. This can include activity in the same or parallel pathways or membership in the same protein complex or the same pathway.

We identified the strongest seven co-dependent genes (“Symbol”) for DUBs and ran GO enrichment analysis. We used Biogrid, IntAct, and Pathway Commons PPIDs, and the NURSA protein-protein interaction databases (PPIDs) to determine whether co-dependent genes interact with one another. The “Evidence” column contains the PPIDs in which the interaction appears as well as whether there is support for the association by an INDRA statement. As another approach to identify potential interactors, we looked at proteomics data from the Broad Institute's Cancer Cell Line Encyclopedia (CCLE) for proteins whose expression across ~375 cell lines strongly correlated with the abundance of each DUB; it has previously been observed that proteins in the same complex are frequently significantly co-expressed. The correlations and associated p-values in the CCLE proteomics dataset are provided. And, we determined whether co-dependent genes yield similar transcriptomic signatures in the Broad Institute's Connectivity Map (CMap). A CMap score greater than 90 is considered significantly similar.

DepMap Correlations

Symbol Name DepMap Correlation Evidence CCLE Correlation CCLE Z-score CCLE p-value (adj) CCLE Significant CMAP Score CMAP Type

Dependency GO Term Enrichment

Gene set enrichment analysis was done on the genes correlated with UCHL1using the terms from Gene Ontology and gene sets derived from the Gene Ontology Annotations database via MSigDB.

Using the biological processes and other Gene Ontology terms from well characterized DUBs as a positive control, several gene set enrichment analyses were considered. Threshold-less methods like GSEA had relatively poor results. Over-representation analysis with a threshold of of the top 7 highest absolute value Dependency Map correlations yielded the best results and is reported below.

GO Identifier GO Name GO Type p-value p-value (adj.) q-value

Transcriptomics

The following table shows the significantly differentially expressed genes after knocking out UCHL1 using CRISPR-Cas9.

Knockout Differential Expression

Symbol Name log2-fold-change p-value p-value (adj.)
ANKRD1 ankyrin repeat domain 1 3.41e-01 5.45e-05 4.75e-02
ANKRD11 ankyrin repeat domain 11 4.29e-01 5.87e-05 4.75e-02
CEP350 centrosomal protein 350 7.40e-01 6.41e-05 4.75e-02
FNBP1 formin binding protein 1 7.55e-01 6.03e-05 4.75e-02
H4C8 H4 clustered histone 8 8.95e-01 2.97e-05 4.75e-02
HSPA9 heat shock protein family A (Hsp70) member 9 4.45e-01 3.63e-05 4.75e-02
PRC1 protein regulator of cytokinesis 1 5.09e-01 2.59e-05 4.75e-02
SASH1 SAM and SH3 domain containing 1 7.82e-01 1.94e-05 4.75e-02
SMC1A structural maintenance of chromosomes 1A 5.68e-01 1.47e-05 4.75e-02
CLINT1 clathrin interactor 1 6.09e-01 7.77e-05 4.94e-02
HMGB2 high mobility group box 2 3.87e-01 8.14e-05 4.94e-02

Gene Set Enrichment Analysis

There were too few differentially expressed genes to run a meaningful GSEA.

Literature Mining

INDRA was used to automatically assemble known mechanisms related to UCHL1 from literature and knowledge bases. The first section shows only DUB activity and the second shows all other results.

Deubiquitinase Activity

psp cbn pc bel_lc signor biogrid tas hprd trrust ctd vhn pe drugbank omnipath conib crog dgi minerva creeds ubibrowser acsn | geneways tees gnbr semrep isi trips rlimsp medscan eidos sparser reach
UCHL1 deubiquitinates NOX4. 10 / 12
1 | 11

reach
UCH-L1 restores H 2 O 2 -generating activity of NOX4 by deubiquitinating NOX4.

reach
We further investigated whether endogenous NOX4 is also deubiquitinated by UCH-L1 in B16F10 cells.

reach
We further showed that UCH-L1 increases ROS levels in HUVEC by deubiquitinating NOX4 in VEGF signaling.

reach
These immunoprecipitation studies confirm that UCH-L1 deubiquitinates NOX4 in HUVECs, and suggest that UCH-L1 is involved in ROS mediated angiogenesis in HUVECs by modulating NOX4 activity via deubiqu[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Fig. 4 B shows that ubiquitination of NOX4 was markedly decreased by adding back of control UCH-L1 in UCH-L1-knocked down HUVECs.

reach
Immunoprecipitation studies confirmed that UCH-L1 deubiquitinates NOX4, suggesting that UCH-L1 might be involved in H 2 O 2 -mediated cell invasion by regulating the NOX4 activity through deubiquitination.

reach
Also, we demonstrated that UCH-L1 restores H 2 O 2 -gernerating activity of NOX4 by deubiquitinating NOX4.

reach
On the other hand, NOX4 overexpressed in HeLa cells happens to be ubiquitinated, and NOX4 following deubiquitination by UCH-L1, restored H2O2 generating activity.

ubibrowser
These findings indicate that H2O2 levels regulated by UCH-L1 are necessary for cell invasion to occur and demonstrate that UCH-L1 promotes cell invasion by up-regulating H2O2 via deubiquitination of NOX4.

reach
Because H 2 O 2 generating activity of NOX4 is negatively modulated by ubiquitination and UCH-L1 promotes ROS induced cell invasion and migration in HeLa cells by deubiquitinating the NOX4 [13], we in[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
UCHL1 deubiquitinates TP53. 6 / 6
1 | 1 4

reach
However, while exploring the relationship between UCH-L1 and p53 ubiquitination, it is important to keep in mind that, despite hypotheses to the contrary [XREF_BIBR, XREF_BIBR], it is unlikely that UCH-L1 directly deubiquitinates or ubiquitinates p53 based on what is known about UCH-L1 structure and function [XREF_BIBR, XREF_BIBR].

trips
These results indicate that UCHL1 could deubiquitinate p53 and p14(ARF) and ubiquitinate MDM2 for p53 stabilization to promote p53 signaling, thus involved in nasopharyngeal carcinoma pathogenesis, whereas it is frequently silenced in this tumor.

ubibrowser
These results indicate that UCHL1 could deubiquitinate p53 and p14(ARF)

reach
These results indicate that UCHL1 could deubiquitinate p53 and p14 (ARF) and ubiquitinate MDM2 for p53 stabilization to promote p53 signaling, thus involved in nasopharyngeal carcinoma pathogenesis, whereas it is frequently silenced in this tumor.

reach
Our previous work demonstrated that UCHL1 could activate the p14ARF-p53 signaling pathway by deubiquitinating p53 and p14ARF as well as ubiquitinating MDM2, which might be through its two opposing enzyme activities, hydrolase and ligase, further resulting in its tumor suppressive role in NPC tumorigenesis XREF_BIBR, XREF_BIBR.

reach
As P53 protein is regulated through ubiquitin dependent degradation in tumorigenesis, UCHL1 promotes p53 signaling by deubiquitinating p53 and p14 ARF and ubiquitinating MDM2 for further MDM2 degradation and p53 stabilization, thus involved in NPC pathogenesis as a functional TSG XREF_BIBR.
UCHL1 deubiquitinates NTRK2. 5 / 5
1 | 4

reach
We provide evidence that UCH-L1 can deubiquitinate TrkB directly.

reach
Together, our results suggest that the ubiquitination of TrkB is a mechanism that controls its downstream signaling pathways via the regulation of its endocytosis and postendocytic trafficking and that UCH-L1 mediates the deubiquitination of TrkB and could be a potential target for the modulation of hippocampus dependent memory.

reach
UCH-L1 mediates the deubiquitylation of TrkB by cleaving ubiquitin (probably polyubiquitin chains) and thereby inhibits TrkB degradation.

ubibrowser
Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) Promotes Hippocampus-Dependent Memory via Its Deubiquitinating Effect on TrkB

reach
Deubiquitination of TrkB by the DUB UCHL1 has been reported, which maintains expression of the receptor on the cell surface [XREF_BIBR].
UCHL1 deubiquitinates CDKN2A. 4 / 4
| 1 3

reach
As P53 protein is regulated through ubiquitin dependent degradation in tumorigenesis, UCHL1 promotes p53 signaling by deubiquitinating p53 and p14 ARF and ubiquitinating MDM2 for further MDM2 degradation and p53 stabilization, thus involved in NPC pathogenesis as a functional TSG XREF_BIBR.

reach
Our previous work demonstrated that UCHL1 could activate the p14ARF-p53 signaling pathway by deubiquitinating p53 and p14ARF as well as ubiquitinating MDM2, which might be through its two opposing enzyme activities, hydrolase and ligase, further resulting in its tumor suppressive role in NPC tumorigenesis XREF_BIBR, XREF_BIBR.

reach
These results indicate that UCHL1 could deubiquitinate p53 and p14 (ARF) and ubiquitinate MDM2 for p53 stabilization to promote p53 signaling, thus involved in nasopharyngeal carcinoma pathogenesis, whereas it is frequently silenced in this tumor.

trips
These results indicate that UCHL1 could deubiquitinate p53 and p14(ARF) and ubiquitinate MDM2 for p53 stabilization to promote p53 signaling, thus involved in nasopharyngeal carcinoma pathogenesis, whereas it is frequently silenced in this tumor.
UCHL1 deubiquitinates EGFR. 3 / 3
| 3

reach
UCHL1 inhibits EGFR ubiquitination and degradation.

reach
UCHL1 deubiquitinates epidermal growth factor receptor, preventing its degradation and resulting in the activation of multiple downstream signaling cascades that positively regulate cardiac hypertrophy.

reach
In addition, knockdown of UCHL1 increased EGFR polyubiquitination and decreased the EGFR level with or without EGF stimulation.
UCHL1 deubiquitinates HIF1A. 3 / 3
1 | 2

ubibrowser
We revealed that UCHL1 directly interacts with HIF-1α, mediates the deubiquitination of HIF-1α, and upregulates HIF-1 activity through the stabilization of HIF1α

reach
UCHL1 deubiquitinates HIF-1alpha protein and upregulates HIF-1 activity in murine breast cancer derived EMT6 cells.

reach
Moreover, when the ubiquitination status of the HIF-1alpha protein was directly evaluated by performing immunoprecipitation assays, the knockdown of endogenous UCHL1 significantly increased HIF-1alpha ubiquitination (XREF_FIG and XREF_SUPPLEMENTARY).
UCHL1 deubiquitinates CD36. 2 / 2
| 1 1

trips
Deubiquitination of CD36 by UCHL1 promotes foam cell formation.

reach
Deubiquitination of CD36 by UCHL1 promotes foam cell formation.
UCHL1 deubiquitinates SNCA. 2 / 2
1 | 1

ubibrowser
The deubiquitination of α-synuclein aggregates by USP9X favor their degradation by autophagy, while UCH-L1 contribute to the accumulation of α-synuclein by downregulating its lysosomal degradation.

reach
No clear substrates have been described for UCHL1 in vivo, but UCHL1 may deubiquitinate alpha-synuclein.
UCHL1 leads to the deubiquitination of VEGF. 1 / 1
| 1

reach
We further showed that UCH-L1 increases ROS levels in HUVEC by deubiquitinating NOX4 in VEGF signaling.
UCHL1 deubiquitinates SLC5A7. 1 / 1
1 |

ubibrowser
These data provide novel and potentially important evidence that UCHL1 may play a role in the regulation of cholinergic function by affecting CHT ubiquitination and degradation.
UCHL1 deubiquitinates TGFBR1. 1 / 1
1 |

ubibrowser
Besides, we found that recombinant UCHL1 protein is able to deubiquitinate TβRI and SMAD2 in vitro directly, and N-ethylmaleimide (NEM) treatment blocked this process by inhibiting UCHL1 DUB activity
UCHL1 deubiquitinates CXCL8. 1 / 1
1 |

ubibrowser
It was showed that UCH-L1 over-expression inhibited NF-κB activation and decrease IL-6 and IL-8 levels, while knockdown of it enhanced NF-κB activation and increase IL-6 and IL-8 levels during TNF-α treatment.
UCHL1 deubiquitinates MAPT. 1 / 1
1 |

ubibrowser
Our results suggest that UCH-L1 may be associated with hippocampal MSF followed the epileptogenesis through mediating phosphorylation of tau.
Modified UCHL1 leads to the deubiquitination of EGFR. 1 / 1
| 1

reach
As expected, overexpression of UCHL1 (WT) significantly abrogated EGFR ubiquitination and increased EGFR levels, whereas this effect was reversed by UCHL1 (C90S; XREF_FIG).
UCHL1 deubiquitinates tyrosine-phosphorylated SNCA on lysine. 1 / 1
1 |

biopax:pid
No evidence text available
UCHL1 deubiquitinates SMAD2. 1 / 1
1 |

ubibrowser
We also found that UCH-L1 interacts, deubiquitinates, and stabilizes SMAD2 and SMAD3.
UCHL1 deubiquitinates SNCA phosphorylated on S129 and tyrosine on lysine. 1 / 1
1 |

biopax:pid
No evidence text available
UCHL1 deubiquitinates UCHL1. 1 / 1
1 |

ubibrowser
Interestingly, UCH-L1 catalyzes its own deubiquitination in an intramolecular manner, thereby regulating the lifetime of this modification.
UCHL1 deubiquitinates RPTOR. 1 / 1
| 1

reach
UCHL1 deubiquitinates Raptor, thereby destabilizing mTORC1 complex formation and shifting the balance toward mTORC2 dependent signaling.
UCHL1 leads to the deubiquitination of HSPA5. 1 / 1
| 1

reach
Downregulation of UCHL1 by UCHL1 siRNA decreased poly-ubiquitination of GRP78.
UCHL1 deubiquitinates BACE1. 1 / 1
| 1

reach
Whether UCHL1, with its physically constrained catalytic site, can deubiquitinate BACE1 and how this would accelerate its degradation is presently unclear.
UCHL1 deubiquitinates NFKB1. 1 / 1
1 |

ubibrowser
It was showed that UCH-L1 over-expression inhibited NF-κB activation and decrease IL-6 and IL-8 levels, while knockdown of it enhanced NF-κB activation and increase IL-6 and IL-8 levels during TNF-α treatment.
Modified UCHL1 leads to the deubiquitination of TP53. 1 / 1
| 1

reach
Similarly, Li et al. have shown that over-expression of UCH-L1 in LNCaP prostate cancer cells reduces polyubiquitination of p53, leading to inhibition of degradation of p53 by the proteasome [XREF_BIBR].
UCHL1 deubiquitinates CTNNB1. 1 / 1
| 1

reach
Although, it is unlikely UCH-L1 directly deubiquitinates beta-catenin [XREF_BIBR, XREF_BIBR], these observations suggest UCH-L1 may convey its oncogenic function through Wnt signaling pathways.
UCHL1 deubiquitinates STUB1. 1 / 1
| 1

reach
No other tested DUB behaved in a similar manner : USP5 deubiquitinated Ub-CHIP in an unregulated manner, while UCHL-1 and UCHL-3 did not deubiquitinate Ub-CHIP under any conditions (XREF_FIG).
UCHL1 leads to the deubiquitination of APP. 1 / 1
| 1

reach
To investigate whether UCHL1 promotes the ubiquitination and degradation of APP by regulating the free ubiquitin pool, Haw cells were co-transfected with pZ-UCHL1-st and ubiquitin expression plasmid pCW7.
UCHL1 deubiquitinates SMAD3. 1 / 1
1 |

ubibrowser
We also found that UCH-L1 interacts, deubiquitinates, and stabilizes SMAD2 and SMAD3.
UCHL1 deubiquitinates IL6. 1 / 1
1 |

ubibrowser
It was showed that UCH-L1 over-expression inhibited NF-κB activation and decrease IL-6 and IL-8 levels, while knockdown of it enhanced NF-κB activation and increase IL-6 and IL-8 levels during TNF-α treatment.
UCHL1 deubiquitinates HDAC6. 1 / 1
1 |

ubibrowser
By reducing the production of lysine (K63)-linked ubiquitin chains, UCH-L1 inhibition decreases HDAC6 deacetylase activity and attenuates the interaction of HDAC6 and tau protein, finally leading to tau aggresome formation impairment.?
UCHL1 deubiquitinates COPS5. 1 / 1
1 |

ubibrowser
UCH-L1 colocalizes with Jab1 sending p27Kip1?to proteasomal degradation, prevents senescence, and ensures proper somatic cell division

Other Statements

psp cbn pc bel_lc signor biogrid tas hprd trrust ctd vhn pe drugbank omnipath conib crog dgi minerva creeds ubibrowser acsn | geneways tees gnbr semrep isi trips rlimsp medscan eidos sparser reach

reach
Restoring UCHL1 expression in silenced cell lines significantly inhibits their growth and colony formation ability, by inhibiting cell proliferation through cell cycle arrest in the G2/M phase and inducing apoptosis through the intrinsic caspase dependent pathway.

reach
UCHL1 promotes in vitro clonogenicity, cell proliferation, and invasion.

reach
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.

reach
In the present study, we explored role of UCH-L1 in the regulation of TNFalpha mediated VSMC proliferation in vitro.

reach
Restoring UCHL1 expression in silenced cell lines significantly inhibited their growth and colony formation ability by inhibiting cell proliferation, causing cell cycle arrest in G2/M phase and inducing apoptosis through the intrinsic caspase dependent pathway.

reach
Thus, one could imagine further improved nerve conduits based on silk with, e.g., binding of neuron specific protein gene product 9.5 (PGP 9.5) protein onto the silk to enhance Schwann cell migration and proliferation or loading the silk with chondroitinase ABC (ChABC) or glial cell derived neurotrophic factor (GDNF) to improve axonal regeneration.

reach
Then, we found that knockdown of UCHL1 in osteosarcoma cell MG63 inhibited cell proliferation and significantly increased cell population in the G1 phase.

reach
Gain- and loss-of-function studies revealed that UCH-L1 enhances proliferation of multiple cell types, including human cancer cells.

reach
These data underscore the importance of the Akt pathway in malignant B-cells and provide precedence for the suggestion that UCH-L1 promotes the survival and proliferation of malignant B-cells through its effect on Akt signaling.

reach
Knockdown of UCHL1 in OC cell lines promoted cell proliferation and reduced cell apoptosis [XREF_BIBR] UCHL1 also promotes prostate cancer metastasis through EMT induction [XREF_BIBR].

sparser
UCH-L1 inhibits cell proliferation in lung and neuro-blastoma cell lines; when these cell lines were treated with these inhibitors, enhanced cell proliferation was observed, further supporting the anti-proliferative role of UCLH-1 enzymes [ xref ].

reach
Our results uncovered for the first time that UCH-L1 facilitates autophagic degradation of p21 WAF1 and Cip1 to suppress proliferation in cardiac fibroblasts, potentially acting as a novel feedback mechanism in the regulation of maladaptive cardiac remodeling and dysfunction.

reach
In the present study, there are several novel findings regarding UCH-L1 as a negative regulator of maladaptive cardiac remodeling and dysfunction as follows : (i) UCH-L1 expression is enhanced in cardiac myocytes and fibroblasts during the earlier stage of cardiac adaptive hypertrophy and declined in the process of maladaptive responses to the sustained hemodynamic stress; (ii) UCH-L1 inhibits cardiac fibroblast proliferation via suppressing PDGF and PDGFRbeta signaling; (iii) UCH-L1 preferentially enhances PDGF-BB-induced suppression autophagic clearance of p21 WAF1 and Cip1 proteins in cardiac fibroblasts.

reach
These data suggest that UCHL1 suppresses cell proliferation of breast cancer.

reach
UCH-L1 siRNA is able to inhibit the proliferation of lung adenocarcinoma cell lines H157 and induce the apoptosis.

reach
XREF_FIG A, MTT absorbance at 490 nm of A2780-shUCHL1 and A2780-control differed significantly on the 5 th day, indicating that reduced expression of UCHL1 in A2780 cells increased cell proliferation.

reach
Adenoviral overexpession of UCH-L1 inhibited the PDGF induced cardiac fibroblast proliferation without affecting the activation of mitogen activated protein kinases (MAPKs), Akt, and signal transducers and activators of transcription 3 (STAT3).

reach
Of interest, overexpression of UCH-L1 enhanced the PDGF-BB-induced posttranscriptional upregulation of p21 WAF1 and Cip1 protein in cardiac fibroblasts (XREF_FIG), suggesting that UCH-L1 inhibits cardiac fibroblast proliferation via posttranscriptional enhancing the expression of p21 WAF1 and Cip1 to suppress the transition of G1 to S phase.

reach
To explore the mechanisms of how reduced expression of UCHL1 promotes cell proliferation, reduces apoptosis and confers cisplatin resistance, we performed a microarray analysis to identify different genes regulated by UCHL1-knockdown.

sparser
Interestingly, a study found that UCH-L1 inhibits breast cancer cell proliferation by stabilizing p53 and blocking G0/G1 cell cycle [ xref ].
| 1 58
| 44

reach
Overexpression of UCHL1 has been found to induce apoptosis in MCF-7 cells XREF_BIBR.

reach
In summary, the present data provide evidence for the first time that UCH-L1 induces apoptosis in cultured breast cancer cells in vitro and the apoptotic effect is possibly through the PI3K and Akt pathway.

reach
Loss of UCHL1, a deubiquitating enzyme responsible for regenerating monoubiquitin from the ubiquitin protein complex, decreased the rate of apoptosis in the first round of spermatogenesis and increased the numbers of premeiotic germ cells in immature mice [XREF_BIBR], whereas asymmetric distribution of UCHL1 in spermatogonia is associated with maintenance and differentiation of spermatogonial stem cells [XREF_BIBR].

reach
Upregulation of UCHL1 enhanced the reversal effect of VER on chemo-resistance to ADM and promoted cell apoptosis.

reach
UCHL1 can induce apoptosis of tumor cells and is involved in various cancers XREF_BIBR - XREF_BIBR.

reach
These data suggest that UCHL1 inhibition suppresses MSC apoptosis induced by proinflammatory cytokines via upregulation of Bcl-2.

reach
Uchl1 (-/-) mice had increased ER stress and beta cell apoptosis.

reach
To this end, we investigated whether UCHL1 regulated proinflammatory cytokines induced MSC apoptosis.

reach
In mice, transgenic over-expression of UCH-L1 in spermatogonia causes a block during spermatogenesis at an early stage (pachytene) of meiosis and increased apoptosis of primary spermatocytes.

reach
In breast cancer, ectopic expression of UCHL1 is able to induce apoptosis by stabilizing p53.
| 1 14

reach
Knockdown of UCHL1 in OC cell lines promoted cell proliferation and reduced cell apoptosis [XREF_BIBR] UCHL1 also promotes prostate cancer metastasis through EMT induction [XREF_BIBR].

eidos
Particularly , UCH-L1 inhibition was reported to contribute to apoptosis through the stimulation of unfolded protein response [ 218 ] .

reach
Since suppression UCHL1 reduced apoptosis, we performed MTT assay to determine whether UCHL1 knockdown in ovarian cancer cells influences resistance to cisplatin, a common reagent used to treat ovarian cancer.

reach
Results showed that UCH-L1 inhibited the growth of breast cancer cells and its action was dependent on the inducement of cell death, showing the typical characteristics of apoptosis but not necrosis.

reach
Moreover, inhibition of UCHL1 in MG63 cells dramatically induced cell apoptosis.

reach
UCH-L1 increases lymphoid proliferation and decreases apoptosis in vivo.

reach
Moreover, SGES upregulated the expression of GDNF, p-Akt and PGP9.5 in the vagotomized rats and inhibited the apoptosis of enteric neurons.

reach
Bheda et al. presented a series of genes regulated by UCH-L1 using microarray and quantitative real-time PCR analysis, and they found that the inhibition of UCH-L1 activated genes controlling apoptosi[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Knockdown of UCHL1 also reduced cell apoptosis and contributed to cisplatin resistance.

reach
Previous studies have shown that Uch-L1 can prevent apoptosis in cells treated with lysosomal protease inhibitors.
UCHL1 affects Ubiquitin
| 36
UCHL1 activates Ubiquitin.
| 16
| 16

reach
In contrast to USP14, UCH-L1 is thought to prevent the inappropriate degradation of ubiquitin by sequestering monomeric ubiquitin [XREF_BIBR].

reach
A neuron specific antisense lncRNA, AS Uchl1, could specifically induce the translation of ubiquitin carboxyl-terminal esterase L1 (Uchl1) under certain stress conditions through its complementarity with target mRNA [XREF_BIBR].

reach
AS Uchl1 enhances translation of UCHL1 (ubiquitin carboxy-terminal hydrolase L1) through an embedded SINE (short interspersed nuclear element) B2 repeat present in AS Uchl1 [XREF_BIBR].

reach
The increases in BAG2 (4-fold) and UCHL1 (2.7-fold) Prevent ubiquitin degradation.

reach
Through these functions, UCH-L1 can increase the free pool of Ub and, therefore, indirectly affect many ubiquitination dependent cellular activities.

reach
The I93M mutation in the UCH-L1 gene, which was reported in a German family with autosomal dominant Parkinson 's Disease (PD), leads to a 50% reduction in catalytic of UCH-L1 activity in vitro, implying that loss of UCH-L1 activity may reduce the availability of free ubiquitin, and contribute to an impaired clearance of proteins by the UPS.

reach
Besides TGFbeta blockade, interesting results were shown using LDN57444, a specific small molecule inhibitor, targeting ubiquitin carboxy-terminal hydrolase L1 (UCH-L1).

reach
Inhibition of UCHL1 using LDN-57444 depletes the hippocampus of monomeric ubiquitin and postsynaptic density protein PSD-95.

reach
UCHL1 associates with monoubiqutin, prolongs the half-life of ubiquitin in neurons, and resists apoptotic stress in testicular germ cells [XREF_BIBR, XREF_BIBR].

reach
Loss of UCHL-1 reduces free ubiquitin, and leads to inadequate ubiquitylation and protein accumulation in neurons (Osaka et al., 2003).
UCHL1 increases the amount of Ubiquitin.
| 13
UCHL1 increases the amount of Ubiquitin. 9 / 11
| 9

reach
UCH-L1 may also elevate free Ub levels by facilitating recycling of Ub (XREF_FIG).

reach
Pharmacological suppression of UCH-L1 activity reduces monomeric ubiquitin levels and leads to dramatic alterations to synaptic structure.

reach
UCHL1 increases free ubiquitin levels and accelerates the lysosomal degradation of APP by promoting its ubiquitination.

reach
A20 overexpression or UCH-L1 inhibition increased expression of synaptoporin and nephrin but decreased desmin expression and ubiquitin accumulation level in podocytes.

reach
UCHL1 increases free ubiquitin level and accelerates the lysosomal degradation of APP by promoting its ubiquitination.

reach
In addition to the deubiquitinating or ubiquitination promoting activity, UCHL1 stabilizes monoubiquitin and increases the level of ubiquitin in neuron (Osaka et al., 2003), which is consistent with o[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Conversely, pharmacological inhibition of UCH-L1 significantly reduces monomeric ubiquitin levels and causes dramatic alterations in synaptic protein distribution and spine morphology.

reach
Pharmacological inhibition of UCH-L1 activity reduces monomeric ubiquitin levels and results in spine enlargement with a concomitant decrease in spine density and synapse number (XREF_FIG).

reach
UCH-L1 can increase levels of monomeric ubiquitin in neurons by binding and stabilizing ubiquitin monomers and by deubiquitinating ubiquitin precursors [XREF_BIBR, XREF_BIBR].
Modified UCHL1 increases the amount of Ubiquitin. 4 / 4
| 4

reach
Overexpression of UCHL1 significantly elevated free ubiquitin levels (p < 0.05) (XREF_FIG), and overexpression of ubiquitin further increased free ubiquitin levels (p < 0.01) (XREF_FIG).

reach
Our studies are consistent with previously published results that demonstrate that loss of Uch-L1 causes a decrease in ubiquitin levels in neurons.

reach
Ubiquitin C-terminal hydrolase L1 (UCHL1) plays an important role in maintenance of nervous system integrity, and overexpression of UCHL1 has been shown to increase ubiquitin levels within neurons.

reach
Furthermore, they also found that overexpression of wild type UCH-L1, which significantly up-regulated free monomeric ubiquitin levels, did not alter proteasome activity in vitro.
UCHL1 inhibits Ubiquitin.
| 5
| 3

reach
Since UCHL1 has a high affinity for ubiquitin, it has been suggested that UCHL1 may serve to sequester ubiquitin and prevent its degradation.

reach
In addition, western blotting of proteins from primary cells derived from the spinal ligament tissues of wild-type mice treated with the ubiquitin ligase inhibitor (HLI 373), treated with recombinant UCHL1, or transfected with miR-340 showed that expression of CXCL7 was not completely suppressed by miR-340 transfection.

reach
Furthermore, free monomeric ubiquitin is reduced by 20-30% in the brains of UCH-L1 deficient mice [XREF_BIBR - XREF_BIBR].
UCHL1-I93M inhibits Ubiquitin. 2 / 2
| 2

reach
Notably, the I93M UCHL1 mutant has markedly reduced ubiquitin hydrolase activity in vitro [XREF_BIBR], suggesting that impaired polyubiquitin hydrolysis could also contribute to dopaminergic neuronal death.

reach
Notably, the I93M UCHL1 mutant display markedly reduced ubiquitin hydrolase activity in vitro; suggesting that impaired polyubiquitin hydrolysis leading to a shortage of free ubiquitin might also promote the accumulation of toxic proteins and contribute to neuronal death.
UCHL1 decreases the amount of Ubiquitin.
| 2
UCHL1 decreases the amount of Ubiquitin. 2 / 4
| 2

reach
Previously, we found that UCHL1 deficient testes of gad mice have reduced ubiquitin levels and are resistant to cryptorchid stress related injury.

reach
On the other hand, UCH-L1 deficiency does reduce ubiquitin levels in the nervous system and this is accompanied by an up-regulation of lysosomal components.
UCHL1 affects APP
| 1 27
UCHL1 inhibits APP.
| 15
UCHL1 inhibits APP. 10 / 15
| 13

reach
Our results indicated that UCHL1 promoted the degradation of APP via the lysosomal pathway.

reach
UCHL1 also accelerates beta-secretase degradation, impairs APP processing and decreases Abeta 109.

reach
The mechanism by which Uch-L1 reduces Abeta accumulation and toxicity is unclear.

reach
In APP and PS1 mice, injection of UCH-L1 improves the retention of contextual learning through the PKA-CREB pathway [XREF_BIBR] and reduces Abeta production, increased free ubiquitin and accelerates proteosomal degradation of APP [XREF_BIBR].

reach
In APP and PS1 mice, injection of UCH-L1 improves the retention of contextual learning through the PKA-CREB pathway [XREF_BIBR] and reduces Abeta production, increased free ubiquitin and accelerates proteosomal degradation of APP [XREF_BIBR].

reach
The Uchl1 overexpression, induced by intracranial injection of Uchl1 expressing virus, decreases the Abeta production and protects AD model mice against memory impairment.

reach
Our data also suggest that ciRS-7 modulates APP and BACE1 levels in a nuclear factor-kappaB (NF-kappaB)-dependent manner : ciRS-7 expression inhibits translation of NF-kappaB and induces its cytoplasmic localization, thus derepressing expression of UCHL1, which promotes APP and BACE1 degradation.

reach
Disruption of UCHL1 gene expression significantly increased APP CTFs in the hippocampi of APP23 and gad mice compared to APP23 mice (XREF_FIG).

reach
UCH-L1 null mice have higher levels of brain Abeta, while overexpression of UCH-L1 slows the deposition of Abeta and attenuates cognitive decline in a mouse model of AD (Zhang et al., 2012).

reach
Facilitation of APP degradation by UCHL1 could be through the lysosomal or proteasomal pathway.
Modified UCHL1 inhibits APP. 2 / 2
| 2

reach
Moreover, overexpression of UCHL1 reduces the levels of beta-secretase BACE1, and consequent BACE1 cleavage products (APP C-terminal fragment C99 and Abeta).

reach
Furthermore, overexpression of UCHL1 reduces the production of Abeta by downregulating the protein level of beta-secretase and APP [XREF_BIBR, XREF_BIBR].
UCHL1 decreases the amount of APP.
| 6
UCHL1 decreases the amount of APP. 4 / 7
| 4

reach
Mature APP level was reduced by UCHL1 as expected (p < 0.05) (XREF_FIG), and was further reduced by ubiquitin expression (p < 0.01) (XREF_FIG).

reach
This study suggests that potentiation of UCHL1 might be able to reduce the level of BACE1 and Abeta in brain, which makes it a novel target for AD drug development.

reach
Overexpressing Uch-L1 reduces BACE1 activity and Abeta levels, whereas Uch-L1 null mice exhibit increased number of Abeta plaques and neurofibrillary tangles, thus displaying an inverse relationship with Uch-L1 levels.

reach
To investigate whether UCHL1 reduced APP protein level by the lysosomal degradation, Haw cells were transfected with UCHL1 and then treated with 100muM chloroquine (XREF_FIG).
Modified UCHL1 decreases the amount of APP. 2 / 2
| 2

reach
Furthermore, viral expression of UCHL1 significantly lowered the APP level (p < 0.05) (XREF_FIG), and partial loss of UCHL1 markedly increased the APP level in APP23 and gad mice (p < 0.05) (XREF_FIG).

reach
Overexpression of UCHL1 significantly reduced APP CTF production (p < 0.01) (XREF_FIG) and markedly lowered Abeta level in the hippocampi of the UCHL1 overexpressing mice 10 weeks after injection (p < 0.05) (XREF_FIG).
UCHL1 activates APP.
| 1 2
UCHL1 activates APP. 3 / 6
| 1 2

reach
BACE1 has been reported to be degraded by the lysosomes and ubiquitin-proteasome pathway, and accelerating BACE1 degradation by ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) reduces 99-amino acid carboxy-terminal fragment (C99) and Abeta production.

reach
34 UCHL1 is also required for normal synaptic function and rescues Abeta related synaptic dysfunction in transgenic AD mice.

eidos
UCH-L1 ameliorates Abeta ( 1-42 ) - induced LTP loss in vitro and in vivo .
UCHL1 increases the amount of APP.
| 4
Modified UCHL1 increases the amount of APP. 3 / 3
| 3

reach
Furthermore, viral expression of UCHL1 significantly lowered the APP level (p < 0.05) (XREF_FIG), and partial loss of UCHL1 markedly increased the APP level in APP23 and gad mice (p < 0.05) (XREF_FIG).

reach
UCHL1 inhibition led to marked accumulation of mature APP (p < 0.01) (XREF_FIG), whereas overexpression of UCHL1 significantly reduced mature APP level in 20E2 cells (p < 0.05) (XREF_FIG).

reach
Consistently, overexpression of UCHL1 increased the level of ubiquitinated wildtype APP as well (XREF_FIG).
UCHL1 increases the amount of APP. 1 / 1
| 1

reach
Depletion of UCHL1 increases the levels of BACE1, C99, and Abeta in the Uchl1-null gad mice.
UCHL1 affects UCHL1
| 24
UCHL1 increases the amount of UCHL1.
| 12
UCHL1 increases the amount of UCHL1. 10 / 12
| 11

reach
Moreover, SMMC-7721 cells were transfected with UCHL1 overexpression vector; XREF_FIG shows transfection of UCHL1 overexpression vector effectively elevated the expression of UCHL1 in SMMC-7721 cells.

reach
For example, antisense Uchl1 increases UCHL1 protein levels via an embedded inverted SINEB2 element.

reach
AS Uchl1 caused an ~ 1.9-fold increase in UchL1 protein levels while maintaining stable Uchl1 mRNA levels, as expected for a post-transcriptional regulatory mechanism.

reach
PcDNA3.1-UCH-L1 plasmid and UCH-L1 siRNA caused specific and effective up- or down-regulation of UCH-L1 expression, respectively.

reach
25,26 The results of our current study also suggest that the expression of PGP9.5 in lung cancer may play a causative role in the oncogenic transformation of human lung epithelial cells, because 1) PG[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
AS Uchl1 induces UchL1 expression by increasing its translation.

reach
Our prior work revealed that UCH-L1 depletion led to cell death in three independent myeloma cell lines (KMS-11, KMS-18, KMS-28) expressing high levels of UCH-L1, whereas there was no impact on the growth of KMS-12 cells that express low levels [XREF_BIBR].

reach
AS Uchl1 promoted the expression of Uchl1 protein by regulating Uchl1 mRNA, while down-regulated AS Uchl1 expression induced PD disease progression.

reach
The Uchl1 overexpression, induced by intracranial injection of Uchl1 expressing virus, decreases the Abeta production and protects AD model mice against memory impairment.

reach
Given that Gene 33 deletion dramatically up-regulates UCHL1, Cr (VI) tends to promote UCHL1 expression, and that elevated UCHL1 is known to up-regulated in lung cancer, we propose that UCHL1 plays an important role in the early stage of lung epithelial cell transformation and lung tumorigenesis.
Methylated UCHL1 increases the amount of UCHL1. 1 / 1
| 1

reach
Promoter methylation of UCHL1 and restoration of UCHL1 expression by demethylation.
UCHL1 inhibits UCHL1.
| 3
UCHL1 inhibits UCHL1. 3 / 8
| 3

reach
However, there is near-complete loss of UCHL1 in the mossy fiber layer after 2h-HCA, where axon terminals from the depleted dentate granule neurons are located (XREF_FIG).

reach
Notably, the EMT phenotype of Cd transformed cells can be suppressed by forced ectopic expression of UCHL1, suggesting UCHL1 as a crucial modulator in the maintenance of the proper differentiation status in lung epithelial cells.

reach
Consistent with this view, our findings support that parkin mediated K63 linked polyubiquitination of UCH-L1 promotes the degradation of UCH-L1 by the autophagy-lysosome pathway.
UCHL1 decreases the amount of UCHL1.
| 4
UCHL1 decreases the amount of UCHL1. 2 / 5
| 2

reach
XREF_BIBR Also, it has been demonstrated that ciRS-7 can repress Alzheimer 's disease (AD) development by suppressing NF-kappaB protein synthesis and inducing its cytoplasmic localization, promoting UCHL1 expression and UCHL1 induced amyloid precursor protein (APP) and BACE1 ubiquitination and degradation.

reach
To further confirm the role of UCH-L1 in breast cancer cell apoptosis, we used MCF7 and Adr derived cells in which over-expression of UCH-L1 was suppressed by transfection of UCH-L1 siRNA.
Methylated UCHL1 decreases the amount of UCHL1. 1 / 1
| 1

reach
We used HeLa cells because the expression of endogenous UCH-L1 in these cells was blocked by methylation of the UCH-L1 gene XREF_BIBR.
Modified UCHL1 decreases the amount of UCHL1. 1 / 1
| 1

reach
Increased striatal UCHL1 expression is also present in a mouse overexpressing wild-type SNCA and reduced UCHL1 levels reduce neuronal survival.
UCHL1 activates UCHL1.
| 5
UCHL1 activates UCHL1. 5 / 5
| 5

reach
Moreover, overexpression of UCHL1 delays AD progression in mouse models, and UCHL1 gene therapy, to overexpress UCHL1, in the brain potentially could be a promising disease modifying strategy for AD therapeutics.

reach
This is due to very high levels of UCH-L1 which lead to an increase in the UCH-L1 substrate and also more damaged UCH-L1.

reach
This observation is consistent with a recent report that the over-expression of UCH-L1 induces testicular germ cell apoptosis in UCH-L1 transgenic mice.

reach
The loss of Cav-1 and compact myelin proteins following hyperglycemia and NRG treatment was not due to neuronal loss, since the axons remained intact and there was no loss of PGP 9.5, an axonal marker protein.

reach
Furthermore, there is frequent overexpression of PGP9.5 in NSCLC with higher expression correlating with advanced stage malignancy, which suggests involvement of the protein in lung carcinogenesis.
| 25

reach
Here we show that the remodelling process is regulated by the ubiquitin C-terminal hydrolase UCH-L1 that promotes the invasion of epithelial cells by Listeria monocytogenes and Salmonella enterica.

reach
UCHL1 up-regulates beta-catenin signaling and possibly promotes invasion of both Salmonella and Listeria by modulating actin dynamics in the host cell.

reach
Overexpression of UCHL1 in MKN45 and BGC823 cells promoted cell proliferation, migration, and invasion depending on its de-ubiquitinase activity.

reach
Thus, these findings demonstrated that UCH-L1 promotes invasion of breast cancer cells and might serve as a potential therapeutic target for treatment of human patients with breast cancers.

reach
Recently, it has been suggested that UCH-L1 promotes cancer cell motility and invasion, which may contribute to its oncogenic role.

reach
Recently, UCH-L1 has been known to enhance tumor cell invasion and migration capability via the Akt mediated pathway [53].

reach
UCHL1 promotes in vitro clonogenicity, cell proliferation, and invasion.

reach
In non small lung cancer cell line H157, UCHL1 promotes invasion by upstream activation of Akt XREF_BIBR.

reach
We have further demonstrated that knockdown of UCHL1 decreased cell migration and invasion in a manner that was concomitant with less pseudopod formation in a 3D collagen matrix and significantly redu[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Knocking down NOX4 in B16F10 cells significantly reduced both basal and UCH-L1 enhanced invasiveness of cells, suggesting that both inherent and UCH-L1-enhanced invasiveness of B16F10 cells depend on NOX4.

reach
As shown in Figure XREF_FIG, B16F10 cells overexpressing UCH-L1 showed increased ability for invasion, while knocking-down UCH-L1 decreased their invasiveness.

reach
Restoration of UCHL1 inhibited the migration and invasion of NPC cells in vitro and in vivo, and knockdown of UCHL1 promoted NPC cell migration and invasion in vitro and in vivo.

reach
We also found that down-regulation of UCHL1 in MG63 significantly inhibited cell invasion.

reach
In addition, restoration of UCHL1 inhibits tumor invasion and metastasis in vitro and in vivo.
| 1 23
| 21

reach
We propose that C-terminal farnesylation of UCH-L1 facilitates LMP1 loading in exosomes and might promote tumor invasion and metastasis through modulating the cancer microenvironment.

reach
UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction.

reach
These studies suggest that UCH-L1 promotes cancer cell metastasis.

reach
We demonstrated that UCHL1 re-expression promoted the proliferation, migration and metastasis potential of HCT8 cells both in vitro and in vivo.

reach
Most of the cancer studies on UCHL1 have revealed that overexpression and promoter methylation of UCHL1 are key reasons for UCHL1 mediated metastasis.

reach
The de-ubiquitinase UCHL1 promotes gastric cancer metastasis via the Akt and Erk1/2 pathways.

reach
UCHL1 is associated with HIF-1 and distant metastasis in cancer patients, suggesting that UCHL1 may promote metastasis through HIF.

reach
UCHL1 has been shown to promote metastasis via the activation of HIF-1 and its overexpression also correlates with poor prognosis in patients with breast and lung cancers [XREF_BIBR].

reach
Together, these data imply that UCH-L1 promotes cancer cell metastasis via beta-catenin-induced EMT (XREF_FIG).

reach
We used an inhibitor of HIF-1, YC-1, and a plasmid expressing shRNA for HIF-1alpha, shHIF-1alpha, to directly examine the involvement of HIF-1alpha in the formation of pulmonary metastasis enhanced by UCHL1.
| 1 2

eidos
In addition , restoration of UCHL1 inhibits tumor invasion and metastasis in vitro and in vivo .

reach
In addition, restoration of UCHL1 inhibits tumor invasion and metastasis in vitro and in vivo.

reach
They further demonstrated that depletion of UCH-L1 attenuates lung metastasis in vivo in a murine xenograft model [XREF_BIBR].
UCHL1 affects TP53
| 2 20
UCHL1 activates TP53.
| 2 14
UCHL1 activates TP53. 10 / 22
| 2 14

reach
In breast cancer, ectopic expression of UCHL1 is able to induce apoptosis by stabilizing p53.

reach
The results indicated that probably the extrinsic (Fas, Fas-L, Trail, DR4 and DR5) and intrinsic (cytochrome C) apoptotic pathways, the activation of p53 (phospho-Mdm-2 and phospho-p53) and the Bcl-2 family members (pro apoptotic member Bax, anti-apoptotic members Bcl-2 and Bcl-xL) combined with each other, participating in the process of apoptosis induced by UCH-L1 in MCF7 cells.

reach
Interestingly, UCHL1 promotes p53 signaling in nasopharyngeal carcinoma 40 and PADI2 facilitates p53 degradation in breast cancer cells.

reach
It is possible that in cells with wild type p53, UCH-L1 promotes degradation p53, resulting in reduced p53 signaling and inhibition of cell death (XREF_FIG).

reach
Contradictorily, UCHL1 has recently been shown to induce G0/G1 cell cycle arrest and apoptosis by stabilizing p53 and has also been shown to be frequently silenced in primary breast tumors, but not in[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Western blot showed that UCHL1 promoted p53 accumulation in breast tumor cells, along with the reduction of MDM2, while UCHL1 C90S did not increase p53 accumulation, but partly decreased the expression of MDM2 (XREF_FIG).

reach
Further studies are needed to determine specifically how UCH-L1 modulates p53.

reach
Furthermore, using catalytic mutant UCHL1 C90S as a control, the accumulation of p53 mediated by UCHL1 was observed, subsequently, p21, as key p53 downstream target genes and regulators of cell cycle G1/S checkpoint, as well as cleaved-caspase 3 and PARP, were obviously upregulated, accompanied by UCHL1 mediated p53 activation, but not in UCHL1 C90S expressing breast cancer cells.

reach
Studies showed that UCHL1 could induce apoptosis by stabilizing p53 in breast and hepatocellular carcinoma XREF_BIBR, XREF_BIBR, and promote ovarian cancer cell apoptosis associated with Bcl-2 family proteins regulated caspase activation 37.

reach
Western blots again indicated that UCHL1 overexpression in LNCaP cells induces accumulation of p53 whereas MDM2 protein is decreased compared to mock control cell line.
UCHL1 increases the amount of TP53.
| 4
UCHL1 increases the amount of TP53. 3 / 4
| 3

reach
Thus, in breast cancer models, UCHL1 can induce the levels of p53 and reduce mdm2 protein levels.

reach
However, the specific manner in which UCH-L1 modulates p53 level and function remains controversial.

reach
On the contrary, UCH-L1 elevates p53 levels in MDA-MB-231 and HONE1 cells, which express DNA binding domain mutant p53 with little to no transcriptional activity [XREF_BIBR - XREF_BIBR] and LNCaP cells, which have also been reported to express DNA binding domain mutant p53 [XREF_BIBR], although this is controversial [XREF_BIBR].
Modified UCHL1 increases the amount of TP53. 1 / 1
| 1

reach
On the other hand, overexpression of UCH-L1 was reported to increase p53 levels in MDA-MB-231 breast carcinoma cells [XREF_BIBR] and HONE1 nasopharyngeal carcinoma cells [XREF_BIBR].
UCHL1 inhibits TP53.
| 2
UCHL1 inhibits TP53. 2 / 2
| 2

reach
Interestingly, UCHL1 promotes p53 signaling in nasopharyngeal carcinoma 40 and PADI2 facilitates p53 degradation in breast cancer cells.

reach
It is also possible that UCH-L1 indirectly elicits control over p53 by modulating negative regulators of p53, such as mdm2, as suggested by Li et al. [XREF_BIBR].
| 23
| 21

reach
Mutations in the gene encoding alpha-synuclein represent autosomal dominant familial PD, and mutations in genes encoding parkin, UCHL1, DJ-1, PINK1, and LRRK2 cause autosomal recessive familial PD.

reach
SNCA, UCH-L1, and LRRK2 mutations cause autosomal dominant PD and the remaining gene mutations autosomal recessive PD.

reach
For example, in addition to the forms of PD caused by UCH-L1 and parkin mutations (Leroy et al., 1998; Kitada et al., 1998; Shimura et al., 2000), a mutant form of Ub called Ub +1 has been detected in[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
AS Uchl1 promoted the expression of Uchl1 protein by regulating Uchl1 mRNA, while down-regulated AS Uchl1 expression induced PD disease progression.

reach
A missense mutation in the UCH-L1 gene (PARK5), resulting in the amino acid substitution Ile 93 --> Met, can also cause very rare autosomal dominant PD [XREF_BIBR].

reach
The genes SNCA (PARK1), UCHL1 (PARK5), LRRK2 (PARK8), GIGYF2 (PARK11), OMI and HTRA2 (PARK13), VPS35 (PARK17), and EIF4G1 (PARK18) result in autosomal dominant PD, and PRKN (PARK2), DJ-1 (PARK7), ATP13A2 (PARK9), PLA2G6 (PARK14), FBX07 (PARK15), DNJC6 (PARK19), and SYNJ1 (PARK20) causes autosomal recessive PD.

reach
Mutations in alpha-synuclein and UchL1 cause autosomal dominant PD and mutations in parkin and DJ-1 cause autosomal recessive PD.

reach
Mutations in alpha-synuclein XREF_BIBR, parkin XREF_BIBR, DJ-1 XREF_BIBR, PINK-1 XREF_BIBR, UCH-L1 XREF_BIBR, LRRK2 XREF_BIBR, ATP13A2 XREF_BIBR, Omi and HtrA2 XREF_BIBR and NR4A2 XREF_BIBR have been reported to cause familial PD.

reach
No pathological data are currently available.It is not clear why mutations in alpha-synuclein, parkin or UCH-L1 genes cause nigral dopaminergic cell death in familial PD.

reach
In PD, one study presents evidence for mutations in UCH-L1 causing familial PD [XREF_BIBR].
Mutated UCHL1 activates Parkinson Disease. 2 / 2
| 2

reach
Our findings may provide novel insights into the molecular links between alpha-synuclein and UCH-L1 and suggest that aberrant interaction of mutant UCH-L1 with CMA machinery, at least partly, underlies the pathogenesis of PD associated with I93M UCH-L1.

reach
Also, a mutant of UCH-L1, I93M (Ile93 to Met), was shown to cause a type of autosomal dominant PD in one German family XREF_BIBR.
| 2

reach
Accordingly, a mutant form of UCH-L1 with decreased E3 ligase activity upon dimerization, but normal DUB activity, decreases PD pathogenesis.

reach
In conclusion, this study in a Swedish case-control sample demonstrates that the S18Y variant in UCH-L1 decreases risk of PD and in particular PD with age of onset below 50 years of age and further st[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
UCHL1 affects HIF1
| 1 20
UCHL1 activates HIF1.
| 1 18
UCHL1 activates HIF1. 10 / 18
| 1 15

reach
Because HIF-1 activity is known to be regulated at multiple steps, we first aimed to identify the key regulatory mechanism in the UCHL1 mediated activation of HIF-1 in EMT6 cells.

reach
First, we performed a luciferase assay using the 5HRE-luc reporter gene 43, which expresses luciferase bioluminescence in a HIF-1-dependent manner, in order to test whether UCHL1 enhanced HIF-1 activity in EMT6 cells.

reach
The inhibitor of UCHL1, LDN-57444 (XREF_FIG J), blocks the UCHL1-HIF1 axis and therefore inhibits HIF-1 activity as UCHL1 deubiquitinate and stabilizes HIF-1alpha.

reach
These results suggested that the expression of UCHL1 would lead to a poor prognosis by activating HIF-1; therefore, it could be a useful prognostic marker.

reach
We then examined the molecular mechanisms underlying the upregulation of HIF-1 by UCHL1.

eidos
The inhibitor of UCHL1 , LDN-57444 ( Figure 6J ) , blocks the UCHL1-HIF1 axis and therefore inhibits HIF-1 activity as UCHL1 deubiquitinate and stabilizes HIF-1alpha .

reach
In order to fully elucidate the molecular mechanisms underlying the UCHL1 mediated upregulation of HIF-1 activity, further investigation is needed.

reach
We performed a luciferase assay using the 5HREp-luc reporter gene, which expressed firefly luciferase under the control of 5HREp XREF_BIBR XREF_BIBR, to examine whether UCHL1 induced HIF-1 activity.

reach
These results collectively indicate that UCHL1 stabilizes HIF-1alpha protein, and elicits HIF-1 activity in a deubiquitinating activity dependent manner in EMT6 cells.

reach
In the present study, we provided direct evidence to show that UCHL1 was responsible for the deubiquitination of HIF-1alpha and upregulated HIF-1 activity.
UCHL1 bound to HIF1A activates HIF1. 1 / 1
| 1

reach
We revealed that UCHL1 directly interacts with HIF-1alpha, mediates the deubiquitination of HIF-1alpha, and upregulates HIF-1 activity through the stabilization of HIF-1alpha.
UCHL1-C90S activates HIF1. 1 / 1
| 1

reach
The luciferase assay using the 5HRE-luc reporter gene showed that a catalytically inactive mutant of UCHL1, UCHL1 C90S 46, failed to upregulate HIF-1 activity.
Mutated UCHL1 activates HIF1. 1 / 1
| 1

reach
The luciferase assay using the 5HRE-luc reporter gene showed that a catalytically inactive mutant of UCHL1, UCHL1 C90S 46, failed to upregulate HIF-1 activity.
UCHL1 increases the amount of HIF1.
| 2
Modified UCHL1 increases the amount of HIF1. 1 / 1
| 1

reach
The resultant clones, EMT6/EF-Luc/UCHL1 and EMT6/EF-Luc/EV cells, showed that the forced expression of UCHL1 induced the expression of HIF-1alpha and HIF-1 activity (XREF_SUPPLEMENTARY) and enhanced cell migration (XREF_SUPPLEMENTARY), but did not promote cell proliferation in vitro, EF-Luc reporter activity or the growth of tumour xenografts following subcutaneous transplantation (XREF_SUPPLEMENTARY).
UCHL1 increases the amount of HIF1. 1 / 1
| 1

reach
Finally, inhibition of UCHL1 promoted HIF-1alpha degradation and lowered the expression of HIF-1 target genes in the 3D model, as also observed in 2D monolayer culture.
| 1 1 17
UCHL1 activates cell migration.
| 1 13
| 1 12

reach
We found that UCH-L1 expression increases apoptotic resistance in the adenocarcinoma cell line (H838) and promotes cell migration in the H157 squamous cell carcinoma cell line.

reach
UCH-L1 promotes cell migration in H157 cells.

eidos
Moreover , in vitro tumorigenesis studies showed that UCHL1 expression stimulated oncogenesis and an invasive phenotype 117-119 , whereas UCHL1 depletion had antitumour effects and blocked cell migration in a lung cancer cell line 117 .

reach
In our previous report, we demonstrated that UCH-L1 promotes prostate cancer cell migration and invasion through EMT induction [11].

reach
This is consistent with our previous finding in H157 cells that UCH-L1 increases cell migration by modulating Akt activation [XREF_BIBR].

reach
Overexpression of UCH-L1 remodeled its actin cytoskeleton, increased its cell migration and impacted its important proteins.

reach
Moreover, in vitro tumorigenesis studies showed that UCHL1 expression stimulated oncogenesis and an invasive phenotype 117-119 , whereas UCHL1 depletion had antitumour effects and blocked cell migration in a lung cancer cell line 117 .

reach
In the Transwell and wound healing assays, we found that knockdown of UCHL1 significantly reduced cell migration, motility, and invasiveness.

reach
UCH-L1 stimulates prostate cancer cell migration and invasion as well by promoting epithelial-to-mesenchymal transition (EMT) [XREF_BIBR].

reach
We have further demonstrated that knockdown of UCHL1 decreased cell migration and invasion in a manner that was concomitant with less pseudopod formation in a 3D collagen matrix and significantly redu[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
Modified UCHL1 activates cell migration. 1 / 1
| 1

reach
The resultant clones, EMT6/EF-Luc/UCHL1 and EMT6/EF-Luc/EV cells, showed that the forced expression of UCHL1 induced the expression of HIF-1alpha and HIF-1 activity (XREF_SUPPLEMENTARY) and enhanced cell migration (XREF_SUPPLEMENTARY), but did not promote cell proliferation in vitro, EF-Luc reporter activity or the growth of tumour xenografts following subcutaneous transplantation (XREF_SUPPLEMENTARY).
UCHL1 inhibits cell migration.
| 1 4
| 1 3

sparser
Results showed that high level UCHL1-AS1 could effectively inhibit HCC cell migration.

reach
Restoration of UCHL1 inhibited the migration and invasion of NPC cells in vitro and in vivo, and knockdown of UCHL1 promoted NPC cell migration and invasion in vitro and in vivo.

reach
HIF-1alpha silencing was confirmed to suppress the UCHL1 mediated promotion of cell migration in a Transwell migration assay (XREF_FIG).

reach
Silencing UCH-L1, as well as inhibition of H 2 O 2 generation by catalase or by DPI, a NOX inhibitor, suppressed the migration potential of B16F10 cells, indicating that UCH-L1 promotes cell migration by up-regulating H 2 O 2 generation.
Modified UCHL1 inhibits cell migration. 1 / 1
| 1

reach
In this present study it was shown that reduced expression of UCH-L1 in H157 cells led to decreased phosphorylation of MLC2, suggesting that UCH-L1 may be involved in tumour cell migration.
UCHL1 affects AKT
| 1 15
UCHL1 activates AKT.
| 1 9
UCHL1 activates AKT. 9 / 12
| 1 8

reach
While UCH-L1 has been shown to inhibit alpha 2 -adrenergic receptor (AR) agonist mediated activation of ERK via a direct association with alpha 2A -AR receptor implicating a role of UCH-L1 in neuro-protection XREF_BIBR, it has also been documented that UCH-L1 up-regulates oncogenic beta-catenin and TCF and Akt signaling to induce tumor cell proliferation and migration contributing to tumor progression XREF_BIBR, XREF_BIBR.

reach
Nevertheless, stimulation of Akt by UCH-L1 and the subsequent promotion of prosurvival signaling may contribute to the function of UCH-L1 in oncogenesis.

trips
UCHL1 activated Akt and Erk1/2, which process also required enzymatic activity and was necessary for mediating cell migration and invasion.

reach
UCHL1 activated Akt and Erk1/2, which process also required enzymatic activity and was necessary for mediating cell migration and invasion.

reach
Finally, we demonstrated that overexpression of UCH-L1 led to activation of Akt as evidenced by upregulation of phosphorylated Akt.

reach
Additionally, it might be possible that activation of Akt signaling by UCH-L1 [XREF_BIBR, XREF_BIBR] might also contribute to its control over p53, as Akt is an established negative regulator of p53 activity [XREF_BIBR, XREF_BIBR].

reach
These findings demonstrated that UCHL1 promoted cell proliferation, migration, and invasion depending on its de-ubiquitinase activity by activating Akt and Erk1/2, which may account for its higher positive expression rate in liver metastases from gastric cancer.

reach
Together, these data suggest UCH-L1 elicits at least some of its cellular effects through Akt dependent signaling and that stimulation of Akt by UCH-L1 is a potential mechanism of UCH-L1-mediated oncogenesis (XREF_FIG).

reach
Similarly, the deubiquitinating enzyme UCHL1 has been shown to enhance AKT pathway activation by suppressing the levels of PHLPP1 an effect found to drive the development of lymphoma in vivo [206].
Modified UCHL1 activates AKT. 1 / 1
| 1

reach
As expected, overexpression of UCHL1 significantly enhanced cardiomyocyte size, the mRNA level of ANF, and the protein levels of EGFR, and phosphorylated EGFR, AKT, and EKR1/2 compared with coinfection with Ad-GFP and siRNA-control after PE stimulation; moreover, this effect was markedly attenuated by coinfection with Ad-GFP or Ad-UCHL1 and siRNA-EGFR.
UCHL1 inhibits AKT.
| 4
UCHL1 inhibits AKT. 4 / 5
| 4

reach
These data provide the first in vivo evidence for DUB driven oncogenesis and suggest that UCH-L1 hyperactivity deregulates normal Akt signaling.

reach
Our data suggest that PI3K and Akt pathway is possibly involved in apoptosis in breast cancer cells and blocked by UCH-L1.

reach
Taken together, it appears that UCHL1 suppresses the growth of LNCaP cells via stabilization of tumour suppressor protein such as p53 and by inactivating AKT and PKB pathway.

reach
Taken together, it appears that UCHL1 suppresses the growth of LNCaP cells via stabilization of tumour suppressor protein such as p53 and by inactivating AKT and PKB pathway.
UCHL1 increases the amount of AKT.
| 1
UCHL1 increases the amount of AKT. 1 / 1
| 1

reach
We also observed that silencing of UCH-L1 decreased the phosphorylation level of Akt and PCNA in the xenograft experiments.
UCHL1 decreases the amount of AKT.
| 1
UCHL1 decreases the amount of AKT. 1 / 1
| 1

reach
Knockdown of UCHL1 markedly reduced the protein levels of total EGFR and phosphorylated EGFR, AKT, and ERK1/2, with no effect on the EGFR mRNA level compared with the siRNA-controls after saline or PE stimulation.
UCHL1 affects translation
| 1 17
UCHL1 activates translation.
| 1 16
| 1 16

reach
Antisense Uchl1 RNA promotes association of Uchl1 mRNA with active polysomes and enhances protein translation.

reach
The mature lncRNA contains a 73-nucleotide complementary site with the 5 ' end of the Uchl1 mRNA, which serves to upregulate translation of Uchl1 mRNA [XREF_BIBR].

reach
Antisense Uchl1 specifically promotes the translation of UCHL1 under rapamycin treatment.

reach
In addition, another lncRNA antisense Uchl1, which activates uchl1 translation through the embedded SINEB2 repeat, also enhances the association of Uchl1 mRNA to active polysomes XREF_BIBR.

reach
Exact molecular mechanism as to how AS Uchl1 promotes the translation of Uchl1 mRNA under stress conditions is still elusive.

reach
A neuron specific antisense lncRNA, AS Uchl1, could specifically induce the translation of ubiquitin carboxyl-terminal esterase L1 (Uchl1) under certain stress conditions through its complementarity with target mRNA [XREF_BIBR].

reach
In a similar case, this new mechanism was also proposed by one previous work which reported that the uchl1 gene lncRNA enhances the translation of its target mRNA via base pairing and by recruiting additional ribosomes via the functional element.

sparser
In addition, another lncRNA antisense Uchl1, which activates uchl1 translation through the embedded SINEB2 repeat, also enhances the association of Uchl1 mRNA to active polysomes xref .

reach
TINCR is induced during epidermal differentiation and is required for stability of differentiation mediators and antisense Uchl1 lncRNA promotes translation of Uchl1 in mouse.

reach
Under stress conditions where cap dependent translation is inhibited, antisense Uchl1 IncRNA, previously enriched in the nucleus, moves into the cytoplasm and hybridizes with Uchl1 mRNA to enable cap independent translation of Uchl1.
UCHL1 inhibits translation.
| 1
| 1

reach
Under cap dependent translation inhibition due to stress, UCHL1 lncRNA moves from the nucleus to the cytoplasm, binds to Uchl1 mRNA and allows its cap independent translation.
UCHL1 affects cell cycle
| 16
UCHL1 inhibits cell cycle.
| 8
| 8

reach
Furthermore, cell cycle analysis revealed up-regulation of S phase both in A2780-shUCHL1 and IGROV1-shUCHL1, indicating that UCHL1 knockdown promoted cell proliferation by progressing cell cycle.

reach
Other recent studies have found that UCHL1 could promote tumor cell proliferation and inhibit cell cycle arrest XREF_BIBR, which are involved in the development of chemoresistance in cervical cancer and pancreatic cancer XREF_BIBR, XREF_BIBR.

reach
Restoring UCHL1 expression in silenced cell lines significantly inhibited their growth and colony formation ability by inhibiting cell proliferation, causing cell cycle arrest in G2/M phase and inducing apoptosis through the intrinsic caspase dependent pathway.

reach
Suppression of UCHL1 protein level by LDN-5744 inhibitor could arrest the cell cycle in G1 phase in cell lines.

reach
Targeting UCHL1 Induces Cell Cycle Arrest in High-Risk Multiple Myeloma with t (4; 14).

reach
Our data showed a low expression of Uch-L1 in UT-B null bladder epithelium and supports that inhibition of Uch-L1 induced cell cycle arrest and apoptosis XREF_BIBR, XREF_BIBR, XREF_BIBR.

reach
Bheda et al. presented a series of genes regulated by UCH-L1 using microarray and quantitative real-time PCR analysis, and they found that the inhibition of UCH-L1 activated genes controlling apoptosi[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
We showed that knockdown of UCHL1 in ovarian cancer cells promoted cell proliferation by inducing S phase cell cycle and reduced apoptosis.
UCHL1 activates cell cycle.
| 8
| 8

reach
Contradictorily, UCHL1 has recently been shown to induce G0/G1 cell cycle arrest and apoptosis by stabilizing p53 and has also been shown to be frequently silenced in primary breast tumors, but not in[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
UCHL1 has been observed to be epigenetically regulated in other cancers, and is believed to induce G0/G1 cell cycle arrest and apoptosis by stabilization of p53.

reach
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.

reach
UCHL1 promoted cell cycle progression and DNA repair through regulating TS.

reach
Suppression of UCHL1 protein level by LDN-5744 inhibitor could arrest the cell cycle in G1 phase in cell lines.

reach
UCH-L1 has been shown to modulate the levels of several cell cycle regulators in cancer cells including cyclin D [XREF_BIBR] and p53 [XREF_BIBR].

reach
The related mechanisms for this resistance appear to involve UCHL1 promoting cell cycle progression and DNA repair.

reach
The Ubiquitin Peptidase UCHL1 Induces G0/G1 Cell Cycle Arrest and Apoptosis Through Stabilizing p53 and Is Frequently Silenced in Breast Cancer.
UCHL1 affects SNCA
| 16
UCHL1 inhibits SNCA.
| 6
UCHL1 inhibits SNCA. 6 / 6
| 6

reach
As an example, inhibition of UCHL-1 in rat ventral mesencephalic neurons induces intracellular alpha-synuclein aggregates (McNaught et al., 2002a).

reach
In addition, UCH-L1 inhibition by LDN-57444 treatment also enhanced cell-to-cell transmission of alpha-synuclein (XREF_FIG).

reach
Severing UCHL1 from the membrane might increase the degradation of alpha-synuclein, effectively reducing levels of this aggregation-prone protein and alleviating neuronal stress.

reach
Membrane associated UCH-L1 has been reported to promote alpha-syn neurotoxicity by possibly negatively regulating the lysosomal degradation of alpha-syn.

reach
Severing UCHL1 from the membrane might increase degradation of alpha-synuclein, effectively reducing levels of this aggregation-prone protein and alleviating neuronal stress.

reach
The mechanism of icariin may be related to upregulate Parkin and UCH-L1 expression in ubiquitin-proteasome system and HSP70 in molecular chaperone, thus enhancing the degradation of alpha-synuclein.
UCHL1 activates SNCA.
| 5
UCHL1 activates SNCA. 5 / 5
| 5

reach
The UCH-L1 ligase activity could produce an elevation of the cytoplasmic concentration of alpha-synuclein by inhibiting its " normal " degradation.

reach
Fractions containing both UCH-L1 and alpha-synuclein were treated with a UCH-L1 antibody (Chemicon, rabbit polyclonal), an alpha-synuclein antibody (Transduction Lab), or buffer (as a control), and th[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
UCH-L1, especially those variants linked to higher susceptibility to PD, causes the accumulation of alpha-synuclein in cultured cells, an effect that can not be explained by its recognized hydrolase activity.

reach
This result indicates that UCH-L1 transfection does not increase alpha-synuclein expression and that accumulation of alpha-synuclein resulted from inhibition of its degradation.

reach
This further sustains the notion that UCH-L1 plays a pathological role in inclusion formation, e.g., in PD, and may modulate the turnover of alpha-syn.
UCHL1 increases the amount of SNCA.
| 4
UCHL1 increases the amount of SNCA. 3 / 3
| 3

reach
Reduction of UCH-L1 (M) in cell culture models of alpha-synuclein toxicity by treatment with a farnesyltransferase inhibitor (FTI-277) reduces alpha-synuclein levels and increases cell viability.

reach
Chemical inhibition of UCHL1 by farnesylation may reduce alpha-synuclein levels and improve neuronal cell viability in cellular models of alpha-synuclein-associated toxicity for PD.

reach
In this line, in vitro studies using a crude cell-free system where alpha-synuclein was conjugated to histidine tagged ubiquitin revealed that the addition of UCHL-3 had little effect, whereas the add[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
Farnesylated UCHL1 increases the amount of SNCA. 1 / 1
| 1

reach
Chemical inhibition of UCHL1 farnesylation reduces the cellular level of alpha-synuclein and thus improves neuronal cell viability.
UCHL1 decreases the amount of SNCA.
| 1
UCHL1 decreases the amount of SNCA. 1 / 1
| 1

reach
Since UCHL1 inhibition increases cytoplasmic alpha-synuclein levels, UCHL1 mutation might interfere with vesicular catecholamine storage in a manner similar to that in PARK1 and PARK4.
UCHL1 affects CDKN1A
| 16
UCHL1 activates CDKN1A.
| 8
UCHL1 activates CDKN1A. 8 / 8
| 8

reach
In the present study, there are several novel findings regarding UCH-L1 as a negative regulator of maladaptive cardiac remodeling and dysfunction as follows : (i) UCH-L1 expression is enhanced in cardiac myocytes and fibroblasts during the earlier stage of cardiac adaptive hypertrophy and declined in the process of maladaptive responses to the sustained hemodynamic stress; (ii) UCH-L1 inhibits cardiac fibroblast proliferation via suppressing PDGF and PDGFRbeta signaling; (iii) UCH-L1 preferentially enhances PDGF-BB-induced suppression autophagic clearance of p21 WAF1 and Cip1 proteins in cardiac fibroblasts.

reach
In the present study, there are several novel findings regarding UCH-L1 as a negative regulator of maladaptive cardiac remodeling and dysfunction as follows : (i) UCH-L1 expression is enhanced in cardiac myocytes and fibroblasts during the earlier stage of cardiac adaptive hypertrophy and declined in the process of maladaptive responses to the sustained hemodynamic stress; (ii) UCH-L1 inhibits cardiac fibroblast proliferation via suppressing PDGF and PDGFRbeta signaling; (iii) UCH-L1 preferentially enhances PDGF-BB-induced suppression autophagic clearance of p21 WAF1 and Cip1 proteins in cardiac fibroblasts.

reach
Of interest, overexpression of UCH-L1 enhanced the PDGF-BB-induced posttranscriptional upregulation of p21 WAF1 and Cip1 protein in cardiac fibroblasts (XREF_FIG), suggesting that UCH-L1 inhibits cardiac fibroblast proliferation via posttranscriptional enhancing the expression of p21 WAF1 and Cip1 to suppress the transition of G1 to S phase.

reach
UCH-L1 enhances PDGF-BB-induced upregulation of p21 WAF1 and Cip1 proteins via suppressing autophagic clearance of p21 WAF1 and Cip1 independent of ubiquitin-proteasomal system (UPS)-mediated protein degradation.

reach
UCH-L1 enhances PDGF-BB-induced upregulation of p21 WAF1 and Cip1 proteins via suppressing autophagic clearance of p21 WAF1 and Cip1 independent of ubiquitin-proteasomal system (UPS)-mediated protein degradation.

reach
To explore the underlying mechanism by which UCH-L1 enhances PDGF-BB-induced posttranscriptional upregulation of p21 WAF1 and Cip1, we determined a potential role of UCH-L1 in regulating p21 clearance by UPS and autophagy, two major pathways in the posttranscriptional control of protein levels XREF_BIBR.

reach
Of interest, overexpression of UCH-L1 enhanced the PDGF-BB-induced posttranscriptional upregulation of p21 WAF1 and Cip1 protein in cardiac fibroblasts (XREF_FIG), suggesting that UCH-L1 inhibits cardiac fibroblast proliferation via posttranscriptional enhancing the expression of p21 WAF1 and Cip1 to suppress the transition of G1 to S phase.

reach
To explore the underlying mechanism by which UCH-L1 enhances PDGF-BB-induced posttranscriptional upregulation of p21 WAF1 and Cip1, we determined a potential role of UCH-L1 in regulating p21 clearance by UPS and autophagy, two major pathways in the posttranscriptional control of protein levels XREF_BIBR.
UCHL1 increases the amount of CDKN1A.
| 5
UCHL1 increases the amount of CDKN1A. 4 / 4
| 4

reach
We further found that UCHL1 induced p53 accumulation and reduced MDM2 protein level, and subsequently upregulated the expression of p21, as well as cleavage of caspase3 and PARP, but not in catalytic mutant UCHL1 C90S expressed cells.

reach
However, in the presence of MG132, PDGF-BB was still able to upregulate p21 WAF1 and Cip1 protein levels while overexpression of UCH-L1 enhanced not only the PDGF-BB-induced upregulation of p21 WAF1 and Cip1 protein in presence of MG132 but also the basal increased p21 WAF1 and Cip1 protein level induced by MG132 per se (XREF_FIG, XREF_SUPPLEMENTARY).

reach
Taken together, these findings demonstrate that UCH-L1 potentiates PDGF-BB-induced upregulation of p21 WAF1 and Cip1 protein expression via suppressing autophagic protein clearance in cardiac fibroblasts.

reach
These results suggest that UCH-L1 enhance PDGF-BB-induced p21 WAF1 and Cip1 protein expression via suppressing autophagy activation by increasing mTOR activity.
Modified UCHL1 increases the amount of CDKN1A. 1 / 1
| 1

reach
Overexpression of UCH-L1 enhanced PDGF-BB-induced mTOR phosphorylation and upregulation of p21 WAF1 and Cip1 protein expression while suppressed autophagic flux in cardiac fibroblasts.
UCHL1 decreases the amount of CDKN1A.
| 2
UCHL1 decreases the amount of CDKN1A. 2 / 2
| 2

reach
In contrast, UCHL1 silencing or inhibition in PEM-R cells decreased the levels of c-Myc and Cyclin D1 and increased the levels of p21 (a cell cycle arrest related protein).

reach
We further found that UCHL1 induced p53 accumulation and reduced MDM2 protein level, and subsequently upregulated the expression of p21, as well as cleavage of caspase3 and PARP, but not in catalytic mutant UCHL1 C90S expressed cells.
UCHL1 inhibits CDKN1A.
| 1
UCHL1 inhibits CDKN1A. 1 / 1
| 1

reach
Thus, whether UCH-L1 regulates these molecular events to suppress autophagic clearance of p21 WAF1 and Cip1 proteins deserves further investigation in cardiac fibroblasts.
UCHL1 affects CTNNB1
| 6
UCHL1 activates CTNNB1. 6 / 14
| 6

reach
These observations imply that UCHL1 may contribute to CRC progression by activating the beta-catenin and TCF pathway through its deubi quitinating activity.

reach
UCHL1 up-regulates beta-catenin signaling and possibly promotes invasion of both Salmonella and Listeria by modulating actin dynamics in the host cell.

reach
Aberrant expression of UCHL1 in pediatric high-grade gliomas may promote cell invasion, transformation, and self-renewal properties, at least in part, by modulating Wnt and Beta catenin activity.

reach
In contrast, other studies have documented that UCH-L1 up-regulates beta-catenin and TCF via a positive feedback mechanism or exerts anti-apoptotic and growth stimulating effects, supporting an oncogenic potential of UCH-L1 [XREF_BIBR, XREF_BIBR].

reach
Of note, UCHL1 also promotes the activity of the WNT pathway by stabilizing beta-catenin.

reach
While UCH-L1 has been shown to inhibit alpha 2 -adrenergic receptor (AR) agonist mediated activation of ERK via a direct association with alpha 2A -AR receptor implicating a role of UCH-L1 in neuro-protection XREF_BIBR, it has also been documented that UCH-L1 up-regulates oncogenic beta-catenin and TCF and Akt signaling to induce tumor cell proliferation and migration contributing to tumor progression XREF_BIBR, XREF_BIBR.
UCHL1 affects NOX4
| 1 7
UCHL1 activates NOX4.
| 1 6
UCHL1 activates NOX4. 7 / 13
| 1 6

reach
These results suggest that UCH-L1 restores H 2 O 2 -generating activity of NOX4 through deubiquitination.

sparser
To verify whether UCH-L1 is involved in NOX4-mediated HO generation in HUVEC, we examined NOX4 activation by UCH-L1.

reach
Because silencing UCH-L1 inhibited the phosphorylation of VEGFR, a signal for angiogenesis, this finding provides another evidence that UCH-L1 promotes ROS generation in HUVECs, and plays a key role i[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
UCH-L1 induced active NOX4 by deubiquitination of NOX4, and then increased ROS which induce angiogenesis in HUVECs.

reach
The present study clearly shows that UCH-L1 increases H 2 O 2 level in HUVECs as well as in melanoma cells by activating NOX4 via deubiquitination [13].

reach
In summary, we demonstrated that UCH-L1 promotes H 2 O 2 generation by up-regulating NOX4 activity through deubiquitination, and that H 2 O 2, so produced, plays an important role in cell invasion in vitro by regulating the upstream kinase Akt.

reach
Here we demonstrated that UCH-L1-dependent NOX4 is involved in VEGF mediated endothelial responses through VEGFR2, suggesting that UCH-L1 may be a novel potential therapeutic target in the treatment o[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
UCHL1 inhibits NOX4.
| 1
UCHL1 inhibits ubiquitinated NOX4. 1 / 1
| 1

reach
UCH-L1 decreases ubiquitinated NOX4.
UCHL1 affects BACE1
| 13
UCHL1 inhibits BACE1.
| 6
UCHL1 inhibits BACE1. 5 / 5
| 5

reach
Our data also suggest that ciRS-7 modulates APP and BACE1 levels in a nuclear factor-kappaB (NF-kappaB)-dependent manner : ciRS-7 expression inhibits translation of NF-kappaB and induces its cytoplasmic localization, thus derepressing expression of UCHL1, which promotes APP and BACE1 degradation.

reach
Specifically, UCH-L1 appears to increase lysosomal degradation of BACE1, as inhibition of UCH-L1 caused a significant increase in BACE1 protein levels in several cell types, and loss of UCH-L1 gene function in gad mice significantly increased levels of endogenous BACE1, C99, and Abeta peptides [XREF_BIBR, XREF_BIBR].

reach
In this study we demonstrated that Uch-L1 inhibition induces BACE1 up-regulation and increases neuronal and apoptotic cell death in control as well as in transgenic AD mouse model subjected to Bengal Rose, a light sensitive dye inducing that induces a cortical infarction through photo activation.

reach
In this study we demonstrated that the inhibition of Uch-L1 induces BACE1 up-regulation and increases neuronal cell death in control as well as in AD transgenic mouse models subjected to Bengal Rose, a light sensitive dye inducing a cortical infarction through photo activation.

reach
These results demonstrated that UCHL1 accelerates BACE1 degradation and affects APP processing and Abeta production.
Modified UCHL1 inhibits BACE1. 1 / 1
| 1

reach
Moreover, overexpression of UCHL1 reduces the levels of beta-secretase BACE1, and consequent BACE1 cleavage products (APP C-terminal fragment C99 and Abeta).
UCHL1 decreases the amount of BACE1.
| 5
UCHL1 decreases the amount of BACE1. 4 / 5
| 4

reach
This study suggests that potentiation of UCHL1 might be able to reduce the level of BACE1 and Abeta in brain, which makes it a novel target for AD drug development.

reach
The restoration of Uch-L1 was able to completely prevent the increase of BACE1 protein levels both in control and Tg mice at 6 h post injury, as reported by the representative blot and by the densitometric analysis.

reach
Thus, the restoration of Uch-L1 was able to completely prevent both the increase in BACE1 protein levels and the amount of cell death.

reach
We found that inhibition of UCHL1 significantly increased BACE1 protein level in a time dependent manner.
Modified UCHL1 decreases the amount of BACE1. 1 / 1
| 1

reach
Moreover, overexpression of UCHL1 reduces the levels of beta-secretase BACE1, and consequent BACE1 cleavage products (APP C-terminal fragment C99 and Abeta).
UCHL1 increases the amount of BACE1.
| 1
UCHL1 increases the amount of BACE1. 1 / 1
| 1

reach
Depletion of UCHL1 increases the levels of BACE1, C99, and Abeta in the Uchl1-null gad mice.
UCHL1 activates BACE1.
| 1
UCHL1 activates BACE1. 1 / 1
| 1

reach
Besides, UCHL1 could promote BACE1 (beta-amyloid cleavage enzyme 1) degradation and decrease Abeta production in vivo and in vitro (Zhang et al., 2012).
UCHL1 affects cell death
| 13
UCHL1 inhibits cell death.
| 7
| 7

reach
Targets for miR-181b include heat shock protein A5 (HSPA5) and ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1), and expression of miR-181b in N2A cells repressed HSPA5 and UCHL1 and protected cells against OGD induced cell death.

reach
UCHL1 mediated cell death can be attenuated by mitochondrial protein HTRA2 [XREF_BIBR], ATP13A2 regulates mitochondrial bioenergetics through macroautophagy [XREF_BIBR], VPS35 mediates vesicle transport between mitochondria and peroxisomes [XREF_BIBR], and EIF4G1 is involved in stress related protection of mitochondria [XREF_BIBR].

reach
Restoration of Uch-L1 Corrects the BACE1 Induction and Prevents Cell Death.

reach
In this study we demonstrated that Uch-L1 inhibition induces BACE1 up-regulation and increases neuronal and apoptotic cell death in control as well as in transgenic AD mouse model subjected to Bengal Rose, a light sensitive dye inducing that induces a cortical infarction through photo activation.

reach
As shown in Figure XREF_FIG D, UCHL1 shRNA 2 and 3 treatments reversed the increased cell death rate induced by cPKCgamma gene knockout in 1-hr OGD/24-hr R treated neurons (P < 0.001, n = 6 per group).

reach
Expression of UCH-L1 was decreased by siRNA in both cell lines, resulting in increased cell death in H838 adenocarcinoma cells but not in the H157 squamous cell line.

reach
Inhibition of UCH-L1 activity induces the aggregation of Ub-proteins and enhances cell death in primary neurons.
UCHL1 activates cell death.
| 6
| 6

reach
To determine whether a decrease in UCH-L1 exacerbates h-IAPP-induced apoptosis, we transfected INS 832/13 cells with UCH-L1 siRNA or scramble (25 nmol/l, 36 h) and transduced these cells with h-IAPP or r-IAPP adenoviruses at 300 MOI for 30 h. Under these conditions, neither UCH-L1 siRNA nor h-IAPP alone induced cell death as illustrated by cleaved caspase-3 and cleaved PARP levels or caspase-3 activity (data not shown).

reach
Down-regulation of endogenous UCHL1 in mouse N2a neuroblastoma cells increases cell death induced by oxygen-glucose deprivation.

reach
The caspase mediated apoptosis in E-64-treated fibroblasts was reversed by transfection with a UCH-L1 plasmid, and increased after downregulation of UCH-L1 by siRNA, suggesting that UCH-L1 deficiency and impairment of the ubiquitin dependent protein degradation pathway can contribute to the increased cell death observed in many lysosomal storage disorders.

reach
Thus, down-regulation of Uch-L1 induces the aggregation of ubiquitinated proteins and promotes cell death in neurons.

reach
Mutation of the C152 CyPG adduction site of UCH-L1, the site identified with conformational change of the protein with CyPG adduction, afforded protection from 15dPGJ2 induced cell death in primary cortical neurons.

reach
The CTTDelta4 truncation provides a useful new tool for studying how UCH-L1 misfolding and dysfunction lead to protein instability and cell death, which pathways are involved, and what measures can be taken to reduce or prevent toxicity.
UCHL1 affects EGFR
| 12
UCHL1 increases the amount of EGFR.
| 3
UCHL1 increases the amount of EGFR. 1 / 2
| 1

reach
In addition, knockdown of UCHL1 increased EGFR polyubiquitination and decreased the EGFR level with or without EGF stimulation.
Modified UCHL1 increases the amount of EGFR. 2 / 2
| 2

reach
As expected, overexpression of UCHL1 (WT) significantly abrogated EGFR ubiquitination and increased EGFR levels, whereas this effect was reversed by UCHL1 (C90S; XREF_FIG).

reach
As expected, overexpression of UCHL1 significantly enhanced cardiomyocyte size, the mRNA level of ANF, and the protein levels of EGFR, and phosphorylated EGFR, AKT, and EKR1/2 compared with coinfection with Ad-GFP and siRNA-control after PE stimulation; moreover, this effect was markedly attenuated by coinfection with Ad-GFP or Ad-UCHL1 and siRNA-EGFR.
UCHL1 activates EGFR.
| 4
UCHL1 activates EGFR. 3 / 3
| 3

reach
Together, these data highlight the importance of the UCHL1 mediated posttranslational mechanism of EGFR in cardiomyocytes in vitro and in vivo.

reach
Together, these results indicate that UCHL1 mediates cardiac hypertrophy and remodeling through deubiquitination and stabilization of EGFR in vivo.

reach
To further examine whether overexpression of UCHL1 in cardiomyocytes accelerates hypertrophy and dysfunction by influencing the stability of EGFR in vivo, we generated cardiomyocyte specific UCHL1 overexpressing and EGFR knockdown mice by injection with rAAV9-UCHL1 and rAAV9-siEGFR or their corresponding controls because EGFR full-knockout mice exhibit embryonic lethality.
Modified UCHL1 activates phosphorylated EGFR. 1 / 1
| 1

reach
As expected, overexpression of UCHL1 significantly enhanced cardiomyocyte size, the mRNA level of ANF, and the protein levels of EGFR, and phosphorylated EGFR, AKT, and EKR1/2 compared with coinfection with Ad-GFP and siRNA-control after PE stimulation; moreover, this effect was markedly attenuated by coinfection with Ad-GFP or Ad-UCHL1 and siRNA-EGFR.
UCHL1 decreases the amount of EGFR.
| 3
UCHL1 decreases the amount of EGFR. 2 / 2
| 2

reach
Knockdown of UCHL1 significantly enhanced EGFR ubiquitination but decreased the EGFR level compared with the siRNA-control (XREF_FIG).

reach
Knockdown of UCHL1 markedly reduced the protein levels of total EGFR and phosphorylated EGFR, AKT, and ERK1/2, with no effect on the EGFR mRNA level compared with the siRNA-controls after saline or PE stimulation.
UCHL1 decreases the amount of phosphorylated EGFR. 1 / 1
| 1

reach
Knockdown of UCHL1 markedly reduced the protein levels of total EGFR and phosphorylated EGFR, AKT, and ERK1/2, with no effect on the EGFR mRNA level compared with the siRNA-controls after saline or PE stimulation.
UCHL1 inhibits EGFR.
| 2
UCHL1 inhibits EGFR. 2 / 2
| 2

reach
As our preceding data showed that UCHL1 interacted with and stabilized EGFR (XREF_FIG to XREF_FIG), we next tested whether UCHL1 promotes cardiac hypertrophy by selectively targeting EGFR and the downstream signaling pathway.

reach
Knockdown of UCHL1 significantly decreased the half-life of EGFR protein compared with the control group (XREF_FIG), whereas its half-life was markedly increased in Ad-UCHL1-infected NRCMs compared with the Ad-GFP control (XREF_FIG).
UCHL1 affects mTORC1
| 1 3 6
UCHL1 inhibits mTORC1.
| 1 1 5
UCHL1 inhibits mTORC1. 7 / 9
| 1 1 5

reach
We find that UCH-L1 impairs mTORC1 activity toward S6 kinase and 4EBP1 while increasing mTORC2 activity toward Akt.

trips
Here, we show that the ubiquitin hydrolase UCH-L1 regulates the balance of mTOR signaling by disrupting mTORC1.

reach
The inhibition of mTORC1 by rapamycin increased UCHL1 protein levels by AS Uchl implied a mechanism of antisense lncRNAs in the control of cellular stress signaling pathways and their roles in neurodegenerative diseases [57].

reach
The inhibition of mTORC1 by rapamycin increased UCHL1 protein levels by AS Uchl implied a mechanism of antisense lncRNAs in the control of cellular stress signaling pathways and their roles in neurodegenerative diseases [XREF_BIBR].

eidos
Consistently , in C2C12 cells , UCHL1 knockdown increased the myotube size , enhanced mTORC1 activity , and reduced mTORC2 activities as compared with control cells .

reach
For example, DDB1 and CUL4 mediated polyubiquitination of Raptor enhances the stability and activity of the mTORC1 complex, which can be antagonized by the ubiquitin hydrolase UCH-L1 [XREF_BIBR, XREF_BIBR].
| PMC

reach
Consistently, in C2C12 cells, UCHL1 knockdown increased the myotube size, enhanced mTORC1 activity, and reduced mTORC2 activities as compared with control cells.
UCHL1 activates mTORC1.
| 2 1
UCHL1 activates mTORC1. 3 / 3
| 2 1

eidos
Overall , these results suggest that UCHL1 elicits a negative effect on mTORC1 and a positive effect on mTORC2 activity in slow twitch skeletal muscle .

eidos
Of note , in vivo , UCHL1 deletion does not lead to a significant and constitutive activation of mTORC1 at rest , but enhances the mTORC1 activity in response to insulin stimulation .

reach
Meanwhile, UCHL1 skmKO enhanced mTORC1 activity and reduced mTORC2 activity in soleus but not in EDL.
UCHL1 affects cell growth
| 1 10
UCHL1 inhibits cell growth.
| 1 7
| 1 7

sparser
Our results have shown that UCHL1 inhibited LNCaP cell growth.

reach
25 The conclusion from these data was that UCH-L1 is an inhibitor of tumor cell growth.

reach
Furthermore, UCHL1 knockdown in ovarian cancer cell lines A2780 and IGROV1 promoted cell growth while causing reduction of apoptosis.

reach
Ectopic UCHL1 expression in breast tumor cells suppresses cell growth, induces G0/G1 arrest and apoptosis through disrupting p53 signaling, depending on its deubiquitinase (DUB) activity, suggesting that UCHL1 is a functional tumor suppressor and potential tumor marker for this cancer.

reach
As shown in XREF_FIG, elevated UCH-L1 expression in MCF7 cells suppressed cell growth, while knockdown of UCH-L1 in MCF7 and Adr cells led to the opposite effect when compared with negative controls.

reach
Our results have shown that UCHL1 inhibited LNCaP cell growth.

reach
Our loss of function studies using these pediatric high-grade gliomas cell lines showed that UCHL1 promoted cell growth, invasiveness, and self-renewal characteristics in vitro.

reach
Ectopic UCHL1 expression in breast tumor cells suppresses cell growth and induces G0/G1 arrest and apoptosis through p53 signaling due to its DUB activity [39].
UCHL1 activates cell growth.
| 3
| 3

reach
UCHL1 over-expression has been reported to induce cell growth arrest in prostate cancer XREF_BIBR and breast cancer XREF_BIBR, XREF_BIBR.

reach
While exploring the mechanism by which UCH-L1 promotes cell growth and survival in B-cell malignancies, we observed a striking effect of UCH-L1 on the Akt signaling pathway.

reach
A role for UCHL1 in proliferation is consistent with the pro oncogenic functions of UCHL1 in various cancers [34] and the findings that in lymphoma cells UCHL1 knockdown decreases cellular growth and [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
UCHL1 affects autophagy
| 2 8
UCHL1 inhibits autophagy.
| 2 6
| 2 6

reach
These data suggest that inhibition of UCH-L1 activity induces activation of the autophagy pathway in a-syn tg mice but not in non tg mice.

reach
Down-regulation of UCHL1 mediated by cPKCgamma decreased OGD induced autophagy through ERK-mTOR pathway.

reach
However, we speculate that the aminochrome induced modification of UCH-L1 also impairs CMA autophagy.

reach
A mutation in ubiquitin C-terminal hydrolase L1 (UCH-L1), which is associated with familial PD, was reported to inhibit CMA autophagy by interacting with the lysosomal receptor of CMA LAMP-2A [XREF_BIBR].

reach
In summary, our results indicate that down-regulation of UCHL1 mediated by cPKCgamma may negatively regulate autophagy through ERK-mTOR pathway, which alleviates ischaemic neuronal injury.

sparser
Mutated UCH-L1 also inhibits CMA autophagy by interacting with the lysosomal receptor for CMA LAMP-2A [ xref ].

sparser
Unfolded UCHL1 also may inhibit autophagy under pathological conditions ( xref ; xref ) UCHL1 closely interacts with proteins of the neuronal cytoskeleton and may regulate axonal transport and maintain axonal integrity ( xref ; xref ).

reach
Inhibition of UCH-L1 causes the upregulation of autophagy, which is involved in the removal of alpha-syn aggregates.
UCHL1 activates autophagy.
| 2
| 2

reach
Furthermore, in the context of a-syn-induced pathology, modulation of UCH-L1 activity could serve as a therapeutic tool to enhance the autophagy pathway and induce clearance of the observed accumulated and aggregated a-syn species in the PD brain.

reach
In conclusion, our results suggest that cPKCgamma activation alleviates ischaemic injuries of mice and cortical neurons through inhibiting UCHL1 expression, which may negatively regulate autophagy through ERK-mTOR pathway.
TNF affects UCHL1
| 9
TNF increases the amount of UCHL1.
| 5
TNF increases the amount of UCHL1. 5 / 7
| 5

reach
While TNFalpha dramatically enhanced UCH-L1 protein expression in vehicle treated RASMCs over-expressed with UCH-L1, it could not up-regulate UCH-L1 protein expression in cycloheximide treated cells (XREF_FIG).

reach
Presumably, TNFalpha is able to up-regulate UCH-L1 protein levels in RASMCs that UCH-L1 gene translation is blocked by cycloheximine if TNFalpha inhibits UCH-L1 degradation.

reach
Taken together, we demonstrate that TNFalpha upregulates UCH-L1 protein expression by enhancing UCH-L1 translation rather than inhibiting its degradation in VSMCs.

reach
These results suggest that TNFalpha up-regulates UCH-L1 protein levels by inhibiting UCH-L1 degradation and/or increasing UCH-L1 translation.

reach
However, Western blot analysis with a long time exposure revealed that TNFalpha stimulation slightly increased UCH-L1 protein expression (XREF_FIG).
TNF activates UCHL1.
| 4
TNF activates UCHL1. 4 / 5
| 4

reach
These results suggest that TNFalpha up-regulates UCH-L1 protein via a posttranscriptional regulation in VSMCs.

reach
Presumably, TNFalpha is able to up-regulate UCH-L1 protein levels in RASMCs that UCH-L1 gene translation is blocked by cycloheximine if TNFalpha inhibits UCH-L1 degradation.

reach
These results indicate that TNFalpha up-regulates UCH-L1 via a translational regulation.

reach
Overall, our data demonstrate that TNFalpha up-regulates UCH-L1 via a translational regulation to inhibit ERK activity, thereby providing a negative feedback to control its growth promoting signaling in VSMCs.
UCHL1 affects hydrolase
| 12
UCHL1 inhibits hydrolase.
| 9
| 6

reach
We found that the experimental data did not agree with the model predictions if the only effect of UCH-L1 was reduced hydrolase activity.

reach
Finally, we found that UCH-L1 modification by HNE decreases its hydrolase activity.The I93M UCH-L1 mutant exhibits reduced hydrolase activity (~ 55% of wild-type), and this mutant displays 80% penetra[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Ile93Met mutation in human UCH-L1 gene that decreased hydrolase activity has been linked to a rare, autosomal dominant form of familial PD in German (Leroy et al., 1998).

reach
Cells were treated with LDN, which acts as a site directed inhibitor of UCH-L1 inhibiting the hydrolase activity.

reach
Monoubiquitination of UCH-L1 was also reported to restrict its hydrolase activity XREF_BIBR, but its effect on the solubility of UCH-L1 has not been studied.

reach
In our previous report, 15dPGJ2 modification of UCH-L1 abolished the protein 's hydrolase activity.
UCHL1-I93M inhibits hydrolase. 3 / 3
| 3

reach
The UCH-L1 I93M mutant displays significant decreased hydrolase activity in vitro, implying that loss of UCH-L1 function may contribute to a decrease in the availability of free ubiquitin, and an impaired clearance of proteins by the Ubiquitin Proteasome System (UPS).

reach
Notably, the I93M UCHL1 mutant has markedly reduced ubiquitin hydrolase activity in vitro [XREF_BIBR], suggesting that impaired polyubiquitin hydrolysis could also contribute to dopaminergic neuronal death.

reach
Notably, the I93M UCHL1 mutant display markedly reduced ubiquitin hydrolase activity in vitro; suggesting that impaired polyubiquitin hydrolysis leading to a shortage of free ubiquitin might also promote the accumulation of toxic proteins and contribute to neuronal death.
UCHL1 activates hydrolase.
| 3
| 3

reach
The major findings of this study are (1) CyPGs such as 15dPGJ2 adduct the C152 of UCH-L1 and mutation of the C152 of UCH-L1 attenuates the loss of hydrolase activity after 15dPGJ2 treatment; (2) the UCH-L1 C152A mutation decreases 15dPGJ2 induced accumulation and aggregation of UCH-L1 and ubiquitinated proteins in primary neurons; and (3) primary neurons derived from UCH-L1-C152A mutant mice are resistant to cell death and neurite injury induced by treatment with 15dPGJ2.

reach
Besides TGFbeta blockade, interesting results were shown using LDN57444, a specific small molecule inhibitor, targeting ubiquitin carboxy-terminal hydrolase L1 (UCH-L1).

reach
To answer these questions of morphogenesis, developing CVP and VEG were examined using the pan-neuronal antibody, PGP9.5, directed against ubiquitin carboxyl terminal hydrolase.
LMP1 affects UCHL1
| 12
LMP1 increases the amount of UCHL1.
| 8
LMP1 increases the amount of UCHL1. 7 / 7
| 7

reach
LMP1 also induced the expression of UCH-L1 in a dosedependent manner (XREF_FIG).

reach
EBV LMP1 induces the expression of UCH-L1.

reach
Results showed that LMP1 was sufficient to induce uch-l1 expression, and co-expression of LMP1 and LANA had an additive effect on uch-l1 expression.

reach
However, because LMP1 levels are low in dually infected PEL cells, and knockdown of LMP1 did not completely abrogate the increase in uch-l1 expression observed in BC-1 cells compared to BC-3 cells, these findings can not eliminate the possibility that EBNA1 or EBV encoded non polyadenylated RNAs (EBER1 and EBER2) contribute to the up-regulation of uch-l1.

reach
KSHV LANA and EBV LMP1 together induce the expression of UCH-L1.

reach
KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation.

reach
These data indicate that EBV LMP1 can induce the UCHL1 endogenous expression in cells by activating its promoter.
Modified LMP1 increases the amount of UCHL1. 1 / 1
| 1

reach
Because we show that co-expression of LANA and LMP1 enhanced activation of the uch-l1 promoter and increased expression of UCH-L1, it is possible that their additive effects on UCH-L1 expression also occur during endogenous infection.
LMP1 activates UCHL1.
| 4
LMP1 activates UCHL1. 4 / 4
| 4

reach
The finding that KSHV LANA can itself induce the expression of EBV LMP1 suggests there is a second mechanism through which UCH-L1 levels are augmented in co-infected cells : LANA activates the expression of LMP1, which in turn activates the uch-l1 promoter, resulting in greater levels of UCH-L1.

reach
Therefore, SP1, STAT3, and c-JUN are likely candidates to contribute to LANA- and LMP1 induced activation of the uch-l1 promoter and will be the subject of future studies.

reach
Finally, the mechanism by which LANA and LMP1 induce the uch-l1 promoter was explored.

reach
In addition, we demonstrate that EBV LMP1 can also activate the uch-l1 promoter and increase levels of UCH-L1.
UCHL1 affects CD36
| 1 1 10
UCHL1 inhibits CD36.
| 4
UCHL1 inhibits CD36. 4 / 4
| 4

reach
Based on UCHL1 mediated lipid uptake via promoting CD36 stability, we assess whether UCHL1 inhibition induced downregulation of CD36 when oxLDL is existing.

reach
Deletion of UCHL1 induces downregulation of scavenger receptor CD36 protein.

reach
To further explore the downregulation of CD36 and considering UCHL1 as a deubiquitinase, we supposed that UCHL1 promoted CD36 degradation was associated with proteasome system.

reach
We next explored the molecule mechanism of reduction of CD36 protein induced by UCHL1 inhibition or knockdown.
UCHL1 increases the amount of CD36.
| 1 2
UCHL1 increases the amount of CD36. 3 / 3
| 1 2

sparser
We supposed whether decreased CD36 expression induced by UCHL1 is associated with UPS.

reach
Our study shows that inhibition of UCHL1 significantly decreases the CD36 expression but not regulate the other proteins with and without oxLDL stimulation.

reach
These results suggested that UCHL1 inhibition or knockdown suppressed protein expression of CD36 but not mRNA level, regardless of oxLDL stimulation.
UCHL1 activates CD36.
| 1 2
UCHL1 activates CD36. 3 / 3
| 1 2

eidos
Subsequently , we found that UCHL1 inhibitor or siRNA downregulates the expression of CD36 protein whereas SR-A , ABCA1 , ABCG1 , Lox-1 , and SR-B1 have no significant change .

reach
To further explore the molecular mechanism of UCHL1 on the regulation of CD36, we observed the inhibition of UCHL1 promotes CD36 degradation.

reach
This results indicates that the suppression of lipid accumulation induced by UCHL1 inhibition or silence is a result of UCHL1 inhibition promoted CD36 degradation.
UCHL1 decreases the amount of CD36.
| 2
UCHL1 decreases the amount of CD36. 2 / 2
| 2

reach
Western blot analysis indicated that UCHL1 inhibition or knockdown induced the downregulation of CD36 protein expression.

reach
We supposed whether decreased CD36 expression induced by UCHL1 is associated with UPS.
UCHL1 affects MITF
| 11
UCHL1 decreases the amount of MITF.
| 5
UCHL1 decreases the amount of MITF. 3 / 3
| 3

reach
The above two experiments suggested that UCHL1 interacted with ubiquitinated MITF and reduced MITF protein levels by increasing polyubiquitinated MITF.To further validate whether UCHL1 decreased MITF [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
However, because the mutant form of UCHL1, which showed reduced or no enzyme activity, did not significantly decrease MITF protein levels, it is possible that UCHL1 functions as an ubiquitin ligase to[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Furthermore, UCHL1 reduced the protein, but not mRNA, levels of MITF, the upstream regulator of tyrosinase, dopachrome tautomerase, and tyrosinase related protein-1.
UCHL1 bound to MITF decreases the amount of MITF. 1 / 1
| 1

reach
The above two experiments suggested that UCHL1 interacted with ubiquitinated MITF and reduced MITF protein levels by increasing polyubiquitinated MITF.To further validate whether UCHL1 decreased MITF [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
Modified UCHL1 decreases the amount of MITF. 1 / 1
| 1

reach
Here, we demonstrated that overexpression of UCHL1 markedly downregulated MITF protein expression by affecting its stability.
UCHL1 inhibits MITF.
| 3
UCHL1 inhibits MITF. 3 / 4
| 3

reach
Therefore, the present finding that UCHL1 can suppress MITF activity might serve as the basis for further studies conducted to evaluate new therapeutic approaches for melanoma and dyspigmentation diso[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
In parallel, UCHL1 dependent degradation of MITF was observed in the total cell lysates (input).

reach
Indeed, overexpression of UCHL1 significantly increased the degradation of MITF protein (P < 0.05).
UCHL1 activates MITF.
| 2
UCHL1 activates MITF. 2 / 2
| 2

reach
UCHL1 downregulation by small interfering RNA resulted in upregulation of microphthalmia associated transcription factor (MITF), tyrosinase, dopachrome tautomerase, tyrosinase related protein-1, and melanin.

reach
These results indicated that UCHL1 negatively influenced the stability of MITF protein.We next investigated the potential molecular mechanism underlying the observed downregulation of MITF protein ind[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
UCHL1 increases the amount of MITF.
| 1
Modified UCHL1 increases the amount of MITF. 1 / 1
| 1

reach
In contrast to the decrease in MITF protein levels, MITF mRNA levels were increased by overexpression of UCHL1, suggesting that this discrepancy may be attributed to modification of MITF protein stabi[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
| 1 5
| 1 2

eidos
UCHL1 can promote the degradation of APP and BACE1 in AD .

reach
Zhang et al. reported that the overexpression of UCHL1 decreased Abeta in the uchl1-null AD mice (Zhang et al., 2012).

reach
Recent studies reported that the level of soluble UCHL1 protein is inversely proportional to the number of tangles, that UCHL1 is oxidized in AD brains and that overexpression of UCHL1 reverses cognit[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
| 3

reach
The levels of UCHL1 were decreased in sporadic AD patients, and the overexpression of UCHL1 rescued the synaptic and cognitive function in AD model mice.

reach
34 UCHL1 is also required for normal synaptic function and rescues Abeta related synaptic dysfunction in transgenic AD mice.
UCHL1 bound to PRKN activates Alzheimer Disease. 1 / 1
| 1

reach
Taken together, our studies show a causative link between the excessive mitochondrial turnover and the NH2htau induced in vitro neuronal death, suggesting that pathogenetic tau truncation may contribute to synaptic deterioration in AD by aberrant recruitment of Parkin and UCHL-1 to mitochondria making them more prone to detrimental autophagic clearance.
PRKN affects UCHL1
| 11
PRKN inhibits UCHL1.
| 7
PRKN inhibits UCHL1. 7 / 7
| 7

reach
We find that parkin mediates K63 linked polyubiquitination of UCH-L1 in cooperation with the Ubc13 and Uev1a E2 ubiquitinconjugating enzyme complex and promotes UCH-L1 degradation by the autophagy-lysosome pathway.

reach
It is reported that interaction with parkin promotes UCHL1 lysosomal degradation [XREF_BIBR] and consequently the lack of parkin could lead to the abnormal UCHL1 accumulation in PD patient cells.

reach
Taken together, these results suggest that loss of parkin mediated UCH-L1 regulation may be a pathogenic mechanism contributing to neurodegeneration in human ARJP patients with parkin mutations.

reach
Together, these results support that parkin promotes UCH-L1 degradation through the autophagylysosome pathway but not the proteasome pathway.

reach
We found that endogenous UCH-L1 protein is a long lived protein with a half-life of ~ 59 hr and the UCH-L1 protein half-life was reduced to ~ 40 hr by parkin overexpression, indicating that parkin indeed promotes UCH-L1 degradation.

reach
Parkin promotes UCH-L1 degradation through the autophagy-lysosome pathway.

reach
We found that parkin overexpression reduced the steady-state level of endogenous UCH-L1 protein (XREF_FIG), consistent with a role of parkin in promoting UCH-L1 degradation.
PRKN activates UCHL1.
| 3
PRKN activates UCHL1. 3 / 3
| 3

reach
The parkin induced UCH-L1 degradation was blocked by the lysosome inhibitor chloroquine (CQ) or the autophagy inhibitor 3MA but not by the proteasome inhibitor MG132 (XREF_FIG).

reach
Taken together, these results suggest that loss of parkin mediated UCH-L1 regulation may be a pathogenic mechanism contributing to neurodegeneration in human ARJP patients with parkin mutations.

reach
Consistent with the accelerated UCH-L1 turnover rate induced by parkin overexpression, the steady-state level of endogenous UCH-L1 protein was significantly lower in parkin WT overexpressing SH-SY5Y cells than that in the vector transfected control cells (XREF_FIG).
PRKN deubiquitinates UCHL1.
| 1
Modified PRKN leads to the deubiquitination of UCHL1. 1 / 1
| 1

reach
Our analysis of UCH-L1 ubiquitination with GST tagged TUBE2 revealed that endogenous UCH-L1 in mouse brain was polyubiquitinated and the UCH-L1 polyubiquitination was significantly reduced by targeted disruption of parkin expression in mice (XREF_FIG).
UCHL1 increases the amount of reactive oxygen species.
| 5
UCHL1 increases the amount of reactive oxygen species. 5 / 5
| 5

reach
Silencing UCH-L1 decreased cellular ROS levels in HUVECs, and reduced angiogenesis.

reach
We further showed that UCH-L1 increases ROS levels in HUVEC by deubiquitinating NOX4 in VEGF signaling.

reach
UCHL1 is found to increase cellular ROS level by up-regulating H 2 O 2 generation in melanoma cells and induce apoptosis in spermatocyte of mice with cryptorchidism and breast tumour cells 54, 55, 56.

reach
UCH-L1 was found to increase cellular ROS levels and promote cell invasion.

reach
Also, UCH-L1 is found to increase cellular ROS levels and promote cell invasion by up-regulating H 2 O 2 via deubiquitinating NOX4 [13].

reach
UCH-L1 induced active NOX4 by deubiquitination of NOX4, and then increased ROS which induce angiogenesis in HUVECs.

reach
Because silencing UCH-L1 inhibited the phosphorylation of VEGFR, a signal for angiogenesis, this finding provides another evidence that UCH-L1 promotes ROS generation in HUVECs, and plays a key role i[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Because H 2 O 2 generating activity of NOX4 is negatively modulated by ubiquitination and UCH-L1 promotes ROS induced cell invasion and migration in HeLa cells by deubiquitinating the NOX4 [13], we in[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
This suggests that UCH-L1 mediates ROS generation via NOXs in B16F10 cells overexpressing UCH-L1.

reach
These results indicate that UCH-L1 increases cellular ROS generation.
TGFB1 affects UCHL1
| 6
TGFB1 increases the amount of UCHL1.
| 4
TGFB1 increases the amount of UCHL1. 4 / 8
| 4

reach
TGF-beta1 induces PGP9.5 expression in CAFs to promote the growth of colorectal cancer cells.

reach
Therefore, TGF-beta1 can promote PGP9.5 expression in CAFs to facilitate the growth of cancer cells.

reach
In addition, TGF-beta1 was also found to promote the expression of PGP9.5 through the ERK1/2 and PI3K pathways.

reach
Western blot analysis was performed, and the results showed that TGF-beta1 promoted expression of PGP9.5 in a time dependent manner.
TGFB1 activates UCHL1.
| 2
TGFB1 activates UCHL1. 2 / 2
| 2

reach
These findings demonstrate differentiation of RGC-5 cells in HNPE-CM leads to expression of multiple markers of neuronal cells and addition of TGF-beta1 further increases some of these markers, namely NF-160 and PGP9.5 to increase neuronal characteristics of these cells.

reach
UCHL1 is elevated in post MI hearts and CFs treated with TGF-beta1.
Glucose affects UCHL1
| 10
Glucose increases the amount of UCHL1.
| 5
Glucose increases the amount of UCHL1. 5 / 5
| 5

reach
Overall, these results indicated that HG upregulated the expression of UCH-L1 in podocytes at both the mRNA and protein levels.

reach
High Glucose Increased the Expression of UCH-L1 in Podocytes in Vitro.

reach
On the premise that HG increased the expression of UCH-L1, we continued to investigate the influence of UCH-L1 overexpression on podocyte morphology and cell migration.

reach
In this study, results demonstrated that HG upregulated the expression of UCH-L1 in murine podocytes, which might be mediated by the Wnt and beta-catenin signaling pathway.

reach
They also proved that the Wnt and beta-catenin signal pathway is promptly activated in podocyte, coinciding with overexpression of UCH-L1 induced by high glucose meanwhile [XREF_BIBR].
Glucose activates UCHL1.
| 4
Glucose activates UCHL1. 4 / 4
| 4

reach
In this experiment, findings demonstrated that HG significantly upregulated UCH-L1 in mouse podocyte cells (XREF_FIG, p < 0.05).

reach
Results demonstrated that HG induced upregulation of UCH-L1 and activation of the Wnt and beta-catenin signaling pathway in podocytes.

reach
To provide the intrinsic mechanism of UCH-L1 upregulation in HG stimulated podocytes, podocyte cells were treated with HG for 24 or 48 h, after preincubated with or without recombinant Dickkopf-1 (DKK1) protein, a secreted Wnt antagonist that can specially block the canonical Wnt signaling [XREF_BIBR].

reach
However, it is unknown whether the canonical Wnt and beta-catenin signaling mediates high glucose induced upregulation of UCH-L1 in podocytes.
Glucose inhibits UCHL1.
| 1
| 1

reach
Inhibition of Wnt and beta-Catenin Pathway Downregulated High Glucose Induced UCH-L1 Upregulation.
UCHL1 affects PHLPP1
| 9
UCHL1 decreases the amount of PHLPP1.
| 7
UCHL1 decreases the amount of PHLPP1. 6 / 6
| 6

reach
UCH-L1 activity leads to reduced levels of the phosphatase PHLPP1.

reach
If UCH-L1 suppressed the transcription of PHLPP1, we would expect to see an increase in PHLPP1 mRNA levels upon UCH-L1 depletion.

reach
In contrast, we observed a dramatic increase in the phosphatase PHLPP1 levels following depletion of UCH-L1 (XREF_FIG and XREF_SUPPLEMENTARY).

reach
UCH-L1 leads to reduced levels of PHLPP1, and boosts Akt signaling.

reach
These data suggest that UCH-L1 leads to reduced PHLPP1 levels in a non-proteasome-dependent manner.

reach
For instance, UCH-L1 decreases PHLPP expression leading to prolonged Akt signaling in lymphomagenesis 19.
Modified UCHL1 decreases the amount of PHLPP1. 1 / 1
| 1

reach
Exploring the underlying mechanism, we found that aberrant UCH-L1 expression leads to a dramatic increase in Akt signaling in vitro and in vivo by decreasing the levels of PHLPP1 : a phosphatase that reverses Akt phosphorylation.
UCHL1 inhibits PHLPP1.
| 1
UCHL1 inhibits PHLPP1. 1 / 2
| 1

reach
However, the mechanism by which UCH-L1 suppresses PHLPP1 merits further investigation as UCH-L1 does not alter PHLPP1 transcription or promote proteasomal degradation of PHLPP1.
UCHL1 increases the amount of PHLPP1.
| 1
UCHL1 increases the amount of PHLPP1. 1 / 1
| 1

reach
Further, UCHL-1 downregulated mTOR activity but promotes Akt activity by deregulating PHLPP1 expression.
UCHL1 affects ERK
| 1 1 7
UCHL1 activates ERK.
| 1 1 2
UCHL1 activates ERK. 4 / 4
| 1 1 2

reach
These findings demonstrated that UCHL1 promoted cell proliferation, migration, and invasion depending on its de-ubiquitinase activity by activating Akt and Erk1/2, which may account for its higher positive expression rate in liver metastases from gastric cancer.

trips
UCHL1 activated Akt and Erk1/2, which process also required enzymatic activity and was necessary for mediating cell migration and invasion.

reach
UCHL1 activated Akt and Erk1/2, which process also required enzymatic activity and was necessary for mediating cell migration and invasion.

sparser
UCHL1 activated Akt and Erk1/2, which process also required enzymatic activity and was necessary for mediating cell migration and invasion.
UCHL1 inhibits ERK.
| 2
UCHL1 inhibits ERK. 2 / 3
| 2

reach
Indeed, it is known that the NOS synthesis is regulated through the activation of the extracellular signal regulated protein kinase (ERK) and the UCHL1 protein has been shown to drastically decrease the activation of ERK XREF_BIBR, arguing for an inactivation of the NOS system in A. algerae infected HFF cells.

reach
While UCH-L1 has been shown to inhibit alpha 2 -adrenergic receptor (AR) agonist mediated activation of ERK via a direct association with alpha 2A -AR receptor implicating a role of UCH-L1 in neuro-protection XREF_BIBR, it has also been documented that UCH-L1 up-regulates oncogenic beta-catenin and TCF and Akt signaling to induce tumor cell proliferation and migration contributing to tumor progression XREF_BIBR, XREF_BIBR.
UCHL1 increases the amount of ERK.
| 2
UCHL1 increases the amount of ERK. 2 / 2
| 2

reach
Our results showed that consistent with the trend of P-mTOR, cPKCgamma knockout significantly decreased the ERK phosphorylation following 1-hr OGD/24-hr R, while UCHL1 shRNAs obviously enhanced the level of P-ERK.

reach
UCHL1 shRNA 2 and 3 treatments could significantly enhance the level of P-ERK, which was consistent with the change of P-mTOR.
UCHL1 decreases the amount of ERK.
| 1
UCHL1 decreases the amount of ERK. 1 / 1
| 1

reach
Knockdown of UCHL1 markedly reduced the protein levels of total EGFR and phosphorylated EGFR, AKT, and ERK1/2, with no effect on the EGFR mRNA level compared with the siRNA-controls after saline or PE stimulation.
9 |
Valproic acid increases the amount of UCHL1. 9 / 9
9 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
UCHL1 affects proteolysis
| 9
UCHL1 activates proteolysis.
| 7
| 7

reach
Thus, UCH-L1 deficiency impairs ubiquitin dependent protein degradation and results in accumulation of highly ubiquitinated proteins.

reach
Our data suggest that UCHL1 upregulation in ACTN4 associated FSGS fuels the proteasome and that UCHL1 deletion may impair proteolysis and thereby preserve K256E and wt-alpha-actinin -4 heterodimers, maintaining podocyte cytoskeletal integrity and protecting the glomerular filtration barrier.

reach
Based on the key enriched GO items, we supposed that miR-1246 targets UBE-2C and UCHL1 for the regulation of ubiquitin mediated proteolysis and, therefore, persuades the prognosis of LUAD patients.

reach
However, data here unequivocally demonstrate that acute disruption of UCHL1 function leads to an impairment in ubiquitin dependent protein degradation in vivo.

reach
Also known as UCHL1, PGP9.5 prevents protein degradation by the proteosome-dependant pathway by removing ubiquitin from ubiquitinated proteins [XREF_BIBR].

reach
In this study, we found a novel therapeutic target, UCHL1, can modulate SMN protein degradation.

reach
Decreasing the activity of UCHL1 in UPS, has been reported to ablate the protein degradation activity induced by UCHL1 and to increase the levels of highly ubiquitinated proteins, both of which can ac[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
UCHL1 inhibits proteolysis.
| 2
| 2

reach
At a cellular level, parkin and UCH-L1 mediate protein degradation via the UPS.

reach
As Uch-l1 is thought to stimulate protein degradation by generating free monomeric ubiquitin, the gad mutation appears to affect protein turnover.
UCHL1 affects Death
| 9
UCHL1 activates Death.
| 5
UCHL1 activates Death. 4 / 4
| 4

reach
No pathological data are currently available.It is not clear why mutations in alpha-synuclein, parkin or UCH-L1 genes cause nigral dopaminergic cell death in familial PD.

reach
Moreover, and identical to podocyte death caused by UCH-L1 overexpression, the addition of zVAD-fmk did not prevent TNF induced cell death, demonstrating that TNF indeed elicits necroptosis in podocytes, and that UCH-L1 represents a downstream mediator of the necroptotic signaling cascade of TNF also in podocytes.

reach
We and others have previously observed this effect of zVAD-fmk in necroptosis [XREF_BIBR, XREF_BIBR, XREF_BIBR], excluding that de novo expression and thus increased UCH-L1 activity causes death of podocytes by apoptosis but rather pointing to programmed necrosis and necroptosis as the responsible suicide program.

reach
Since UCH-L1 clearly contributes to the non apoptotic death of podocytes, interference with the necroptotic properties of HtrA2 and Omi and UCH-L1 may prove beneficial for the treatment of patients, e.g. in kidney failure.
UCHL1-I93M activates Death. 1 / 1
| 1

reach
The I93M point mutation in UCH-L1 is associated with familial Parkinson 's disease (Leroy et al., 1998) and we have previously shown that I93M UCH-L1 expression in the cell or in transgenic mice induc[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
UCHL1 inhibits Death.
| 4
UCHL1 inhibits Death. 3 / 3
| 3

reach
In this study we demonstrated that the inhibition of Uch-L1 induces BACE1 up-regulation and increases neuronal cell death in control as well as in AD transgenic mouse models subjected to Bengal Rose, a light sensitive dye inducing a cortical infarction through photo activation.

reach
Together, these studies indicate that UCH-L1 inhibition induced by genetic mutations or pathological conditions is an important contributor not only to the accumulation of ubiquitinated proteins in ag[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
UCH-L1 prevents neuronal cell death from oxidative stress, and down-regulation of UCH-L1 leads to neuronal degeneration [XREF_BIBR, XREF_BIBR].
UCHL1-C152A inhibits Death. 1 / 1
| 1

reach
As shown in XREF_FIG, 15dPGJ2 significantly induced primary neuronal cell death and this toxic effect was attenuated by the overexpression of the UCH-L1 C152A mutation.
UCHL1 affects TGFB
| 1 7
UCHL1 activates TGFB. 7 / 7
| 1 6

reach
Here, we show that the deubiquitinating enzyme UBH-1 in Caenorhabditis elegans and its human homolog, ubiquitin C-terminal hydrolase-L1 (UCH-L1), stimulate DAF-7 and TGF-beta signaling, suggesting that this mode of regulation of TGF-beta signaling is conserved across animal species.

reach
Overexpression of UCH-L1, but not of UCH-L3 (the other human homolog of UBH1) or of the catalytic mutant UCH L1C90A, enhanced TGF-beta and SMAD-induced transcriptional activity, indicating that the deubiquitination activity of UCH-L1 is indispensable for enhancing TGF-beta and SMAD signaling.

reach
Overexpression of UCH-L1, but not of UCH-L3 (the other human homolog of UBH1) or of the catalytic mutant UCH-L1 C90A, enhanced TGF-beta and SMAD-induced transcriptional activity, indicating that the deubiquitination activity of UCH-L1 is indispensable for enhancing TGF-beta and SMAD signaling.

eidos
Mechanistically , we found UCHL1 could promote the transforming growth factor-beta ( TGFbeta ) - SMAD canonical signaling pathway by protecting the cell surface TGFbeta type I receptor and its downstream intracellular effector SMAD2 from proteasomal degradation .

reach
These results indicate that UCH-L1 activity supports DAF-7 and TGF-beta signaling and suggest that UCH-L1 's deubiquitination activity is a potential therapeutic target for managing lung cancer.

reach
Here, we show that the deubiquitinating enzyme UBH-1 in Caenorhabditis elegans and its human homolog, ubiquitin C-terminal hydrolase-L1 (UCH-L1), stimulate DAF-7 and TGF-beta signaling, suggesting that this mode of regulation of TGF-beta signaling is conserved across animal species.

reach
These results indicate that UCH-L1 activity supports DAF-7 and TGF-beta signaling and suggest that UCH-L1 's deubiquitination activity is a potential therapeutic target for managing lung cancer.
UCHL1-C90A activates TGFB. 1 / 1
| 1

reach
Overexpression of UCH-L1, but not of UCH-L3 (the other human homolog of UBH1) or of the catalytic mutant UCH-L1 C90A, enhanced TGF-beta and SMAD-induced transcriptional activity, indicating that the deubiquitination activity of UCH-L1 is indispensable for enhancing TGF-beta and SMAD signaling.

sparser
The inhibition of UCHL1 by LDN (a specific inhibitor) significantly reduced the Ang II-induced increase in blood pressure, atrial fibrillation, fibrosis, inflammation, and oxidative stress.

sparser
In this study, we examined the effect of UCHL1 inhibition by LDN, a specific inhibitor, on the development of AF in a murine model of Ang II-induced AF.

sparser
Both inhibition of UCHL1 by LDN and knockdown UCHL1 by siRNA downregulated TGF-β1-mediated expression of pro-fibrotic proteins in CFs.

sparser
To assess whether UCHL1 mediates post-MI cardiac fibrosis in vivo, we used LDN to inhibit UCHL1.

sparser
The mechanism(s) by which inhibition of UCH-L1 by LDN affects its interaction with the members of autophagy pathway are unknown.

sparser
In vitro studies verified the LDN-induced inhibition of UCH-L1 had minimal effect on LC3 (a marker of autophagy) in control cells, in cells over expressing a-syn UCH-L1 inhibition resulted in increased LC3 activity.

sparser
To demonstrate the efficacy of UCH-L1 inhibition by LDN, neuronal lysates were pre-incubated with increasing amounts of LDN prior to DUB labeling assays.

sparser
Inhibition of UCH-L1 by LDN Leads to MT Reorganization and Stabilization in Oligodendroglial Cells.
CTNNB1 affects UCHL1
| 1 6
CTNNB1 increases the amount of UCHL1.
| 3
CTNNB1 increases the amount of UCHL1. 3 / 4
| 3

reach
In the transformed cells, beta-catenin can upregulate the expression of endogenous UCH-L1 mRNA and protein [XREF_BIBR].

reach
Accumulation of stabilized beta-catenin stimulates expression of UCHL1, a marker for pulmonary neuroendocrine cells, PNECs.

reach
Therefore, whether UCH-L1 expression is increased or not in HG stimulated podocytes and is mediated by Wnt and beta-catenin is not clear at present.
CTNNB1 activates UCHL1.
| 1 3
CTNNB1 activates UCHL1. 4 / 4
| 1 3

reach
Maybe, in HG circumstance, the increased UCH-L1 which was mediated by Wnt and beta-catenin pathway changed several important proteins of podocytes, and corresponding remolded actin cytoskeleton and improved cell migration.

eidos
Moreover , they also showed reciprocal upregulation of UCHL1 expression by beta-catenin , suggesting a positive feedback loop in transformed cells .

reach
Intracellular " accumulation of beta-catenin blocked differentiation of spatially-appropriate airway epithelial cell types, Clara cells, ciliated cells and basal cells, and activated UCHL1, a marker for pulmonary neuroendocrine cells.

reach
However, it is unknown whether the canonical Wnt and beta-catenin signaling mediates high glucose induced upregulation of UCH-L1 in podocytes.
Ubiquitin affects UCHL1
| 6
Ubiquitin activates UCHL1.
| 3
| 3

reach
For example, Ubiquitin carboxy-terminal hydrolase L1 antisense RNA 1 (UCHL1-AS1) interacts with polysomes and thus promotes the translation of UCHL1 mRNA.

reach
It remains to be established how and whether the ubiquitin modulating functions of PGP9.5 observed in neuronal cells translate into a functional role of the protein in naphthalene exposed lung epithelium.

reach
Indeed, the addition of 1.2 molar equivalent of ubiquitin slightly increased the thermal stability of UCH-L1 and -L3, raising the melting temperature by 2.2 +/-0.1 degreesC and 0.9 +/-0.2 degreesC, respectively, while no significant change in thermal stability was observed for UCH-L5 N240 (XREF_SUPPLEMENTARY).
Ubiquitin inhibits UCHL1.
| 2
| 2

reach
We found that the expression of ubiquitin for 12 hours completely rescued the effects of UCH-L1 inhibition on PSD-95 size and distribution.

reach
Strikingly, over-expression of ubiquitin rescues the effects of UCH-L1 inhibition.
Ubiquitin increases the amount of UCHL1.
| 1
Ubiquitin increases the amount of UCHL1. 1 / 2
| 1

reach
UCH-L1 is abundantly expressed in the brain (1-2%), and promotes protein degradation by liberating ubiquitin conjugates.
UCHL1 affects TNF
| 7
UCHL1 inhibits TNF.
| 5
UCHL1 inhibits TNF. 5 / 6
| 5

reach
An earlier report from our lab demonstrated that UCHL1 deubiquitination can itself negatively regulate TNFalpha mediated VSMC proliferation by suppressing Erk [XREF_BIBR].

reach
Over-expression of UCH-L1 inhibits TNFalpha mediated VSMC proliferation.

reach
Our results uncovered for the first time that UCH-L1 negatively regulates TNFalpha mediated VSMC proliferation via suppressing ERK activity.

reach
Overexpression of the UCHL1 gene significantly attenuated tumor necrosis factor (TNF)-alpha-induced NF-kappaB activity in vascular cells and increased inhibitor of kappa B-alpha (IkappaB-alpha), possibly through the attenuation of IkappaB-alpha ubiquitination, leading to decreased neointima in the balloon injured artery.

reach
It worthy to note that UCH-L1 suppresses tumor necrosis factor alpha (TNFalpha) - rather than PDGF-BB-mediated activation of ERK and proliferation in vascular smooth muscle cells (VSMCs) XREF_BIBR.
UCHL1 increases the amount of TNF.
| 1
UCHL1 increases the amount of TNF. 1 / 1
| 1

reach
These results demonstrate that TNFalpha could not regulate either UCH-L1 transcription or its mRNA stability.
UCHL1 activates TNF.
| 1
UCHL1 activates TNF. 1 / 1
| 1

reach
For example, a novel deubiquinating enzyme, ubiquitin carboxyl-terminal hydrolase L1 (UCHL1), mutated in a rare inherited form of Parkinson 's disease, is normally present in vascular endothelial cells of atherosclerotic lesions of human carotid arteries and attenuates pathological vascular remodeling by inhibiting tumor necrosis factor a induced NF-kappaB activation [XREF_BIBR].
UCHL1 affects NFkappaB
| 6
UCHL1 inhibits NFkappaB.
| 4
| 4

reach
UCHL1 inhibition promotes the activation of NF-kappaB and STAT1 signaling.

reach
Additionally, to evade host innate immunity, Hr-HPV can inhibit PRR signaling through the induction of ubiquitin C-terminal hydrolase L1 (UCHL1) expression; UCHL1 blocks the activation of NF-kappaB and IRF3, both of which are transcription factors that induce the production of proinflammatory cytokines and chemokines XREF_BIBR.

reach
Overexpression of the UCHL1 gene significantly attenuated tumor necrosis factor (TNF)-alpha-induced NF-kappaB activity in vascular cells and increased inhibitor of kappa B-alpha (IkappaB-alpha), possibly through the attenuation of IkappaB-alpha ubiquitination, leading to decreased neointima in the balloon injured artery.

reach
These data together suggest that UCHL1 also negatively regulates the NF-kappaB and STAT1 pathway to inhibit the immunosuppressive capacity and IDO expression of human MSCs, indicating an essential role of UCHL1 to regulate the immunosuppressive capacity of both human and murine MSCs.
UCHL1 increases the amount of NFkappaB.
| 1
UCHL1 increases the amount of NFkappaB. 1 / 1
| 1

reach
Expression of NF-kappaB suppressed UCH-L1 gene transcription.
UCHL1 activates NFkappaB.
| 1
| 1

reach
For example, a novel deubiquinating enzyme, ubiquitin carboxyl-terminal hydrolase L1 (UCHL1), mutated in a rare inherited form of Parkinson 's disease, is normally present in vascular endothelial cells of atherosclerotic lesions of human carotid arteries and attenuates pathological vascular remodeling by inhibiting tumor necrosis factor a induced NF-kappaB activation [XREF_BIBR].
NFkappaB affects UCHL1
1 | 7
NFkappaB decreases the amount of UCHL1.
1 | 3
NFkappaB decreases the amount of UCHL1. 3 / 3
| 3

reach
It has been reported that NF-kappaB pathway transactivates BACE1 promoter and concomitantly down-regulates Uch-L1 expression.

reach
Moreover, upon activation by tumor necrosis factor -alpha (TNF-alpha), NF-kappaB negatively regulates the transcription of the UCHL1 gene by binding to its response sequences within the promoter.

reach
Expression of NF-kappaB suppressed UCH-L1 gene transcription.
Active NFkappaB decreases the amount of UCHL1. 1 / 1
1 |

bel
The decrease in Uch-L1 depends on NF-κB pathway since NF-κB p65 can interact with the −300 bp and −109 bp NF-κB binding sequences of the Uch-L1 gene promoter [55].
NFkappaB increases the amount of UCHL1.
| 3
NFkappaB increases the amount of UCHL1. 3 / 3
| 3

reach
In vitro experiments confirmed that tumor necrosis factor-alpha induced NF-kappaB activation, which led to UCH-L1 overexpression, UPS impairment, the upregulation of desmin and the downregulation of synaptopodin in A20 gene silenced podocytes.

reach
Activation of NF-kappaB up-regulates UCH-L1 expression following changing of other podocytes molecules, such as nephrin and snail.

reach
Interestingly, overexpression of CDR1as elevates the NF-kappaB inhibited UCHL1 promoter activity and thereby increases the mRNA and protein levels of UCHL1.
NFkappaB activates UCHL1.
| 1
| 1

reach
NF-kappaB up-regulates UCH-L1 via binding the -- 300 bp and -- 109 bp sites of its promoter, which was confirmed by the electrophoretic mobility shift assay of DNA-nuclear protein binding.
UCHL1 affects LTP
| 7
UCHL1 activates LTP. 7 / 7
| 7

reach
These results indicate that Usp14 and Uch-L1 are dispensable for induction of LTP at CA3-CA1 hippocampal synapses.

reach
The hippocampal slices from the nm3419 mice showed a similar strong enhancement of synaptic activity that also lasted over 1 h (XREF_FIG), indicating that loss of Uch-L1 does not impair LTP induced by theta burst stimulation.

reach
5 Furthermore, UCH-L1 activity modulates LTP in hippocampus and is deficient in a mouse model of AD.

reach
A recent study has demonstrated that pharmacological inhibition of UCH-L1 activity by 40% is sufficient to significantly attenuate LTP in rat hippocampal slices.

reach
Since decreased UCH-L1 activity is associated with several neurodegenerative disorders, and pharmacological inhibition of UCH-L1 activity substantially reduces LTP, we assessed any structural alterations to synapses in UCH-L1-inhibited neurons.

reach
We have shown : (i) a reduction of soluble Uch-L1 protein levels in the hippocampus of APP and PS1 mice; (ii) that inhibition of Uch-L1 activity leads to the inhibition of hippocampal LTP; and (iii) that transduction of Uch-L1 protein restores LTP in APP and PS1 mice and also reestablishes normal Uch activity, basal neurotransmission and synaptic plasticity, and improves associative memory in mice.

reach
Pharmacological inhibition of UCH-L1 impairs LTP, whereas its overexpression can rescue cognitive function in an AD mouse model, however the mechanism is far from being elucidated.
UCHL1 affects TYMS
| 7
UCHL1 increases the amount of TYMS.
| 4
UCHL1 increases the amount of TYMS. 4 / 4
| 4

reach
Furthermore, we revealed that UCHL1 upregulated the expression of TS, which promotes cell cycle progression and DNA repair, thereby conferring resistance to PEM and other drugs.

reach
Therefore, UCHL1 may indirectly promote the transcription of TS by targeting other enzymes or proteins, such as HIF-1alpha and mTOR, and further studies are needed to explore this topic.

reach
Mechanistically, UCHL1 promoted PEM resistance in NSCLC by upregulating the expression of thymidylate synthase (TS), based on reduced TS expression after UCHL1 inhibition and re-emergence of PEM resistance upon TS restoration.

reach
Furthermore, UCHL1 upregulated TS expression, which mitigated PEM induced DNA damage and cell cycle arrest in NSCLC cells, and also conferred resistance to PEM and other drugs.
UCHL1 activates TYMS.
| 3
UCHL1 activates TYMS. 3 / 3
| 3

reach
Interestingly, we found that the TS mRNA and protein levels were remarkably upregulated in the two PEM-R cell lines, and were significantly reduced by UCHL1 silencing or inhibition.

reach
While the present study revealed that UCHL1 increased TS mRNA and protein expression, without any affections on TS enzyme activity (per pmol), and the underlying mechanisms remain unclear.

reach
Conclusions : It appears that UCHL1 promotes PEM resistance by upregulating TS in NSCLC cells, which mitigated DNA damage and cell cycle arrest.
UCHL1 affects TRAF3
| 1 1 3
UCHL1 inhibits TRAF3.
| 1 1 1
UCHL1 inhibits TRAF3. 3 / 5
| 1 1 1

sparser
TRAF3 are inhibited by DUBA, OTUB1 and UCHL1 that specilally remove TRAF3 K63‐linked ubiquitination.

reach
TRAF3 are inhibited by DUBA, OTUB1 and UCHL1 that specilally remove TRAF3 K63‐linked ubiquitination.

eidos
TRAF3 are inhibited by DUBA , OTUB1 and UCHL1 that specilally remove TRAF3 K63-linked ubiquitination .
UCHL1 activates TRAF3.
| 2
UCHL1 activates TRAF3. 2 / 2
| 2

reach
However, UCHL1 mediated TRAF3 hampering could also lead to constitutive NIK accumulation and subsequent pathway activation.

reach
The UCHL1 associated decreased detection of poly-ubiquitinated TRAF3 was not the result of increased TRAF3 degradation as blocking the proteasomal degradation pathway by the inhibitor MG132 did not result in a reappearance of poly-ubiquitinated TRAF3 (XREF_FIG).
UCHL1 affects HIF1A
| 6
UCHL1 activates HIF1A.
| 3
UCHL1 activates HIF1A. 3 / 4
| 3

reach
UCHL1 increases the stability of HIF-1alpha.

reach
XREF_BIBR, XREF_BIBR Work from the field of oncological science indicated UCHL1 might prevent HIF-1alpha degradation.

reach
In 2D monolayer culture, a UCHL1 inhibitor suppressed HIF activity and decreased the transcription of HIF downstream genes by inhibiting the UCHL1 mediated accumulation of HIF-1alpha.
UCHL1 increases the amount of HIF1A.
| 3
UCHL1 increases the amount of HIF1A. 2 / 2
| 2

reach
In addition to such a molecular mechanism, we recently revealed the possibility that UCHL1 increases the expression levels of HIF-1alpha by upregulating the efficiency of the transcriptional initiation of the HIF-1alpha gene (data not shown).

reach
Western blotting consistently showed that the UCHL1 dependent increase in HIF-1alpha protein levels was only observed in the presence of VHL (XREF_FIG).
Modified UCHL1 increases the amount of HIF1A. 1 / 1
| 1

reach
The resultant clones, EMT6/EF-Luc/UCHL1 and EMT6/EF-Luc/EV cells, showed that the forced expression of UCHL1 induced the expression of HIF-1alpha and HIF-1 activity (XREF_SUPPLEMENTARY) and enhanced cell migration (XREF_SUPPLEMENTARY), but did not promote cell proliferation in vitro, EF-Luc reporter activity or the growth of tumour xenografts following subcutaneous transplantation (XREF_SUPPLEMENTARY).

reach
UCH-L1 promotes EMT but similarly, the target substrates have not yet been identified.

reach
A specific small molecule inhibitor, LDN57444, targeting UCH-L1 significantly inhibited HIF-1 alpha activity in the presence of endogenous UCHL1 expression and suppressed EMT reducing the incidence of distant tumor metastases.

reach
We have already shown that UCH-L1, a close relative of UCH-L3, induces EMT and promotes metastasis in prostate cancer cells [11].

reach
These results indicate that UCH-L3 inhibits EMT by repression of EMT promoting genes such as Snail, Slug, Twist, and MMPs in normal prostate cell lines.In our previous report, we found that UCH-L1 exp[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Notably, the EMT phenotype of Cd transformed cells can be suppressed by forced ectopic expression of UCHL1, suggesting UCHL1 as a crucial modulator in the maintenance of the proper differentiation status in lung epithelial cells.
UCHL1 increases the amount of epithelial to mesenchymal transition.
| 1

reach
Recently, it was shown that UCH-L1 enhances prostate cancer cell metastasis by increasing the expression of pro EMT genes such as vimentin and matrix metalloproteinases (MMPs) and reducing transcription of the EMT suppressor E-cadherin [XREF_BIBR].
UCHL1 decreases the amount of epithelial to mesenchymal transition.
| 1

reach
Recently, it was shown that UCH-L1 enhances prostate cancer cell metastasis by increasing the expression of pro EMT genes such as vimentin and matrix metalloproteinases (MMPs) and reducing transcription of the EMT suppressor E-cadherin [XREF_BIBR].
5-aza-2'-deoxycytidine increases the amount of UCHL1. 2 / 6
2 |

ctd
No evidence text available

ctd
No evidence text available
| 6
Prostaglandins inhibits UCHL1.
| 5

reach
In addition, some cyclopentenone prostaglandins, such as delta12-PGJ2 and 15d-PGJ2, inhibit the activities of UCH-L1 and induce ubiquitinated protein aggregation in neuronal cells, which may provide a molecular mechanism linking inflammation with neurodegeneration [XREF_BIBR, XREF_BIBR].

reach
Sequestosome 1/p62 and ubiquitin C-terminal hydrolase L1 (UCH-L1), which is inhibited by some of the prostaglandins of the J2 series, were co-localized in the protein aggregates containing ubiquitinat[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Additionally, the release of prostaglandins, such as biologically active cyclopentenone prostaglandins, that are massively produced in the rat brain after temporary focal ischemia, selectively blocks Uch-L1 activity.

reach
Moreover, J2 prostaglandins inhibit the de-ubiquitinating enzyme UCH-L1, which is down-regulated in AD brains; UCH-L1 down-regulation is inversely proportional to the number of neurofibrillary tangles.

reach
For example, the oxidative stress products cyclopentenone prostaglandins (CyPGs) and 4-hydroxynonenal (4-HNE) both decrease UCH-L1 solubility and facilitate aberrant protein interactions [XREF_BIBR].
Prostaglandins activates UCHL1.
| 1

reach
These prostaglandins trigger UCH-L1 unfolding and aggregation by forming a covalent adduct with a single thiol group on Cys 152.
UCHL1 affects MSC
| 2 4
UCHL1 inhibits MSC.
| 2 1
UCHL1 inhibits MSC. 3 / 3
| 2 1

sparser
As a consequence, UCHL1-inhibited MSCs effectively alleviated concanavalin A (ConA)-induced inflammatory liver injury.

sparser
As a consequence, UCHL1-inhibited MSCs effectively alleviated concanavalin A-induced inflammatory liver injury.

reach
Thus, iNOS plays an important role in UCHL1 mediated modulation of murine MSC immunosuppression.
UCHL1 activates MSC.
| 3
UCHL1 activates MSC. 3 / 3
| 3

reach
These data suggest that UCHL1 inhibition suppresses MSC apoptosis induced by proinflammatory cytokines via upregulation of Bcl-2.

reach
The results suggest that the proinflammatory cytokines upregulate UCHL1, which in turn promotes MSC apoptosis via Bcl-2-regulated activation of caspase 3.

reach
To this end, we investigated whether UCHL1 regulated proinflammatory cytokines induced MSC apoptosis.
UCHL1 affects HSPA5
| 6
UCHL1 activates HSPA5.
| 3
UCHL1 activates HSPA5. 3 / 3
| 3

reach
We found that GRP78 was significantly increased in CFs treated with UCHL1 siRNA, consistent with an investigation in SK-N-SH cells 35.

reach
This study demonstrates that UCHL1 enhances cardiac fibrosis after MI by interacting with and downregulating GRP78 by ubiquitination.

reach
We found that GRP78 was upregulated in TGF-beta1 stimulated CFs and a greater increase of GRP78 was observed in TGF-beta1 stimulated CFs treated with UCHL1 siRNA.
UCHL1 inhibits HSPA5.
| 2
UCHL1 inhibits HSPA5. 2 / 2
| 2

reach
Knockdown of UCHL1 upregulated GRP78 in CFs with TGF-beta1 stimulation and inhibition of GRP78 diminished the antifibrotic effect of UCHL1 knockdown.

reach
Moreover, we wondered if the effect of UCHL1 on fibrosis was related to GRP78, so we determined the GRP78 protein levels in CFs with and without TGF-beta1 and treated with and without UCHL1 knockdown.
UCHL1 decreases the amount of HSPA5.
| 1
UCHL1 decreases the amount of HSPA5. 1 / 1
| 1

reach
To find whether GRP78 is regulated by UCHL1, we examined the GRP78 protein level and found that knockdown of UCHL1 in CFs elevates the GRP78 protein levels.
UCHL1 affects HMBS
| 6
UCHL1 activates HMBS.
| 4
UCHL1 activates HMBS. 3 / 3
| 3

reach
We also found that overexpression of UCHL1 increased the UPS related proteins UBE1, PSMA7, ubiquitinated proteins, and monoubiquitin, and proteasomal activity.

reach
Mutants of alpha-synuclein, Uch-L1 and Parkin support the involvement of UPS dysfunction in PD.

reach
Mutants of alpha-synuclein, Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) and parkin support the involvement of UPS dysfunction in PD [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR].
UCHL1-C152A activates HMBS. 1 / 1
| 1

reach
Taken together, the UCH-L1 C152A mutation attenuated the disruption of the UPS induced by 15dPGJ2 treatment in primary neurons.
UCHL1 inhibits HMBS.
| 2
UCHL1 inhibits HMBS. 2 / 2
| 2

reach
Moreover, UCHL-1 mutation (I93M) reported in autosomal dominant PD reduces catalytic UPS activity in vitro (Nishikawa et al., 2003), and is associated with parkinsonism, cognitive deficits and cortica[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Inhibition of UCH-L1 hydrolase function in MN reduced UPS impairment and ameliorated proteinuria.
SNCA affects UCHL1
| 6
SNCA inhibits UCHL1. 4 / 4
| 4

reach
We also speculate that extracellular wild-type UCH-L1 plays some physiological role.In conclusion, this study showed that PD associated mutations in alpha-synuclein and UCH-L1 inhibit the unconvention[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Alpha-Synuclein and huntingtin mutations also inhibit the secretion of endogenous UCH-L1.

reach
In Figs. 4 and 5, we showed that alpha-synuclein and huntingtin mutations decreased the secretion of endogenous UCH-L1.

reach
Furthermore, under pathological conditions, when alpha-syn was overexpressed, blocking UCH-L1 by LDN resulted in an increase in LC3-II, which was not observed in control cells, suggesting a differential role of UCH-L1 activity under normal and pathological conditions.
SNCA-A53T inhibits UCHL1. 1 / 1
| 1

reach
A30P and A53T alpha-synuclein significantly reduced the secretion of UCH-L1 compared with wild-type alpha-synuclein.
SNCA-A30P inhibits UCHL1. 1 / 1
| 1

reach
A30P and A53T alpha-synuclein significantly reduced the secretion of UCH-L1 compared with wild-type alpha-synuclein.
UCHL1 affects glutathione
| 6
UCHL1 increases the amount of glutathione.
| 4
Modified UCHL1 increases the amount of glutathione. 2 / 2
| 2

reach
Quantitative analyses of the ratio of NADPH to NADP + (NADPH and NADP +) and that of GSH to GSSG (GSH and GSSG) revealed that the aberrant overexpression of UCHL1 increased intracellular levels of both NADPH and GSH.

reach
In agreement with these results, luciferase assay based quantification experiments also confirmed that overexpression of UCHL1 significantly increased the intracellular levels of both NADPH and GSH in a pentose phosphate pathway dependent manner.
UCHL1 increases the amount of glutathione. 2 / 2
| 2

reach
The UCHL1 mediated reprogramming elevated intracellular GSH levels, and consequently induced a radioresistant phenotype in a HIF-1-dependent manner.

reach
The UCHL1 dependent increase in the intracellular GSH levels was significantly suppressed by silencing the expression of a key molecule of the pentose phosphate pathway, the glucose-6-phosphate dehydrogenase X linked (G6pdx) gene XREF_BIBR, XREF_BIBR.
UCHL1 inhibits glutathione.
| 1
| 1

reach
The availability of a pharmacological inhibitor of UCHL1 allowed us to corroborate the glutathione effect in cultured cells.
UCHL1 activates glutathione.
| 1
| 1

reach
Because NADPH is known to be provided as a byproduct of the pentose-phosphate pathway (PPP) XREF_BIBR, XREF_BIBR, our result that UCHL1 overexpression increased radioresistance by producing GSH through the accelerated glycolysis and PPP is reasonable.
UCHL1 affects MDM2
| 1 5
UCHL1 decreases the amount of MDM2.
| 3
UCHL1 decreases the amount of MDM2. 2 / 2
| 2

reach
We further found that UCHL1 induced p53 accumulation and reduced MDM2 protein level, and subsequently upregulated the expression of p21, as well as cleavage of caspase3 and PARP, but not in catalytic mutant UCHL1 C90S expressed cells.

reach
Thus, in breast cancer models, UCHL1 can induce the levels of p53 and reduce mdm2 protein levels.
UCHL1-C90S decreases the amount of MDM2. 1 / 1
| 1

reach
Western blot showed that UCHL1 promoted p53 accumulation in breast tumor cells, along with the reduction of MDM2, while UCHL1 C90S did not increase p53 accumulation, but partly decreased the expression of MDM2 (XREF_FIG).
UCHL1 inhibits MDM2.
| 1 1
UCHL1 inhibits MDM2. 2 / 2
| 1 1

reach
They also observed an increase in polyubiquitination and degradation of mdm2 in response to UCH-L1 over-expression, suggesting UCH-L1 suppresses mdm2 to stabilize p53 levels [XREF_BIBR].

eidos
Thus , in breast cancer models , UCHL1 can induce the levels of p53 and reduce mdm2 protein levels .
UCHL1 activates MDM2.
| 1
UCHL1 activates MDM2. 1 / 1
| 1

reach
The results indicated that probably the extrinsic (Fas, Fas-L, Trail, DR4 and DR5) and intrinsic (cytochrome C) apoptotic pathways, the activation of p53 (phospho-Mdm-2 and phospho-p53) and the Bcl-2 family members (pro apoptotic member Bax, anti-apoptotic members Bcl-2 and Bcl-xL) combined with each other, participating in the process of apoptosis induced by UCH-L1 in MCF7 cells.
Methylmercury chloride increases the amount of UCHL1. 5 / 5
5 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
MTORC1 affects UCHL1
| 1 4
MTORC1 inhibits UCHL1. 5 / 5
| 1 4

reach
Antisense Uchl1 function is under the control of stress signalling pathways, as mTORC1 inhibition by rapamycin causes an increase in UCHL1 protein that is associated to the shuttling of antisense Uchl1 RNA from the nucleus to the cytoplasm.

reach
Under normal physiological conditions, AS Uchl1 is enriched in the nucleus, and upon rapamycin treatment, inhibition of mTORC1 triggers the transport of AS Uchl1 to the cytoplasm, which then targets the overlapping Uchl1 mRNA to active polysomes for cap independent translation.

reach
Inhibition of mTORC1 results in up-regulation of Uchl1 and is associated with the shuttling of Uchl1 from the nucleus to the cytoplasm [46].

eidos
Inhibition of mTORC1 results in up-regulation of Uchl1 and is associated with the shuttling of Uchl1 from the nucleus to the cytoplasm [ 46 ] .

reach
For example, TORC1 inhibition by rapamycin causes the shuttling of Uchl1 lncRNA from the nucleus to the cytoplasm.
UCHL1 affects cisplatin
| 5
UCHL1 inhibits cisplatin.
| 3
| 3

reach
Furthermore, UCHL1 expression level is negatively related to cisplatin resistance in ovarian cancer and knockdown of UCHL1 increased cisplatin resistance.

reach
Moreover, we have extended this finding to further experimentation and showed that knockdown of UCHL1 increased cisplatin resistance in both A2780 and IGROV1 ovarian cancer cells.

reach
For example, the level of UCHL1 is negatively related to cisplatin resistance in ovarian cancer, and knockdown of UCHL1 promotes cisplatin resistance.
UCHL1 activates cisplatin.
| 2
| 2

reach
However, the mechanism of how UCHL1 modulating cisplatin resistance has not been established.

reach
In this study, we described, for the first time, how UCHL1 modulates cisplatin resistance in ovarian cancers.
| 3
UCHL1 inhibits cell adhesion.
| 2

reach
Here we show that knockdown of UCH-L1 by RNAi inhibits the proliferation of BL cells in suspension and semisolid agar and activates strong LFA-1-dependent homotypic adhesion.

reach
Expression of a catalytically active UCH-L1 promoted the proliferation of a UCH-L1-negative EBV transformed lymphoblastoid cell line (LCL) and inhibited cell adhesion, whereas a catalytic mutant had no effect, confirming the requirement of UCH-L1 enzymatic activity for the regulation of these phenotypes.
UCHL1 activates cell adhesion.
| 1
| 1

reach
Uch-L1 changes cell morphology by regulating cell adhesion through Akt mediated pathwayby down-regulating the antagonistic phosphatase PHLPP1.
| 4
UCHL1 activates angiogenesis.
| 3
| 3

reach
This study also showed that UCH-L1 promotes angiogenesis of HUVECs, as well as invasion in cancer cells, by up-regulating ROS by deubiquitination of NOX4, suggesting that UCH-L1 plays a key role in angiogenesis of HUVECS by regulating ROS levels by deubiquitination of NOX4.

reach
These immunoprecipitation studies confirm that UCH-L1 deubiquitinates NOX4 in HUVECs, and suggest that UCH-L1 is involved in ROS mediated angiogenesis in HUVECs by modulating NOX4 activity via deubiqu[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Thus, a positive feedback loop between UCHL1, HIF-1alpha, and POSTN might be proposed where UCHL1 may promote angiogenesis directly via HIF-1alpha stabilization and indirectly via POSTN upregulation.
UCHL1 inhibits angiogenesis.
| 1
| 1

reach
Silencing UCH-L1 suppressed tubule formation in HUVECs, indicating that UCH-L1 promotes angiogenesis in vitro.
| 4
UCHL1 inhibits Cell Survival.
| 2

reach
Besides its soluble form, UCHL1 also exists in a membrane associated form (UCHL1 (M)) which has been shown to correlate with intracellular levels of alpha-synuclein : decreased UCHL1 (M) reduces alpha -synuclein levels and increases cell viability.

reach
Pharmacological inhibition of UCH-L1 farnesylation, on the other hand, was shown to reduce a-syn levels possibly by promoting its degradation through lysosomal pathway, and increased cell viability XREF_BIBR.
UCHL1 activates Cell Survival.
| 2
| 2

reach
UCH-L1 is highly expressed in neurons and has been demonstrated to promote cell viability and maintain neuronal integrity.

reach
UCH-L1 supports cell survival in H838 cells.
UCHL1 affects CD274
| 1 4
UCHL1 increases the amount of CD274.
| 4
UCHL1 increases the amount of CD274. 4 / 4
| 4

reach
UCHL1 promotes expression of PD-L1 in non small cell lung cancer cells.

reach
In the present study, we found that UCHL1 promotes the expression of PD-L1 in NSCLC cell lines.

reach
Moreover, the mechanism for UCHL1 to upregulate PD-L1 expression is that UCHL1 facilitated activation of AKT-P65 signaling pathway.

reach
In conclusion, these results demonstrated that UCHL1 promoted PD-L1 expression in NSCLC cells.
UCHL1 activates CD274.
| 1
UCHL1 activates CD274. 1 / 1
| 1

eidos
Moreover , the mechanism for UCHL1 to upregulate PD-L1 expression is that UCHL1 facilitated activation of AKT-P65 signaling pathway .

reach
UCHL1 wild type and TM were treated with different concentrations of GSNO and the reaction mixture was incubated at 37degreesC for 2h.

reach
Recombinant UCHL1 (200mul, 250muM) was treated with different concentrations of GSNO for 2h and loaded onto a Superdex 200, 10/30 (GE Healthcare Life Sciences, USA) gel filtration column.

reach
In case of cellular UCHL1 study, SH-SY5Y cells were treated with GSNO (500nM) and rotenone (1muM) for 16h.

reach
To identify whether UCHL1 was S nitrosylated in vitro the purified recombinant UCHL1 (2mg/ml) was treated with GSNO (10 molar excess).
| 1

reach
UCHL1 C90A (300muL, 0.1 mM) was treated with varying concentrations of GSNO (300muL, 0.1 mM, 1mM and 5mM) at 37degreesC for 30min.
Oxime affects UCHL1
| 2 3
Oxime inhibits UCHL1. 3 / 3
| 3

reach
LDN-57444 is an isatin O-acyl oxime reported to selectively inhibit UCHL1 in a reversible, competitive, and active site directed manner.

reach
These results suggested UCHL1 could regulate cellular SMN protein degradation as a result of ubiquitination at different stimulation.LDN-57444, a recently identified UCHL1 specific inhibitor, is an is[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
LDN-57444 is an isatin O-acyl oxime reported to selectively inhibit UCHL1 in a reversible, competitive, and active site directed manner [XREF_BIBR].
Oxime inhibits UCHL1. 1 / 1
| 1

sparser
Isatin O-acyl oximes efficiently inhibit UCH-L1 and tumor growth in lung cancer cells.
| PMC
Oxime inhibits UCHL1. 1 / 1
| 1

sparser
By utilizing high-throughput screening (HTS) to find inhibitors and traditional medicinal chemistry to optimize their affinity and specificity, we have identified a class of isatin O-acyl oximes that selectively inhibit UCH-L1 as compared to its systemic isoform, UCH-L3.
LanA1 affects UCHL1
| 5
LanA1 increases the amount of UCHL1.
| 3
Modified lanA1 increases the amount of UCHL1. 1 / 1
| 1

reach
Because we show that co-expression of LANA and LMP1 enhanced activation of the uch-l1 promoter and increased expression of UCH-L1, it is possible that their additive effects on UCH-L1 expression also occur during endogenous infection.
LanA1 bound to UCHL1 increases the amount of UCHL1. 1 / 1
| 1

reach
KSHV LANA interacts with UCH-L1 and induces the endogenous expression of UCHL1.
LanA1 bound to RBPJ increases the amount of UCHL1. 1 / 1
| 1

reach
While RBP-Jkappa itself can activate the uch-l1 promoter, indicating that RBP-Jkappa binds to the promoter independent of viral protein expression, the strong combined effect of LANA and RBP-Jkappa co-expression on the activity of the promoter suggests that LANA interacts with RBP-Jkappa and enhances activation of UCH-L1 expression.
LanA1 activates UCHL1.
| 2
LanA1 activates UCHL1. 2 / 2
| 2

reach
Our findings show that RBP-Jkappa expression enhanced LANA induced activation of the uch-l1 promoter and that endogenous RBP-Jkappa binds to endogenous uch-l1 promoter sequences in transformed B-cells.

reach
Finally, the mechanism by which LANA and LMP1 induce the uch-l1 promoter was explored.
UCHL1 affects daf-7
| 4
UCHL1 activates daf-7. 4 / 4
| 4

reach
These results indicate that UCH-L1 activity supports DAF-7 and TGF-beta signaling and suggest that UCH-L1 's deubiquitination activity is a potential therapeutic target for managing lung cancer.

reach
Here, we show that the deubiquitinating enzyme UBH-1 in Caenorhabditis elegans and its human homolog, ubiquitin C-terminal hydrolase-L1 (UCH-L1), stimulate DAF-7 and TGF-beta signaling, suggesting that this mode of regulation of TGF-beta signaling is conserved across animal species.

reach
Here, we show that the deubiquitinating enzyme UBH-1 in Caenorhabditis elegans and its human homolog, ubiquitin C-terminal hydrolase-L1 (UCH-L1), stimulate DAF-7 and TGF-beta signaling, suggesting that this mode of regulation of TGF-beta signaling is conserved across animal species.

reach
These results indicate that UCH-L1 activity supports DAF-7 and TGF-beta signaling and suggest that UCH-L1 's deubiquitination activity is a potential therapeutic target for managing lung cancer.
UCHL1 affects TCF_LEF
| 3
UCHL1 activates TCF_LEF. 3 / 4
| 3

reach
While UCH-L1 has been shown to inhibit alpha 2 -adrenergic receptor (AR) agonist mediated activation of ERK via a direct association with alpha 2A -AR receptor implicating a role of UCH-L1 in neuro-protection XREF_BIBR, it has also been documented that UCH-L1 up-regulates oncogenic beta-catenin and TCF and Akt signaling to induce tumor cell proliferation and migration contributing to tumor progression XREF_BIBR, XREF_BIBR.

reach
These observations imply that UCHL1 may contribute to CRC progression by activating the beta-catenin and TCF pathway through its deubi quitinating activity.

reach
In contrast, other studies have documented that UCH-L1 up-regulates beta-catenin and TCF via a positive feedback mechanism or exerts anti-apoptotic and growth stimulating effects, supporting an oncogenic potential of UCH-L1 [XREF_BIBR, XREF_BIBR].
UCHL1 affects NADPH
| 4
Modified UCHL1 increases the amount of NADPH. 4 / 4
| 4

reach
UCHL1 overexpression induced the reprogramming of carbohydrate metabolism and increased NADPH levels in a pentose phosphate pathway (PPP)-dependent manner.

reach
In agreement with these results, luciferase assay based quantification experiments also confirmed that overexpression of UCHL1 significantly increased the intracellular levels of both NADPH and GSH in a pentose phosphate pathway dependent manner.

reach
Quantitative analyses of the ratio of NADPH to NADP + (NADPH and NADP +) and that of GSH to GSSG (GSH and GSSG) revealed that the aberrant overexpression of UCHL1 increased intracellular levels of both NADPH and GSH.

reach
In detail, we found that UCHL1 overexpression induced the reprogramming of carbohydrate metabolism from oxidative phosphorylation to glycolysis in a HIF-1-dependent manner, and consequently increased [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
UCHL1 affects Caspase
| 4
UCHL1 activates Caspase. 4 / 4
| 4

reach
We found that UCH-L1 is a mediator of caspase independent, non apoptotic cell death also in diseased kidney podocytes by measuring cleavage of the protein PARP-1, caspase activity, cell death and cell morphology.

reach
Interestingly, Drosophila genetic studies have shown that increased UCH-L1 levels in the eye imaginal discs induces caspase dependent apoptosis, resulting in a rough eye phenotype [XREF_BIBR].

reach
It is possible that this contributes to our observation that UCH-L1 depletion (resulting in reduced Akt phosphorylation) enhanced caspase activation in response to bortezomib.

reach
UCH-L1 is a mediator of caspase independent, non apoptotic cell death in diseased kidney podocytes.
| 2 2
| 2 2

eidos
Moreover , in vitro tumorigenesis studies showed that UCHL1 expression stimulated oncogenesis and an invasive phenotype 117-119 , whereas UCHL1 depletion had antitumour effects and blocked cell migration in a lung cancer cell line 117 .

reach
The precise mechanism by which UCHL1 contributes to tumorigenesis remains unclear, although reports suggest that it contributes to cell survival signalling, cell cycle Regulatory T cells (T reg cells).

reach
Moreover, in vitro tumorigenesis studies showed that UCHL1 expression stimulated oncogenesis and an invasive phenotype 117-119 , whereas UCHL1 depletion had antitumour effects and blocked cell migration in a lung cancer cell line 117 .

eidos
The precise mechanism by which UCHL1 contributes to tumorigenesis remains unclear , although reports suggest that it contributes to cell survival signalling , cell cycle Regulatory T cells ( T reg cells ) .
TFDP1 affects UCHL1
4 |
TFDP1 decreases the amount of UCHL1. 4 / 4
4 |

biopax:msigdb
No evidence text available

biopax:msigdb
No evidence text available

biopax:msigdb
No evidence text available

biopax:msigdb
No evidence text available
4 |
Sodium arsenite increases the amount of UCHL1.
3 |
Sodium arsenite increases the amount of UCHL1. 3 / 3
3 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
Sodium arsenite decreases the amount of UCHL1.
1 |
Sodium arsenite decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
UCHL1 affects sub
| 4
UCHL1 inhibits sub.
| 2
UCHL1-I93M inhibits sub. 2 / 2
| 2

reach
In in vitro reconstituted assays, UCHL1 I93M was found to have reduced DUB activity, thus it was initially hypothesized that PD could be due to partial loss of UCHL1 activity.

reach
UCHL1 I93M has reduced DUB activity in vitro [XREF_BIBR], thus it was initially hypothesized that partial loss of UCHL1 function may result in PD.
UCHL1 activates sub.
| 2
UCHL1 activates sub. 2 / 2
| 2

reach
Thus, upregulated p53 signaling by UCHL1 through its DUB activity was involved in G0/G1 cell cycle arrest and apoptosis in breast cancer cells.

reach
The UCH-L1 substrate increases with time, since UCH-L1 overexpression leads to increase DUB activity of its substrate which has the effect of lowering the degradation rate.
UCHL1 affects mTORC2
| 2 2
UCHL1 activates mTORC2.
| 2 1
UCHL1 activates mTORC2. 3 / 3
| 2 1

eidos
Overall , these results suggest that UCHL1 elicits a negative effect on mTORC1 and a positive effect on mTORC2 activity in slow twitch skeletal muscle .

eidos
Consistently , in C2C12 cells , UCHL1 knockdown increased the myotube size , enhanced mTORC1 activity , and reduced mTORC2 activities as compared with control cells .

reach
Consistently, in C2C12 cells, UCHL1 knockdown increased the myotube size, enhanced mTORC1 activity, and reduced mTORC2 activities as compared with control cells.
UCHL1 inhibits mTORC2.
| 1
UCHL1 inhibits mTORC2. 1 / 1
| 1

reach
Meanwhile, UCHL1 skmKO enhanced mTORC1 activity and reduced mTORC2 activity in soleus but not in EDL.
| 3

reach
Downregulation of UCH-L1 expression and activity in beta-cells induces ER stress and apoptosis.

reach
Uchl1 (-/-) mice had increased ER stress and beta cell apoptosis.

reach
Downregulation of UCH-L1 expression and activity in beta cells induces ER stress and apoptosis [XREF_BIBR].

reach
Here, we show that increased expression of h-IAPP (but not r-IAPP) decreased UCH-L1 levels and that loss of UCH-L1 expression and activity induced ER stress and apoptosis in beta-cells.
UCHL1 affects STMN1
| 3
UCHL1 inhibits STMN1.
| 1
UCHL1 inhibits STMN1. 1 / 2
| 1

reach
Over-expression of UCHL1 in P19 and NSC34 cells significantly reduced the level of SMN proteins in vivo, and, in fact, purified UCHL1 was shown to be able to enhance, in a dose dependent manner, the level of ubiquitinated SMN in vitro.
UCHL1 activates STMN1.
| 2
UCHL1 activates STMN1. 2 / 2
| 2

reach
The same result was observed in P19 cells, although the decreased level of SMN protein mediated by UCHL1 was not in parallel with the increased amounts of UCHL1 transfection plasmid.

reach
In this study, we found a novel therapeutic target, UCHL1, can modulate SMN protein degradation.
UCHL1 affects Proteasome
| 3
UCHL1 inhibits Proteasome.
| 1
| 1

reach
Although the overexpression of UCH-L1 inhibits proteasome activity in cultured cells, its biological significance in living organisms has not been clarified in detail.
UCHL1 activates Proteasome.
| 2
| 2

reach
The first study to show the effect of PDE inhibition on UPS mediated degradation of disease related proteins [XREF_BIBR, XREF_BIBR] demonstrated that administration of either rolipram (a selective PDE4 inhibitor) or purified cell-permeable Uch-L1 (ubiquitin C-terminal hydrolase L1) led to proteasome mediated degradation in a mouse model of Alzheimer 's-related amyloid deposition [XREF_BIBR].

reach
Conversely, pharmacological inhibition of UCH-L1 activity resulted in decreased levels of monomeric ubiquitin and decreased rates of proteasome mediated degradation.
UCHL1 affects BDNF
| 4
UCHL1 activates BDNF.
| 3
UCHL1 activates BDNF. 3 / 3
| 3

reach
We found that UCHL-1 restored BDNF and TrkB transport not only in the presence of Abeta but also with IL-1beta, suggesting the two agents share a common mechanism of interfering with ubiquitination dependent trafficking mechanisms.

reach
Based on our previous findings that UCH-L1 rescues BDNF and TrkB retrograde transport deficits induced by Abeta [XREF_BIBR], we believe UCH-L1 is a mechanistically interesting and relevant protein of interest.

reach
We previously demonstrated that impaired retrograde transport in the presence of Abeta occurs through an ubiquitin dependent mechanism, and that the deubiquiting enzyme UCHL-1 restores retrograde transport of BDNF and TrkB [XREF_BIBR].
UCHL1 inhibits BDNF.
| 1
UCHL1 inhibits BDNF. 1 / 1
| 1

reach
Importantly, UCH-L1 treatment rescued IL-1beta-induced impairment of BDNF retrograde signaling to 1.8 times baseline +/-23%, n = 3 independent cultures).
APP affects UCHL1
| 4
APP inhibits UCHL1.
| 3
APP inhibits UCHL1. 3 / 3
| 3

reach
It has been found that Abeta may down-regulate Uch-L1 in the AD brain, which in turn impairs BDNF and TrkB mediated retrograde signaling, compromising synaptic plasticity and neuronal survival.

reach
It is also known that Abeta downregulates the UCHL1 in AD, thereby, compromising synaptic plasticity, as well as neuronal survival.

reach
Further, our results support the idea that in AD, Abeta may down-regulate UCH-L1 in the AD brain, which in turn impairs BDNF and TrkB mediated retrograde signaling, compromising synaptic plasticity and neuronal survival.
APP activates UCHL1.
| 1
APP activates UCHL1. 1 / 1
| 1

reach
In a model of APP and PS1 mice, UCHL1 transduction restored normal cognition and synaptic function in hippocampal slices treated with Abeta.

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
Bisphenol A affects UCHL1
3 | 1
Bisphenol A increases the amount of UCHL1.
2 |
Bisphenol A increases the amount of UCHL1. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Bisphenol A decreases the amount of UCHL1.
1 |
Bisphenol A decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Bisphenol A activates UCHL1.
| 1
| 1

reach
Generally, BPA caused a decrease in the number of the enteric neuronal cell bodies containing PGP 9.5, but the intensity of these fluctuations was conditional upon the dosage of BPA and kind of the enteric plexus (XREF_TABLE and XREF_FIG).
UCHL3 affects UCHL1
| 4
UCHL3 inhibits UCHL1.
| 2
UCHL3 inhibits UCHL1. 2 / 2
| 2

reach
The screening of over 40 000 compounds against the closely related ubiquitin Cterminal hydrolase L1 (UCH-L1) and L3 (UCH-L3) enzymes allowed the development of a UCHL1-specific inhibitor based on an isatin O-acyl oxime scaffold [105] .

reach
We found that UCH-L1 is highly induced by UCH-L3 knockdown in RWPE1.
UCHL3 decreases the amount of UCHL1.
| 1
UCHL3 decreases the amount of UCHL1. 1 / 1
| 1

reach
Interestingly, we found that knockdown of UCH-L3 induces the expression of UCH-L1 which is repressed by epigenetic modification in RWPE1.
UCHL3 activates UCHL1.
| 1
UCHL3 activates UCHL1. 1 / 1
| 1

reach
UCHL1 and UCHL3 are 73% similar but display different patterns of tissue specific gene expression : an upstream neuron-restrictive silencing element (NRSE) drives neuron specific expression in the former and renders it a critical player in neuronal homeostasis (UCHL1 deficiency in neurodegeneration is not physiologically rescued by UCHL3).
REST affects UCHL1
| 3
REST increases the amount of UCHL1.
| 1
REST increases the amount of UCHL1. 1 / 2
| 1

reach
Transient overexpression of NRSF reduces endogenous levels of UCHL1 in DMS53 cells, whereas NRSF siRNA transfection increases UCHL1 expression in U87-MG.
REST inhibits UCHL1.
| 1
REST inhibits UCHL1. 1 / 1
| 1

reach
28 Therefore, we tested whether NRSF and REST overexpression reduced the mRNA levels of known target genes SNAP25 and synaptophysin and the products of putative target genes UCHL1 and alpha-internexin[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
REST decreases the amount of UCHL1.
| 1
Modified REST decreases the amount of UCHL1. 1 / 1
| 1

reach
Transient overexpression of NRSF reduces endogenous levels of UCHL1 in DMS53 cells, whereas NRSF siRNA transfection increases UCHL1 expression in U87-MG.
LPL affects UCHL1
| 4
LPL decreases the amount of UCHL1.
| 2
LPL decreases the amount of UCHL1. 2 / 2
| 2

reach
Since adult (12 months, rescued) and new born LPL deficient mice (without rescue) both displayed presynaptic dysfunction (Xian et al., 2009; Liu et al., 2014), we examined adult LPL deficient mice and[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
These results indicated that LPL deficiency gave rise to increased alpha-syn aggregation and decreased UCHL1 expression, which may further influence synaptic function.LPL deficient mice on C57BL/6J ba[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
LPL increases the amount of UCHL1.
| 1
LPL increases the amount of UCHL1. 1 / 1
| 1

reach
These results suggest that DNMT1 inhibition regulates UCHL1 expression, eventually affecting ubiquitination.Taken together, LPL deficiency causes nuclear retention of DNMT1, and affects DNA methylatio[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
LPL activates UCHL1.
| 1
LPL activates UCHL1. 1 / 1
| 1

reach
In order to examine whether excess LPL will lead to increased UCHL1, we overexpressed LPL in HEK293 cells.
IAPP affects UCHL1
| 4
IAPP activates UCHL1.
| 2
IAPP activates UCHL1. 2 / 2
| 2

reach
In contrast, Costes etal.11 reported that beta-cell dysfunctional endoplasmic reticulum associated degradation in type 2 diabetes is mediated by human IAPP induced UCH-L1 deficiency.

reach
beta-Cell Dysfunctional ERAD/Ubiquitin/Proteasome System in Type 2 Diabetes Mediated by Islet Amyloid Polypeptide Induced UCH-L1 Deficiency.
IAPP decreases the amount of UCHL1.
| 2
IAPP decreases the amount of UCHL1. 1 / 1
| 1

reach
One of the factors associated with dysfunctional proteasome activity is mediated by the accumulation of IAPP, which lowers the expression of UCH-L1 protein (ubiquitin hydrolase), leading to ER stress and increased levels of cleaved caspase 3, activating apoptosis [XREF_BIBR].
Modified IAPP decreases the amount of UCHL1. 1 / 1
| 1

reach
Further studies in human islets revealed that elevated levels of human IAPP downregulates the expression of UCH-L1 by an unknown mechanism [XREF_BIBR].
Paraquat affects UCHL1
3 |
Paraquat decreases the amount of UCHL1. 3 / 3
3 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
| 3
| 3

reach
In the present study we also have demonstrated that the nitric oxide modification which is likely to happen in nitrosative stress or excitotoxicity condition destabilizes the UCHL1 structure and induces the aggregation of UCHL1.

reach
Collectively, above findings indicated that increase of cellular nitric oxide promoted UCHL1 nitrosylation of three critical cysteine residues (XREF_FIG).

reach
Rotenone treated SH-SY5Y cells enhance NO production thereby promoting S nitrosylation of UCHL1.
Naphthalene affects UCHL1
2 | 1
Naphthalene increases the amount of UCHL1. 3 / 3
2 | 1

ctd
No evidence text available

ctd
No evidence text available

reach
We found that naphthalene induces a significant increase in PGP9.5 expression in the days immediately following the exposure, whereas no significant effect on PGP9.5 expression was detected on a longer term in mice that were exposed to NNK when compared to control animals.
Isatin affects UCHL1
| 3
Isatin inhibits UCHL1. 3 / 3
| 3

reach
By utilizing high-throughput screening (HTS) to find inhibitors and traditional medicinal chemistry to optimize their affinity and specificity, we have identified a class of isatin O-acyl oximes that selectively inhibit UCH-L1 as compared to its systemic isoform, UCH-L3.

reach
LDN-57444 is an isatin O-acyl oxime reported to selectively inhibit UCHL1 in a reversible, competitive, and active site directed manner.

reach
LDN-57444 is an isatin O-acyl oxime reported to selectively inhibit UCHL1 in a reversible, competitive, and active site directed manner [XREF_BIBR].
3 |
Benzo[a]pyrene increases the amount of UCHL1. 3 / 3
3 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

reach
Unlike in apoptosis, HtrA2 and Omi did not cleave another protease, ubiquitin C-terminal hydrolase (UCH-L1) during TNF induced necroptosis, but rather induced monoubiquitination indicative for UCH-L1 activation.
UCHL1 affects doxorubicin
| 3
| 3

reach
The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis.

reach
Upregulation of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Mediates the Reversal Effect of Verapamil on Chemo-Resistance to Adriamycin of Hepatocellular Carcinoma.

reach
Erratum : The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis.

reach
Overexpression of UCHL1 was found to induce senescence, likely due to increased production of p14ARF, p53, p27KIP1 and decreased MDM2 levels [XREF_BIBR].

reach
In this context, PEM treatment may induce senescence in NSCLC cells XREF_BIBR, however, it is possible that UCHL1 levels could be increased in senescent cells, thereby modifying the senescence process XREF_BIBR.

reach
Indeed, we could observe more cells with an increased level of SA-beta-gal in cells overexpressing UCHL1 compared to the respective mock control cells, suggesting that the overexpression of UCHL1 leads to the induction of cellular senescence in LNCaP prostate cancer cells.
UCHL1 affects Melanin
| 3
| 3

reach
Conversely, knockdown of UCHL1 using siRNA induced melanin contents by 21.5% in NHEMs.

reach
A melanin content assay revealed that overexpression of UCHL1 significantly inhibited melanin synthesis in NHEMs and MNT-1 cells by 16.2% and 35.5%, respectively.

reach
In contrast, overexpression of UCHL1 in melanocytes via adenovirus transfection led to downregulation of tyrosinase, dopachrome tautomerase, and tyrosinase related protein-1 and decreased melanin contents.
RBPJ affects UCHL1
| 1 2
RBPJ activates UCHL1. 3 / 3
| 1 2

reach
The ability of RBP-Jkappa to activate the uch-l1 promoter during EBV infection was confirmed by ChIP assays.

sparser
Reporter assays revealed that LANA and RBP-Jκ separately activated the uchl-1 promoter to modest, yet significant (p < 0.05), levels.

reach
Activation of the uch-l1 promoter by RBP-Jkappa.
NOX4 affects UCHL1
| 3
NOX4 activates UCHL1. 3 / 3
| 3

reach
The amount of NOX4 protein expressed in B16F10 cells overexpressing UCH-L1 was also not significantly different from that in B16F10 cells in which UCH-L1 was knocked down (XREF_SUPPLEMENTARY).

reach
Silencing NOX4, which generates H 2 O 2, with siRNA eliminated the effect of UCH-L1 on cell migration.

reach
UCH-L1 induced active NOX4 by deubiquitination of NOX4, and then increased ROS which induce angiogenesis in HUVECs.
HTRA2 affects UCHL1
| 1
HTRA2 decreases the amount of UCHL1. 1 / 3
| 1

reach
Notably, we show that released, cytosolic HtrA2 decreases UCH-L1 protein level and its hydrolase activity through HtrA2 mediated cleavage of UCH-L1 under apoptotic conditions.
Ethanol affects UCHL1
3 |
Ethanol increases the amount of UCHL1.
2 |
Ethanol increases the amount of UCHL1. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Ethanol decreases the amount of UCHL1.
1 |
Ethanol decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Cadmium dichloride decreases the amount of UCHL1.
2 |
Cadmium dichloride decreases the amount of UCHL1. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Cadmium dichloride increases the amount of UCHL1.
1 |
Cadmium dichloride increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Wnt affects UCHL1
| 3
Wnt activates UCHL1.
| 2
Wnt activates UCHL1. 2 / 2
| 2

reach
However, it is unknown whether the canonical Wnt and beta-catenin signaling mediates high glucose induced upregulation of UCH-L1 in podocytes.

reach
Maybe, in HG circumstance, the increased UCH-L1 which was mediated by Wnt and beta-catenin pathway changed several important proteins of podocytes, and corresponding remolded actin cytoskeleton and improved cell migration.
Wnt increases the amount of UCHL1.
| 1
Wnt increases the amount of UCHL1. 1 / 1
| 1

reach
Therefore, whether UCH-L1 expression is increased or not in HG stimulated podocytes and is mediated by Wnt and beta-catenin is not clear at present.
UCHL1 affects dopamine
| 3
UCHL1 activates dopamine.
| 2
| 2

reach
Similarly, inactivation of UCHL-1 in mice did not produce DA neurodegeneration, but did result in axonal dystrophy syndrome or motor ataxia [XREF_BIBR].

reach
All these findings seem consistent with a gain-of-toxic function of the UCH-L1 I93M mutant but little or no function of UCH-L1 wildtype or its lack in alphaSN induced DA damage.
UCHL1 decreases the amount of dopamine.
| 1
UCHL1-I93M decreases the amount of dopamine. 1 / 1
| 1

reach
Mice over-expressing UCH-L1 (I93M) had fewer dopaminergic neurons in the substantia nigra and decreased striatal dopamine levels compared to wild-type mice.
UCHL1 affects ZUP1
| 3
UCHL1 inhibits ZUP1.
| 2
UCHL1 inhibits ZUP1. 2 / 2
| 2

eidos
Thus , the finding in this study that UCHL1 / L3 inhibition is not as efficient in blocking viral replication as general inhibition of proteasome function or knockdown of ubiquitin is likely attributed to incomplete inhibition of DUBs by UCHL1 / L3 inhibitors .

eidos
Thus , it is speculated that DUB inhibition by UCHL1 / L3 inhibitors alone , in the absence of apparent inhibition of protein degradation , is not sufficient enough to block viral replication .
UCHL1 activates ZUP1.
| 1
UCHL1 activates ZUP1. 1 / 1
| 1

eidos
Although UCHL1 is identified as an important DUB , inhibition of UCHL1 alone has been shown to only partially block the activities of DUBs [ 41 ] .
UCHL1 affects STAT1
| 3
UCHL1 inhibits STAT1.
| 2
UCHL1 inhibits STAT1. 2 / 2
| 2

reach
UCHL1 inhibition promotes the activation of NF-kappaB and STAT1 signaling.

reach
These data together suggest that UCHL1 also negatively regulates the NF-kappaB and STAT1 pathway to inhibit the immunosuppressive capacity and IDO expression of human MSCs, indicating an essential role of UCHL1 to regulate the immunosuppressive capacity of both human and murine MSCs.
UCHL1 activates STAT1.
| 1
UCHL1 activates STAT1. 1 / 1
| 1

reach
UCHL1 negatively regulates cytokines and induces NF-κB and STAT1 signaling [137].
UCHL1 affects NTRK2
| 3
UCHL1 activates NTRK2.
| 2
UCHL1 activates NTRK2. 2 / 2
| 2

reach
We found that UCHL-1 restored BDNF and TrkB transport not only in the presence of Abeta but also with IL-1beta, suggesting the two agents share a common mechanism of interfering with ubiquitination dependent trafficking mechanisms.

reach
We previously demonstrated that impaired retrograde transport in the presence of Abeta occurs through an ubiquitin dependent mechanism, and that the deubiquiting enzyme UCHL-1 restores retrograde transport of BDNF and TrkB [XREF_BIBR].
UCHL1 increases the amount of NTRK2.
| 1
Modified UCHL1 increases the amount of NTRK2. 1 / 1
| 1

reach
Loss of UCHL1 diminished TrkB expression at the plasma membrane and programmed its trafficking to the degradation pathway, leading to abrogated RTK signaling.
UCHL1 affects CASP3
| 3
UCHL1 inhibits CASP3.
| 2
UCHL1 inhibits CASP3. 2 / 2
| 2

reach
Inhibition of UCH-L1 function led to increased caspase-3 activity and cleavage at concentrations above 30 mumol/l (XREF_FIG A and B).

reach
UCH-L1 knockdown increased the cleavage of caspase-3 and PARP in both r-IAPP- and h-IAPP-transduced cells in comparison to scramble transfected cells.
UCHL1 activates CASP3.
| 1
UCHL1 activates CASP3. 1 / 1
| 1

reach
Interestingly, UCHL1 inhibition markedly inhibited IFN-gamma plus TNF-alpha-induced decrease of Bcl-2 and activation of caspase 3, indicating the suppression of IFN-gamma plus TNF-alpha-induced MSC apoptosis.
UCHL1 affects BACE
| 3
UCHL1 inhibits BACE.
| 2
UCHL1 inhibits BACE. 2 / 2
| 2

reach
UCHL1 also accelerates beta-secretase degradation, impairs APP processing and decreases Abeta 109.

reach
Ubiquitin C-terminal hydrolase 1 is oxidized and downregulated in AD 110, and UCHL1 inhibition up-regulates beta-secretase.
UCHL1 decreases the amount of BACE.
| 1
Modified UCHL1 decreases the amount of BACE. 1 / 1
| 1

reach
Furthermore, overexpression of UCHL1 reduces the production of Abeta by downregulating the protein level of beta-secretase and APP [XREF_BIBR, XREF_BIBR].
UCHL1 is modified
| 2 1
UCHL1 is produced.
| 1 1
UCHL1 is produced. 2 / 2
| 1 1

trips
UCH-L1 has been implicated in the regulation of phenotypic properties associated with malignant cell growth but the underlying mechanisms have not been elucidated.

reach
Our data show that GSPB2 preincubation markedly inhibited AGE induced proliferation and migration of HASMCs in a dose dependent manner and upregulated the protein level of UCH-L1.
UCHL1 is degraded.
| 1
UCHL1 is degraded. 1 / 1
| 1

trips
By two-dimensional (2D) immunoblotting, comigration and microsequencing of proteins recovered from 2D gels we have identified PGP 9.5 UCH-L1 as polypeptide IEF SSP 6104 (Mr = 27,000, pI = 5.49) in the comprehensive 2D gel cellular protein database of human embryonal lung MRC-5 fibroblasts [(1989) Electrophoresis 10, 76 115; (1990) Electrophoresis 11, 1072 1113].
HTT affects UCHL1
| 3
Mutated HTT inhibits UCHL1. 2 / 2
| 2

reach
alpha-Synuclein and huntingtin mutations also inhibit the secretion of endogenous UCH-L1.

reach
In Figs. 4 and 5, we showed that alpha-synuclein and huntingtin mutations decreased the secretion of endogenous UCH-L1.
HTT inhibits UCHL1. 1 / 1
| 1

reach
Thus, mutant alpha synuclein and huntingtin do not directly inhibit the secretion of UCH-L1; instead, they may affect components of the unknown machinery required for UCH-L1 secretion.
CNOT7 affects UCHL1
| 3
CNOT7 activates UCHL1.
| 2
CNOT7 activates UCHL1. 2 / 2
| 2

reach
Furthermore, ectopic expression of CNOT7 in CNOT7KD cells appeared to partially rescue the increase in both Uchl1 and Cdkl2 mRNA, indicating that this increased stability was due to CNOT7 depletion (XREF_SUPPLEMENTARY).

reach
These results indicate that CNOT7 directly regulates the poly (A) tail length and overall stability of Uchl1 and likely many other RNAs identified in XREF_FIG.
CNOT7 inhibits UCHL1.
| 1
CNOT7 inhibits UCHL1. 1 / 1
| 1

reach
Ectopic CNOT7 prevented the glycine induced increase in Uchl1 poly (A) (XREF_FIG).
BACE1 affects UCHL1
2 |
BACE1 inhibits UCHL1.
1 |
BACE1 inhibits UCHL1. 1 / 2
1 |

bel
Aβ 42 mediated increase in BACE1 expression is accompanied by a decrease in Uch-L1 expression and activity in dif- ferent cellular models and in sporadic AD brains, which interferes with the lysosomal degradation of BACE1 [52,56].
BACE1 decreases the amount of UCHL1.
1 |
BACE1 decreases the amount of UCHL1. 1 / 1
1 |

bel
Aβ 42 mediated increase in BACE1 expression is accompanied by a decrease in Uch-L1 expression and activity in dif- ferent cellular models and in sporadic AD brains, which interferes with the lysosomal degradation of BACE1 [52,56].

reach
For example, the oxidative stress products cyclopentenone prostaglandins (CyPGs) and 4-hydroxynonenal (4-HNE) both decrease UCH-L1 solubility and facilitate aberrant protein interactions [XREF_BIBR].

reach
We examined whether HNE directly modifies and inactivates UCH-L1 in vitro.

reach
To support this view, in vitro data showed that addition of HNE induced the HNE modification of recombinant UCHL1 [XREF_BIBR].
2,2',4,4',5-brominated diphenyl ether decreases the amount of UCHL1.
2 |

ctd
No evidence text available

ctd
No evidence text available
2,2',4,4',5-brominated diphenyl ether increases the amount of UCHL1.
1 |

ctd
No evidence text available
2 | 1
Streptozocin inhibits UCHL1.
| 1
| 1

reach
In vivo, streptozotocin progressively depleted UCHL1 from islet cores and in 50% of animals, an associated plasma UCHL1 surge was detected preceding the GAD65 peak.
Streptozocin increases the amount of UCHL1.
1 |
Streptozocin increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Streptozocin decreases the amount of UCHL1.
1 |
Streptozocin decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
3 |
Pirinixic acid increases the amount of UCHL1.
1 |
Pirinixic acid increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Pirinixic acid decreases the amount of UCHL1.
1 |
Pirinixic acid decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Pirinixic acid activates UCHL1.
1 |

ctd
No evidence text available
2 | 1
| 1

reach
Pathological methamphetamine exposure triggers the accumulation of neuropathic protein amyloid-beta by inhibiting UCHL1.
Methamphetamine increases the amount of UCHL1.
1 |
Methamphetamine increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Methamphetamine decreases the amount of UCHL1.
1 |
Methamphetamine decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Doxycycline affects UCHL1
| 3
Doxycycline inhibits UCHL1.
| 1
| 1

reach
After selection of stable integrants, doxycycline was added to deplete endogenous UCH-L1, and cell viability was monitored daily.
Doxycycline increases the amount of UCHL1.
| 1
Doxycycline increases the amount of UCHL1. 1 / 1
| 1

reach
As shown in Figure XREF_FIG A, cell death in untreated UCH-L1 tet-on podocytes was negligible whereas induction of UCH-L1 expression by doxycycline significantly increased the numbers of dying podocytes (thereby also demonstrating the functionality of the system).
Doxycycline activates UCHL1.
| 1
| 1

reach
When we analyzed lysates from UCH-L1 tet-on podocytes treated with doxycycline for 72h or not in Western blots, the full-length 116-kDa PARP-1 band was uniformly visible in all samples, together with a pattern of additional bands.
UCHL1 affects NOS2
| 3
UCHL1 decreases the amount of NOS2.
| 2
UCHL1 decreases the amount of NOS2. 1 / 1
| 1

reach
UCHL1 inhibition enhances iNOS expression in murine MSCs.
Modified UCHL1 decreases the amount of NOS2. 1 / 1
| 1

reach
Besides, compared with shNC-MSCs, shUCHL1-MSCs also exhibited upregulated iNOS expression after IFN-gamma plus TNF-alpha stimulation, whereas UCHL1 overexpression inhibited iNOS expression.
UCHL1 inhibits NOS2.
| 1
UCHL1 inhibits NOS2. 1 / 1
| 1

reach
The phenomenon that overexpression of UCHL1 could inhibit TNF-alpha-induced iNOS in vascular endothelial cells, has also been presented by Yoichi et al. 31.
UCHL1 affects Cyclin
| 3
UCHL1 increases the amount of Cyclin.
| 1
UCHL1 increases the amount of Cyclin. 1 / 1
| 1

reach
UCHL1 silencing reduced cell proliferation in vitro and in vivo, cyclin B1 protein levels and cell cycle progression.
UCHL1 decreases the amount of Cyclin.
| 1
Modified UCHL1 decreases the amount of Cyclin. 1 / 1
| 1

reach
Exogenous expression of UCHL1 results in accumulation of p27Kip1 and suppressed Cyclin A expression.
UCHL1 activates Cyclin.
| 1
Modified UCHL1 activates Cyclin. 1 / 1
| 1

reach
In further analysis, we found evidence that exogenous expression of UCHL1 suppress LNCaP cells growth probably via p53 mediated inhibition of Akt and PKB phosphorylation and also via accumulation of p27kip1 a cyclin dependant kinase inhibitor of cell cycle regulating proteins.
UCHL1 affects CDKN1B
| 3
UCHL1 increases the amount of CDKN1B.
| 2
Modified UCHL1 increases the amount of CDKN1B. 1 / 1
| 1

reach
In our hands we observed that UCHL1 overexpression positively regulates p27Kip1 levels in LNCaP cells.
UCHL1 increases the amount of CDKN1B. 1 / 1
| 1

reach
UCH-L1 enhanced cytoplasmic p27 (Kip1) levels by nuclear export and decreased poly-ubiquitination and proteasomal degradation of p27 (Kip1).
UCHL1 activates CDKN1B.
| 1
UCHL1 activates CDKN1B. 1 / 1
| 1

reach
In contrast, UCH-L1 levels and activity increased podocyte hypertrophy and total protein content in culture, specifically of cytoplasmic p27 (Kip1).
| 3
| 2

reach
We also speculate that extracellular wild-type UCH-L1 plays some physiological role.In conclusion, this study showed that PD associated mutations in alpha-synuclein and UCH-L1 inhibit the unconvention[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
| 1

reach
Additionally, the familial PD associated I93M mutation in UCH-L1 decreases the secretion of I93M UCH-L1.
| 1

reach
The recent finding that mutations in the carboxy-terminal hydrolase UCH-L1 cause PD supports this hypothesis 35.
PKC affects UCHL1
| 3
PKC increases the amount of UCHL1.
| 1
PKC increases the amount of UCHL1. 1 / 1
| 1

reach
The activator of PKCβII greatly increased the expression of PGP9.5 and VEGF ( P < 0.05, P < 0.01) and enhanced MWT ( P < 0.001), while inhibitor of PKCβII decreased the expression of PGP9.5 and VEGF and attenuated MWT ( P < 0.05, P < 0.01, P < 0.001).
PKC decreases the amount of UCHL1.
| 1
PKC decreases the amount of UCHL1. 1 / 1
| 1

reach
The activator of PKCβII greatly increased the expression of PGP9.5 and VEGF ( P < 0.05, P < 0.01) and enhanced MWT ( P < 0.001), while inhibitor of PKCβII decreased the expression of PGP9.5 and VEGF and attenuated MWT ( P < 0.05, P < 0.01, P < 0.001).
PKC activates UCHL1.
| 1
PKC activates UCHL1. 1 / 1
| 1

reach
PKCβII-induced upregulation of PGP9.5 and VEGF in postoperative persistent pain in rats.

eidos
2 ) Figure 1A and B , showed FK506 caused more than 40 % reduction of PGP9.5 + and IL-31R fiber density , why do the authors think this is not significant ?

eidos
2 ) Figure 1A and B , showed FK506 caused more than 40 % reduction of PGP9.5 + and IL-31R fibre density , why do the authors think this is not significant ?
| 2

reach
XREF_BIBR Western blots of lysates from these cells (XREF_FIG) indicated that only staurosporine induced the degradation of either eIF4G1 or UCH-L1 when HtrA2 and Omi was expressed (Lane 3 versus 8).

reach
The ucf-101 inhibitor also prevented the staurosporine induced degradation of the verified HtrA2 and Omi substrate UCH-L1 (XREF_FIG).
Sirolimus affects UCHL1
| 2
Sirolimus increases the amount of UCHL1. 2 / 2
| 2

reach
Though UCHL1 transcription was maintained after SE, we observed downregulation of the pro translational antisense Uchl1 (AsUchl1) and confirmed that both AsUchl1 and rapamycin can increase UCHL1 expression in vivo.

reach
Furthermore, as AsUchl1 export into the cytoplasm increases following mTOR inhibition [XREF_BIBR], we confirmed that rapamycin, a potent mTOR inhibitor and anti-epileptogenic agent [XREF_BIBR, XREF_BIBR], increased UCHL1 expression.
| 2

sparser
Sequestosome 1/p62 and ubiquitin C-terminal hydrolase L1 (UCH-L1), which is inhibited by some of the prostaglandins of the J2 series, were co-localized in the protein aggregates containing ubiquitinat[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

sparser
Moreover, J2 prostaglandins inhibit the de-ubiquitinating enzyme UCH-L1 (Li et al., xref ; Liu et al., xref ), which is down-regulated in AD brains; UCH-L1 down-regulation is inversely proportional to the number of neurofibrillary tangles (Choi et al., xref ).
| 2

reach
We also showed that some of the PGJ2 metabolites inhibit the ubiquitin C-terminal hydrolase UCH-L1 without directly affecting proteasome activity.

reach
Neither PGJ2 nor PGA1, D2, and E2 were found to inhibit UCH-L1 and UCH-L3.
Phenylmercury acetate increases the amount of UCHL1. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
1 | 1
Phenylephrine increases the amount of UCHL1. 2 / 2
1 | 1

reach
However, the molecular mechanism by which Ang II, PE, or TAC up-regulates UCHL1 expression remains to be determined.

ctd
No evidence text available
P-chloromercuribenzoic acid increases the amount of UCHL1. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Oxidopamine affects UCHL1
1 | 1
Oxidopamine increases the amount of UCHL1. 2 / 2
1 | 1

ctd
No evidence text available

reach
Our study revealed that 6-OHDA impaired the UPS by reducing the proteins level of free ubiquitin, UCH-L1, and PARKIN, in addition to inhibiting proteasome activity.
2 |
Mercury dibromide increases the amount of UCHL1. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Maneb affects UCHL1
2 |
Maneb decreases the amount of UCHL1. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available

reach
Four days of IA LPS exposure causes a decreased PGP9.5- and S100beta positive surface area in the myenteric plexus along with submucosal and mucosal intestinal inflammation that coincided with systemic inflammation.

reach
Four days of IA LPS exposure causes a decreased PGP9.5- and S100beta positive surface area in the myenteric plexus along with submucosal and mucosal intestinal inflammation that coincided with systemic inflammation.
| PMC
Hydrolase affects UCHL1
| 2
| 2

reach
Notably, we show that released, cytosolic HtrA2 decreases UCH-L1 protein level and its hydrolase activity through HtrA2 mediated cleavage of UCH-L1 under apoptotic conditions.

reach
For example, Ubiquitin carboxy-terminal hydrolase L1 antisense RNA 1 (UCHL1-AS1) interacts with polysomes and thus promotes the translation of UCHL1 mRNA.
Genistein affects UCHL1
2 |
Genistein decreases the amount of UCHL1. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Copper atom affects UCHL1
2 |
Copper atom increases the amount of UCHL1. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Chloroquine affects UCHL1
| 2
| 2

reach
To investigate whether UCHL1 physically interacts with APP, Haw cells were transfected with UCHL1 and then treated with chloroquine.

reach
To investigate whether UCHL1 reduced APP protein level by the lysosomal degradation, Haw cells were transfected with UCHL1 and then treated with 100muM chloroquine (XREF_FIG).
Brefeldin A affects UCHL1
| 2
| 2

reach
Brefeldin A did not inhibit the secretion of UCH-L1, although it inhibited the secretion of the control secretory luciferase, indicating that UCH-L1 is not secreted via the conventional pathway.The De[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Brefeldin A does not block the secretion of UCH-L1, which confirms that its secretory pathway is not conventional.
Anthralin affects UCHL1
| 2
| 2

reach
Dithranol abolishes UCH-L1 immunoreactivity in the nerve fibers of the rat orofacial skin.

reach
We conclude that dithranol, incidentally similarly to psoriasis, causes inflammation and abolishes UCH-L1 immunoreactivity in the rat orofacial skin in a corticosteroid-reversible manner.
UCHL1 affects transport
| 2
| 2

reach
We previously demonstrated that impaired retrograde transport in the presence of Abeta occurs through an ubiquitin dependent mechanism, and that the deubiquiting enzyme UCHL-1 restores retrograde transport of BDNF and TrkB [XREF_BIBR].

reach
We found that UCHL-1 restored BDNF and TrkB transport not only in the presence of Abeta but also with IL-1beta, suggesting the two agents share a common mechanism of interfering with ubiquitination dependent trafficking mechanisms.

reach
The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis.

reach
Erratum : The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis.
UCHL1 affects mscS
| 2
UCHL1 inhibits mscS. 2 / 2
| 2

sparser
As a consequence, UCHL1-inhibited MSCs effectively alleviated concanavalin A (ConA)-induced inflammatory liver injury.

sparser
As a consequence, UCHL1-inhibited MSCs effectively alleviated concanavalin A-induced inflammatory liver injury.
| 2

reach
LC/MS based metabolite analyses demonstrated that the overexpression of UCHL1 significantly increases the flux of metabolism from glucose to lactate and, on the other hand, it decreased glucose metabolism to both citrate and isocitrate.

reach
Since UCH-L1 contributes many different functions to cell metabolism, its role and regulation might be more complex than previously thought and it has become a research target in many laboratories.
UCHL1 affects Wnt
| 2
UCHL1 activates Wnt. 2 / 2
| 2

reach
Aberrant expression of UCHL1 in pediatric high-grade gliomas may promote cell invasion, transformation, and self-renewal properties, at least in part, by modulating Wnt and Beta catenin activity.

reach
UCHL1 has also been proposed to activate Wnt signaling through deubiquitination and stabilization of beta-catenin [XREF_BIBR].
UCHL1 affects SERPINE1
| 2
| 2

reach
One cell line (NUEC2) with PGP9.5 expression exhibited PAI-1 expression, suggesting the possibility that PGP9.5 might induce PAI-1 directly or indirectly.

reach
To confirm the data obtained, we performed Northern analysis using a PGP9.5 or a PAI-1 cDNA probe and found that PAI-1 mRNA was induced by PGP9.5 expression in NUEC1 cells.
UCHL1 affects Pain
| 2
UCHL1 activates Pain. 2 / 2
| 2

reach
Inhibition of spinal UCHL1 attenuates pain facilitation in a cancer-induced bone pain model by inhibiting ubiquitin and glial activation.

reach
Inhibition of spinal UCHL1 attenuated pain facilitation by down-regulation of ubiquitin expression and glial activation.
UCHL1 affects MMP3
| 2
UCHL1 inhibits MMP3. 2 / 2
| 2

reach
Interestingly, when the terminal hairpin structure was disrupted by deleting nucleotides 68–77 of the invSINEB2 sequence from the full length AS Uchl1 (ΔSL1 mutant), SINEUP ability to up-regulate UchL1 protein levels was completely abolished proving a crucial role of SL1 in the activity.

reach
Interestingly, when the terminal hairpin structure was disrupted by deleting nucleotides 68-77 of the invSINEB2 sequence from the full length AS Uchl1 ( SL1 mutant), SINEUP ability to up-regulate UchL1 protein levels was completely abolished proving a crucial role of SL1 in the activity.
UCHL1 affects MAPT
| 2
UCHL1 activates MAPT. 2 / 2
| 2

reach
UCH-L1 Inhibition Decreases the Microtubule Binding Function of Tau Protein.

reach
RESULTS: Among 251 patients, admission serum ptau-181 and UCHL1 were significantly elevated in patients with encephalopathy (both P<0.05) and total tau, GFAP, and NFL were significantly lower in those discharged home(all P<0.05).
| DOI
UCHL1 affects IRF3
| 2
UCHL1 inhibits IRF3. 2 / 2
| 2

reach
Additionally, to evade host innate immunity, Hr-HPV can inhibit PRR signaling through the induction of ubiquitin C-terminal hydrolase L1 (UCHL1) expression; UCHL1 blocks the activation of NF-kappaB and IRF3, both of which are transcription factors that induce the production of proinflammatory cytokines and chemokines XREF_BIBR.

reach
The importance of K63 linked ubiquitination for TRAF3 dependent signaling was strengthened by the identification of several DUBs removing the K63 linked ubiquitination from TRAF3 : the deubiquitinating enzyme A (DUBA), OTUB1, as well as the ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) that is specifically subverted by high-risk human papillomaviruses to downregulate IRF3 activation and PRR responses [XREF_BIBR, XREF_BIBR - XREF_BIBR].
UCHL1 affects IKBKG
| 2
UCHL1 inhibits IKBKG. 2 / 2
| 2

reach
Our data on the suppression of NF-kappaB signaling via the degradation of NEMO by UCHL1 fits well with earlier observations concerning the overexpression of UCHL1 in vascular cells.

reach
Furthermore, UCHL1 mediated the degradation of the NF-kappa-B essential modulator with as result the suppression of p65 phosphorylation and canonical NF-kappaB signaling.
UCHL1 affects IFNG
| 2
UCHL1 activates IFNG. 2 / 2
| 2

reach
Interestingly, UCHL1 inhibition markedly inhibited IFN-gamma plus TNF-alpha-induced decrease of Bcl-2 and activation of caspase 3, indicating the suppression of IFN-gamma plus TNF-alpha-induced MSC apoptosis.

reach
Here, we found that inhibition of UCHL1 suppressed IFN-gamma plus TNF-alpha-induced MSC apoptosis, and this effect was not dependent on p53, the known target protein of UCHL1.
UCHL1 affects DNA repair
| 2
| 2

reach
The related mechanisms for this resistance appear to involve UCHL1 promoting cell cycle progression and DNA repair.

reach
UCHL1 promoted cell cycle progression and DNA repair through regulating TS.
UCHL1 affects CSF2
| 2
UCHL1 activates CSF2. 2 / 2
| 2

reach
Concentrations of UCH-L1 protein increase in human blood and CSF after a wide range of diseases or conditions leading to brain damage like subarachnoid hemorrage, traumatic brain injury, and epileptic seizure, carbon monoxide poisoning and neonatal hypoxic-ischemic encephalopathy.

reach
However, due to the semi-quantitative and less sensitive nature of Western blot, it does not detect low levels of UCH-L1 increase in CSF as well as the ELISA is capable.
UCHL1 affects ATP6AP2
| 2
| 2

reach
All together, these data clearly demonstrate that UCHL1 can downregulate the PRR mediated activation of both the type I IFN and proinflammatory cytokine and chemokine pathways.

reach
To test whether hrHPV induced UCHL1 inhibits PRR signaling, we used lentiviral vectors expressing short-hairpin RNA (shRNA) against UCHL1 and this resulted in a downregulated expression of UCHL1 transcripts and protein levels in hrHPV+ KCs (XREF_FIG).

reach
MG-132 (0-5 microM) alone dose-dependently up-regulated UCH-L1 protein expression in RASMCs (data not shown).

reach
As shown in XREF_FIG, MG-132 treatment for 24 hours significantly increased basal UCH-L1 protein levels, and the MG-132-induced up-regulation of UCH-L1 protein expression was further enhanced by TNFalpha in RASMCs.
MYBL2 affects UCHL1
| 2
MYBL2 increases the amount of UCHL1. 2 / 2
| 2

reach
42,43 Two conserved evolutionary sequences in the 5 '-untranscribed region functioning as potential regulatory elements have been reported, whereas another study has demonstrated that the transcriptio[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
We conclude that B-Myb can stimulate expression of the Uchl1 both in cultured cells and in vivo.
MTOR affects UCHL1
| 2
MTOR decreases the amount of UCHL1. 2 / 2
| 2

reach
Finally, we demonstrated that mTOR inhibition increases UCHL1 expression and proffer that the upregulation of UCHL1 is a hitherto unappreciated aspect of rapamycin efficacy.

reach
It will be interesting to assess whether Uchl1 mRNA is normally associated to heavy polisomes and whether mTOR inhibition or stress are able to increase UchL1 protein levels according to an antisense independent mechanism.
MAFG affects UCHL1
2 |
MAFG decreases the amount of UCHL1. 2 / 2
2 |

biopax:msigdb
No evidence text available

biopax:msigdb
No evidence text available
Ile-Ala affects UCHL1
| 2
| 2

reach
Four days of IA LPS exposure causes a decreased PGP9.5- and S100beta positive surface area in the myenteric plexus along with submucosal and mucosal intestinal inflammation that coincided with systemic inflammation.

reach
Four days of IA LPS exposure causes a decreased PGP9.5- and S100beta positive surface area in the myenteric plexus along with submucosal and mucosal intestinal inflammation that coincided with systemic inflammation.
| PMC
ESRRA affects UCHL1
2 |
ESRRA decreases the amount of UCHL1. 2 / 2
2 |

biopax:msigdb
No evidence text available

biopax:msigdb
No evidence text available
2 |
Titanium dioxide increases the amount of UCHL1.
1 |
Titanium dioxide increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Titanium dioxide decreases the amount of UCHL1.
1 |
Titanium dioxide decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Synuclein affects UCHL1
| 2
Mutated synuclein inhibits UCHL1. 1 / 1
| 1

reach
In addition, Parkinson 's disease linked alpha synuclein mutants reduced the secretion of endogenous UCH-L1.
| 1

reach
Thus, mutant alpha synuclein and huntingtin do not directly inhibit the secretion of UCH-L1; instead, they may affect components of the unknown machinery required for UCH-L1 secretion.
Paracetamol affects UCHL1
2 |
Paracetamol increases the amount of UCHL1.
1 |
Paracetamol increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Paracetamol decreases the amount of UCHL1.
1 |
Paracetamol decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available

ctd
No evidence text available
Methylmercury compound increases the amount of UCHL1.
1 |
Methylmercury compound increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Capsaicin affects UCHL1
| 2
Capsaicin decreases the amount of UCHL1.
| 1
Capsaicin decreases the amount of UCHL1. 1 / 1
| 1

reach
In contrast to TRPV1 and SP, patients with IR did not show higher expression of TRPM8 (see also Keh et al 25) or higher NKA levels in nasal secretions.Regarding the therapeutic action of capsaicin, it[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
Capsaicin activates UCHL1.
| 1
| 1

reach
Male and female offspring 2-3 months of age were evaluated for: a) baseline mechanical sensitivity of the hind paw by using von Frey filaments; b) number of flinches and time spent guarding induced by intraplantar capsaicin (0.1%); and c) density of PGP-9.5 and CGRP axons in the epidermis from the hind paw glabrous skin.

reach
These results uncover a novel mechanism by which UCH-L1 suppresses vascular inflammation.
| 1

reach
Stroke and Amyloid-beta Downregulate TREM-2 and Uch-L1 Expression that Synergistically Promote the Inflammatory Response.
UCHL1 affects endocytosis
| 2
UCHL1 inhibits endocytosis.
| 1
| 1

reach
Interestingly, loss of UCH-L1 enhanced lipid raft dependent endocytosis and then, cell-to-cell transmission of alpha-synuclein.
UCHL1 activates endocytosis.
| 1
| 1

reach
As shown in XREF_FIG, downregulation of UCH-L1 in SH-SY5Y cells enhanced lipid raft dependent endocytosis, but not clathrin dependent endocytosis.
UCHL1 affects UPP
| 2
UCHL1 inhibits UPP.
| 1
UCHL1 inhibits UPP. 1 / 1
| 1

reach
Other work proposes that UCHL1 has specific substrates and may increase UPP dependent degradation of the beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1).
UCHL1 activates UPP.
| 1
UCHL1 activates UPP. 1 / 1
| 1

reach
Thus, inhibition of UCH-L1 hydrolase activity with LDN impairs the UPP resulting in accumulation of Ub-proteins and exacerbates cell death in hypoxic neuronal cells.
UCHL1 affects TGFB1
| 2
UCHL1 inhibits TGFB1.
| 1
UCHL1 inhibits TGFB1. 1 / 1
| 1

reach
Moreover, we wondered if the effect of UCHL1 on fibrosis was related to GRP78, so we determined the GRP78 protein levels in CFs with and without TGF-beta1 and treated with and without UCHL1 knockdown.
UCHL1 activates TGFB1.
| 1
UCHL1 activates TGFB1. 1 / 1
| 1

reach
We found that GRP78 was upregulated in TGF-beta1 stimulated CFs and a greater increase of GRP78 was observed in TGF-beta1 stimulated CFs treated with UCHL1 siRNA.
UCHL1 affects SLC5A7
| 2
UCHL1 increases the amount of SLC5A7.
| 1
UCHL1 increases the amount of SLC5A7. 1 / 1
| 1

reach
Reduction of UCHL1 by siRNA gene knockdown significantly increased poly-ubiquitinated CHT and decreased native CHT protein level, but did not affect CHT mRNA expression.
UCHL1 activates SLC5A7.
| 1
UCHL1 activates SLC5A7. 1 / 1
| 1

reach
Biotinylation assay showed that UCHL1 is localized only in the cytosol of the cells and that the gene knockdown of UCHL1 significantly reduced cytosolic CHT but had no significant effect on membrane CHT level.
UCHL1 affects NPHS1
| 2
UCHL1 decreases the amount of NPHS1. 1 / 1
| 1

reach
A20 overexpression or UCH-L1 inhibition increased expression of synaptoporin and nephrin but decreased desmin expression and ubiquitin accumulation level in podocytes.
Modified UCHL1 decreases the amount of NPHS1. 1 / 1
| 1

reach
As illustrated in our early study [XREF_BIBR], UCH-L1 overexpression could decrease the expression of nephrin, a slit diaphragm protein that is a hallmark for podocyte injury, and increased the expression of Snail, a special transcription factor that is involved in mediating podocyte morphology and function (XREF_FIG).
UCHL1 affects NOS1
| 2
UCHL1 inhibits NOS1.
| 1
UCHL1 inhibits NOS1. 1 / 1
| 1

reach
All 3 patients with idiopathic gastroparesis and decreased PGP 9.5 immunolabeling had decreased nNOS.
UCHL1 increases the amount of NOS1.
| 1
UCHL1 increases the amount of NOS1. 1 / 1
| 1

reach
Our results showed that continuous abdominal massage could not only upregulate the mRNA and protein expressions of nNOS and CHAT but also upregulate the mRNA and protein expression of protein gene product 9.5 (PGP9.5).
UCHL1 affects MFN2
| 2
UCHL1 increases the amount of MFN2.
| 1
Modified UCHL1 increases the amount of MFN2. 1 / 1
| 1

reach
Conversely, overexpression of UCH-L1 increased Mfn2 levels, an effect dramatically enhanced by the mutation of the farnesylation site (C220S), which drives UCH-L1 binding to membranes.
UCHL1 decreases the amount of MFN2.
| 1
UCHL1 decreases the amount of MFN2. 1 / 1
| 1

reach
We demonstrate that knock-down (KD) of UCH-L1 in different cell lines reduces the levels of the mitochondrial fusion protein Mitofusin-2, but not Mitofusin-1, resulting in mitochondrial enlargement and disruption of the tubular network.
UCHL1 affects LMP1
| 2
UCHL1 inhibits LMP1.
| 1
UCHL1 inhibits LMP1. 1 / 1
| 1

reach
Our data show that blocking of cellular farnesylation with selective inhibitor FTI-277 and inhibition of specific C-terminal farnesylation of UCH-L1 with the use of C220S mutant inhibit LMP1 targeting to the exosomes but not its expression in the cells (XREF_FIG).
UCHL1 activates LMP1.
| 1
UCHL1 activates LMP1. 1 / 1
| 1

reach
This result suggests that UCH-L1 requires its C-terminal farnesylation to promote sorting of LMP1 to exosomes.
UCHL1 affects CXCL8
| 2
UCHL1 increases the amount of CXCL8.
| 1
UCHL1 increases the amount of CXCL8. 1 / 1
| 1

reach
This suggests that downregulation of UCHL1 increases the gene expression of IL-8 and MIP3alpha in hrHPV+ KCs.
UCHL1 decreases the amount of CXCL8.
| 1
Modified UCHL1 decreases the amount of CXCL8. 1 / 1
| 1

reach
It was showed that UCH-L1 over-expression inhibited NF-kappaB activation and decrease IL-6 and IL-8 levels, while knockdown of it enhanced NF-kappaB activation and increase IL-6 and IL-8 levels during TNF-alpha treatment.
UCHL1 affects BCL2
| 2
UCHL1 decreases the amount of BCL2.
| 1
UCHL1 decreases the amount of BCL2. 1 / 1
| 1

reach
UCHL1 inhibition markedly increased Bcl-2 expression and suppressed the expression of cleaved caspase 3.
UCHL1 activates BCL2.
| 1
UCHL1 activates BCL2. 1 / 1
| 1

reach
The results indicated that probably the extrinsic (Fas, Fas-L, Trail, DR4 and DR5) and intrinsic (cytochrome C) apoptotic pathways, the activation of p53 (phospho-Mdm-2 and phospho-p53) and the Bcl-2 family members (pro apoptotic member Bax, anti-apoptotic members Bcl-2 and Bcl-xL) combined with each other, participating in the process of apoptosis induced by UCH-L1 in MCF7 cells.
UCHL1 affects BAX
| 2
UCHL1 increases the amount of BAX.
| 1
UCHL1 increases the amount of BAX. 1 / 1
| 1

reach
Finally, we found that the restoration of Uch-L1 rescues Bax control levels and protects the decrease Bcl-2, both in controls and Tg mice.
UCHL1 activates BAX.
| 1
UCHL1 activates BAX. 1 / 1
| 1

reach
The results indicated that probably the extrinsic (Fas, Fas-L, Trail, DR4 and DR5) and intrinsic (cytochrome C) apoptotic pathways, the activation of p53 (phospho-Mdm-2 and phospho-p53) and the Bcl-2 family members (pro apoptotic member Bax, anti-apoptotic members Bcl-2 and Bcl-xL) combined with each other, participating in the process of apoptosis induced by UCH-L1 in MCF7 cells.
UCHL1 affects AKT1S1
| 1 1
UCHL1 inhibits AKT1S1.
| 1
UCHL1 inhibits AKT1S1. 1 / 1
| 1

eidos
This result suggests that UCHL1 may prevent PRAS40 from proteasome-mediated degradation , potentially via deubiquitination of this protein .
UCHL1 activates AKT1S1.
| 1
UCHL1 activates AKT1S1. 1 / 1
| 1

reach
UCHL1 knockdown did not change the major proteins of mTOR complex but decreased the protein turnover of PRAS40, an inhibitory factor of mTORC1.
U74 affects UCHL1
| 2
U74 increases the amount of UCHL1.
| 1
U74 increases the amount of UCHL1. 1 / 1
| 1

reach
In addition, compared to control group (0.75 +/- 0.01), PGP 9.5 expression in the ectopic cyst was promoted by CB1R agonist ACPA (0.81 +/- 0.01, P < 0.05), and inhibited by CB1R antagonist AM251 (0.67 +/- 0.03, P < 0.01).
U74 decreases the amount of UCHL1.
| 1
U74 decreases the amount of UCHL1. 1 / 1
| 1

reach
In addition, compared to control group (0.75 +/- 0.01), PGP 9.5 expression in the ectopic cyst was promoted by CB1R agonist ACPA (0.81 +/- 0.01, P < 0.05), and inhibited by CB1R antagonist AM251 (0.67 +/- 0.03, P < 0.01).
Particulate Matter increases the amount of UCHL1.
1 |
Particulate Matter increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Particulate Matter decreases the amount of UCHL1.
1 |
Particulate Matter decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
GCH1 affects UCHL1
| 2
GCH1 decreases the amount of UCHL1. 1 / 1
| 1

reach
In myocardial cells, transfection of GCH1 overexpression lentiviruses also decreased PGP9.5 expression to 26% of the control group.
Modified GCH1 decreases the amount of UCHL1. 1 / 1
| 1

reach
Moreover, GCH1 overexpression attenuated canines ' atrial PGP9.5 level to ~ 56% of the controls.
GADD45A affects UCHL1
| 2
GADD45A increases the amount of UCHL1.
| 1
Modified GADD45A increases the amount of UCHL1. 1 / 1
| 1

reach
Loss of GADD45a significantly reduces UCHL1 expression via UCHL1 promoter methylation resulting in increased Akt K48 ubiquitination and reduced Akt levels.
GADD45A activates UCHL1.
| 1
GADD45A activates UCHL1. 1 / 1
| 1

reach
The expression and methylation state of the GADD45a target UCHL1 were evaluated, revealing a hypermethylation of its promoter in lesional skin compared to controls.
EBNA2 affects UCHL1
| 2
EBNA2 bound to uridine 5'-monophosphate activates UCHL1. 1 / 1
| 1

reach
During EBV infection, EBNA2 interacts with PU.1 to activate the uch-l1 promoter.
EBNA2 activates UCHL1. 1 / 1
| 1

reach
However, EBNA2 can not be responsible for up-regulation of UCH-L1 in co-infected PELs because the type III latency promoter Cp is not active in EBV positive PEL cells, and EBNA2 is not expressed.
2 |
Complex Mixtures increases the amount of UCHL1.
1 |
Complex Mixtures increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Complex Mixtures decreases the amount of UCHL1.
1 |
Complex Mixtures decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
CTTN affects UCHL1
| 2
CTTN inhibits UCHL1.
| 1
CTTN inhibits UCHL1. 1 / 1
| 1

reach
Additionally, restoration of CTTN in NPC cells that overexpressed UCHL1 rescued UCHL1 suppressive effects on NPC cell migration and invasion, which indicated that CTTN is a functional target of UCHL1 in NPC.
CTTN activates UCHL1.
| 1
CTTN activates UCHL1. 1 / 1
| 1

reach
Additionally, restoration of CTTN in NPC cells that overexpressed UCHL1 rescued UCHL1 suppressive effects on NPC cell migration and invasion, which indicated that CTTN is a functional target of UCHL1 in NPC.
2 |
Air Pollutants increases the amount of UCHL1.
1 |
Air Pollutants increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Air Pollutants decreases the amount of UCHL1.
1 |
Air Pollutants decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
17alpha-ethynylestradiol increases the amount of UCHL1.
1 |
17alpha-ethynylestradiol increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
17alpha-ethynylestradiol decreases the amount of UCHL1.
1 |
17alpha-ethynylestradiol decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Zinc sulfate decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Zidovudine affects UCHL1
| 1
| 1

reach
AZT completely reversed the LP-BM5-induced reduction of the density of both PGP9.5 (p < 0.01) and CGRP (p < 0.05) IENFs whereas AZT alone did not induce significant changes in IENF density (Figure 7).
Vincristine affects UCHL1
1 |
Vincristine increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Urea affects UCHL1
| 1
Urea activates UCHL1. 1 / 1
| 1

reach
In addition, urine protein, blood urea nitrogen, serum creatinine, and ds-DNA antibody levels decreased with elevated A20 or depleted UCH-L1.
1 |
Tungsten carbide increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
| 1

reach
Pimozide, flupenthixol and trifluoperazine were poor inhibitors of UCH-L1 and UCH-L3 (IC 50> 500 muM).
1 |
Trichostatin A increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Triacetylcellulose increases the amount of UCHL1. 1 / 1
| 1

reach
However, the molecular mechanism by which Ang II, PE, or TAC up-regulates UCHL1 expression remains to be determined.
1 |
Trans-pinosylvin increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available

ctd
No evidence text available
Tobacco tar affects UCHL1
1 |
Tobacco tar increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Sunitinib affects UCHL1
1 |
Sunitinib increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Sodium fluoride decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Sodium chromate increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Silver(0) affects UCHL1
1 |
Silver(0) increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Silicon dioxide decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Selenate affects UCHL1
| 1
| 1

reach
In the present study the phosphorylation level of UCHL1 was found significantly increased in the N2aSW cells treated with selenate, suggesting that selenate can affect the activity of UPS via modulating the phosphorylation level of UCHL1, thus has an impact on AD formation and progress.
Rutin affects UCHL1
1 |
Rutin increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Rotenone affects UCHL1
1 |
Rotenone decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Resveratrol affects UCHL1
| 1
| 1

reach
Our results demonstrate that resveratrol prevents the down-regulation of UCH-L1 in focal cerebral ischemia.

reach
As predicted, using the DUB activity UbVME probe, we showed that UCH-L1, a Cys dependent DUB belonging to the UCH family is also inhibited by ROS, like USP2, albeit to a different extent (XREF_FIG).

ctd
No evidence text available
Pyrogallol affects UCHL1
1 |
Pyrogallol increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Proteolysis affects UCHL1
| 1
| 1

reach
Upregulated UBE-2C, TNNT1, TRAIP, and UCHL1 may point out better survival of LUAD patients through the ubiquitin mediated proteolysis, protein processing in the endoplasmic reticulum, and skeletal muscle contraction pathways.
Protein affects UCHL1
| 1
Protein activates UCHL1. 1 / 1
| 1

eidos
In PELs with LANA and LMP1 co-expression , both proteins synergize to activate UCH-L1 , which enhances a tumorigenic phenotype with increased proliferation , adhesion , cell migration , and inhibition of apoptosis [ 35 ] .
| PMC
1 |
Progesterone decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Ppy affects UCHL1
| 1
Ppy inhibits UCHL1. 1 / 1
| 1

sparser
Our group and others showed PGP9.5 inactivation by PH in several types of solid tumors xref , xref , xref .
Pimozide affects UCHL1
| 1
| 1

reach
Pimozide, flupenthixol and trifluoperazine were poor inhibitors of UCH-L1 and UCH-L3 (IC 50> 500 muM).
Perfluoroundecanoic acid increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Perfluorooctanoic acid increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Pentobarbital decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Pentachlorophenol increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Paclitaxel affects UCHL1
1 |
Paclitaxel increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Ozone affects UCHL1
1 |
Ozone increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Oximes affects UCHL1
| 1
Oximes inhibits UCHL1. 1 / 1
| 1

reach
By utilizing high-throughput screening (HTS) to find inhibitors and traditional medicinal chemistry to optimize their affinity and specificity, we have identified a class of isatin O-acyl oximes that selectively inhibit UCH-L1 as compared to its systemic isoform, UCH-L3.
Nitrofen affects UCHL1
1 |
Nitrofen decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Methyltestosterone decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Methyl methanesulfonate increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Metabolite affects UCHL1
| 1
| 1

sparser
We also showed that some of the PGJ2 metabolites inhibit the ubiquitin C-terminal hydrolase UCH-L1 without directly affecting proteasome activity.
Manganese(II) chloride decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Manganese atom decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
| 1
MTOR inhibitor decreases the amount of UCHL1. 1 / 1
| 1

reach
Furthermore, as AsUchl1 export into the cytoplasm increases following mTOR inhibition [XREF_BIBR], we confirmed that rapamycin, a potent mTOR inhibitor and anti-epileptogenic agent [XREF_BIBR, XREF_BIBR], increased UCHL1 expression.
1 |
Lithium chloride increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Ketone body affects UCHL1
1 |
Ketone body increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Kainic acid affects UCHL1
1 |
Kainic acid increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Isoprenaline increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Indometacin affects UCHL1
1 |
Indometacin increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Hsa-miR-92a-3p decreases the amount of UCHL1. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-877-5p decreases the amount of UCHL1. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-218-5p decreases the amount of UCHL1. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-193b-3p decreases the amount of UCHL1. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-181a-5p decreases the amount of UCHL1. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
| 1

reach
UCHL1 protein, which was highly specific to beta cells, was increased by palmitate at basal glucose, but not in the context of hyperglycaemia associated with frank diabetes.
Hexabromocyclododecane increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Hemin affects UCHL1
1 |
Hemin increases the amount of UCHL1. 1 / 1
1 |

bel
Cluster 2: 60 genes upregulated in the presence of Hemin, represented by 66 probes
Glycitein affects UCHL1
1 |
Glycitein decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Glutathione affects UCHL1
1 |
1 |

ctd
No evidence text available
Furan affects UCHL1
1 |
Furan increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Folic acid affects UCHL1
1 |
Folic acid increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Flame retardant decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |

ctd
No evidence text available
Env affects UCHL1
| 1
Env activates UCHL1. 1 / 1
| 1

reach
Our results showed that nicotine and gp120 were able to increase blood levels of both molecular (UCHL1 and S100B) and cellular (cBMECs and EPCs) markers (XREF_FIG), suggesting that UCHL1 is a potential new biomarker for BBB disorders caused by drugs of abuse and microbial factors.
Endosulfan affects UCHL1
1 |
Endosulfan increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available

sparser
These endogenous electrophiles (1) inhibit ubiquitin isopeptidase activity [ xref ] as well as ubiquitin hydrolases UCH-L1 and UCH-L3 [ xref ], (2) induce the formation of cysteine-targeted thyolation of UCH-L1 [ xref ] and of PGJ2/proteasome conjugates [ xref ], (3) trigger the oxidation of the S6 ATPase subunit of the 26S proteasome [ xref ], and disrupt 26S proteasome assembly [ xref ].
1 |
Dorsomorphin increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Dopamine affects UCHL1
| 1
| 1

reach
The high correlation between the ability of DA neurons to increase UCHL-1 and the maintenance of axon terminal DA suggest UCHL-1 (like parkin) may play a role in this process.
Diuron affects UCHL1
1 |
Diuron decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Dinitrogen affects UCHL1
| 1
| 1

reach
In addition, urine protein, blood urea nitrogen, serum creatinine, and ds-DNA antibody levels decreased with elevated A20 or depleted UCH-L1.

reach
Recovered activity was normalized to UCHL1 samples treated with DMSO.
Diarsenic trioxide increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Diallyl trisulfide decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Dexamethasone decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Daidzein affects UCHL1
1 |
Daidzein decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Cyclosporin A increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
1 |

ctd
No evidence text available
Crocidolite asbestos increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Creatinine affects UCHL1
| 1
| 1

reach
In addition, urine protein, blood urea nitrogen, serum creatinine, and ds-DNA antibody levels decreased with elevated A20 or depleted UCH-L1.
Copper(II) sulfate increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Copper(II) chloride increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Copper(2+) affects UCHL1
| 1
Copper(2+) increases the amount of UCHL1. 1 / 1
| 1

reach
However, HepG2 copper transcriptome analysis showed that copper significantly up-regulated UCHL1 expression more than 1.5-fold in 8 out of 16 treatment conditions [XREF_BIBR].
Cocaine affects UCHL1
1 |
Cocaine decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Cobalt atom affects UCHL1
1 |
Cobalt atom increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Choline affects UCHL1
1 |
Choline increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Chloroprene affects UCHL1
1 |
Chloroprene increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Chloropicrin decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Chalcone affects UCHL1
| 1
| 1

reach
RA-9, a chalcone derivative with a structure similar to b-AP15, was reported to inhibit proteasomal DUBs [XREF_BIBR] as well as UCHL1, UCHL3, USP2, USP5, and USP8 [XREF_BIBR].
1 |
Cefaloridine increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Carbon nanotube increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Carbamazepine decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Caffeine affects UCHL1
1 |
Caffeine decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
| 1

reach
Inhalation of 346-ppm diacetyl significantly increased PGP9.5 NFD in the detaching regions of tracheal epithelium (0.04 +/- 0.01%) compared to air exposed controls (0.02 +/- 0.0003%).
1 |
Buta-1,3-diene increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Beta-1,3-D-glucan increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available

ctd
No evidence text available
Benzo[b]fluoranthene increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Arsenite(3-) decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
| 1

reach
In contrast to staurosporine induced apoptosis, where HtrA2 and Omi translocates into the cytosol and directly cleaves and thus inactivates UCH-L1 [XREF_BIBR], the intramitochondrial localization of HtrA2 and Omi during TNF induced necroptosis prevents a direct interaction of both proteins.
All-trans-retinoic acid decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Aflatoxin M1 decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Aflatoxin B1 increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
Acrylamide affects UCHL1
1 |
Acrylamide increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
ZIC3 affects UCHL1
1 |
ZIC3 decreases the amount of UCHL1. 1 / 1
1 |

biopax:msigdb
No evidence text available
ZEB1 affects UCHL1
1 |
ZEB1 decreases the amount of UCHL1. 1 / 1
1 |

biopax:msigdb
No evidence text available
ZC3HAV1 affects UCHL1
| 1
ZC3HAV1 activates UCHL1. 1 / 1
| 1

reach
ZAP and rIL-1 alpha also stimulated the migration of both UCHL1 and SN130 positively stained cells.
Vitamin E affects UCHL1
1 |
Vitamin E increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
VTN affects UCHL1
| 1
VTN inhibits UCHL1. 1 / 1
| 1

reach
Further, either prior manipulation of the spleen or transection of the VN below the diaphragm (being careful not to manipulate the spleen), promoted loss of acetylcholine esterase staining in these PGP9.5 positive mesothelial cells and prevented the increase in splenic mass we previously observed in response to oral NaHCO 3 4.

reach
Recently, an antisense lncRNA to mouse Ubiquitin carboxyl-terminal hydrolase L1 (Uchl1) was reported to increase UCHL1 protein synthesis, representing a new functional class of lncRNAs, designated as SINEUPs, for SINE element containing translation UP-regulators.
USP30 affects UCHL1
| 1
USP30 activates UCHL1. 1 / 1
| 1

reach
Structure of a USP20 inhibitor from GSK.Figure 29 Structure of a USP30 inhibitor.Structures of UCHL1 inhibitors.VAE(OMe)-FMK Structure of a weak tripeptide FMK UCHL1 inhibitor.Figure 33 Structures of UCHL3 inhibitors.Structures of TRABID and RPN11 inhibitors.

reach
UCH-L1 forms endogenous complexes with beta-catenin, stabilizes it and up-regulates beta-catenin/TCF/Lef-dependent transcription.
UCHL1 affects synapse
1 |
UCHL1 activates synapse. 1 / 1
1 |

bel
Moreover, administration of UCH-L1 can reverse the amyloid b-protein–induced synaptic dysfunction and memory loss in transgenic mice overexpressing APP and PS1 (Gong et al. 2006).
UCHL1 affects span
| 1
UCHL1 activates span. 1 / 1
| 1

reach
Therefore, the higher expression of the antioxidants HSP70 and UCHL1 in RGE treated flies may facilitate slower aging progression and prolong life span.
| 1
| 1

reach
No difference in mRNA expression of HRH1, HRH2, TRPV1, or the pan-neuronal marker PGP9.5 was found between IBS and HVs in rectal biopsy specimens, further supporting TRPV1 sensitization rather than up[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

bel
It has been reported recently that while the monomeric form of UCH-L1 catalyzes deubiquitination, the dimers display a ubiquitin ligase activity that generates ubiquitin-K63 bonds (Liu et al., 2002).

bel
Activated PKA induces transcription of ApUCH (UCH-L1 in mammals), a deubiquitinating enzyzme, which has been found to be critical for the induction of long-term facilitation (Hegde et al. 1997).
1 |

bel
It has been reported recently that while the monomeric form of UCH-L1 catalyzes deubiquitination, the dimers display a ubiquitin ligase activity that generates ubiquitin-K63 bonds (Liu et al., 2002).

bel
The simple explanation is that the mutation leads to a shortage in free ubiquitin that should have been recycled from conjugates, which results in general impairment of the function of the UPS.

reach
UCH-L1 accumulates at the motile edge of the cell membrane during the initial phases of adhesion, colocalizes with focal adhesion kinase (FAK), p120-catenin, and vinculin, and enhances the formation of focal adhesions, which correlates with enhanced FAK activation.
UCHL1 affects picloram
| 1
| 1

eidos
Research showed that UCHL1 removes activation K63-linked ubiquitin molecules from TRAF3 , suppressing the type 1 IFN pathway , and when bound to TRAF6 , UCHL1 mediates enhanced degradation of NEMO , which suppresses the NF-kappaB pathway [ 528 ] .
| PMC
| 1
| 1

reach
These in vitro data suggest that UCHL1 mediates PE induced cardiomyocyte hypertrophy by increasing EGFR signaling.

reach
Results showed that UCH-L1 inhibited the growth of breast cancer cells and its action was dependent on the inducement of cell death, showing the typical characteristics of apoptosis but not necrosis.
UCHL1 affects memory
1 |
UCHL1 activates memory. 1 / 1
1 |

bel
Moreover, administration of UCH-L1 can reverse the amyloid b-protein–induced synaptic dysfunction and memory loss in transgenic mice overexpressing APP and PS1 (Gong et al. 2006).
UCHL1 affects inositol
| 1
| 1

reach
Of note, we found that inhibition of UCHL1 improved cardiac function and attenuated cardiac fibrosis post MI.

reach
It is worth mentioning that UCHL1 was specifically up-regulated by high-risk HPV in primary keratinocytes to escape innate immunity.
| 1

reach
Recently, UCH-L1 has been found to increase cancer cell migration and invasion by modulating hydrogen peroxide generated by NADPH oxidase 4 (NOX4).

reach
Collectively, these results indicate that UCHL1 promotes HGSOC growth by mediating protein homeostasis through the PSMA7-APEH-proteasome axis.
UCHL1 increases the amount of green fluorescent protein. 1 / 1
| 1

reach
Enhanced green fluorescent protein (eGFP) expression, under the control of UCHL1 promoter, is stable and long lasting in the UCHL1-eGFP reporter line.
UCHL1 affects esterase
| 1
| 1

reach
A neuron specific antisense lncRNA, AS Uchl1, could specifically induce the translation of ubiquitin carboxyl-terminal esterase L1 (Uchl1) under certain stress conditions through its complementarity with target mRNA [XREF_BIBR].
| 1

reach
As a consequence, UCHL1 inhibited MSCs effectively alleviated concanavalin A (ConA)-induced inflammatory liver injury.

bel
UCH-L1 mutations are linked to autosomal-dominant PD, however the mechanism by which it caused the disease is unclear, with conflicting evidence reported for its in vivo functions. Recent studies reveal a role for UCH-L1 in chaperone-mediated autophagy (CMA) and mutant UCH-L1 was shown to inhibit CMA-mediated removal of alpha-synuclein [83].
| 1
| 1

reach
Recently, it has been suggested that UCH-L1 promotes cancer cell motility and invasion, which may contribute to its oncogenic role.

sparser
Our data revealed that knockdown of UCHL1 markedly promoting myoblast differentiation and myotube formation, suggesting that UCHL1 inhibits myoblast differentiation.
UCHL1 affects cadmium(2+)
| 1
UCHL1-S18Y activates cadmium(2+). 1 / 1
| 1

reach
The wild-type and S18Y UCH-L1 proteins elicit essentially identical CD spectra while the I93M mutant exhibits a decrease in alpha-helical content.
UCHL1 affects bortezomib
| 1
| 1

reach
It is possible that this contributes to our observation that UCH-L1 depletion (resulting in reduced Akt phosphorylation) enhanced caspase activation in response to bortezomib.

eidos
UCHL1 modulates antigen processing by affecting the colocalization of intracellular MHC I with late endosomal / lysosomal compartments necessary for cross priming of CD8 T cells ( 113 ) .
UCHL1 affects VHL
| 1
UCHL1 bound to HIF1A inhibits VHL. 1 / 1
| 1

reach
To fully elucidate the physiological and pathophysiological importance of deubiquitination, it is critical to more thoroughly analyse the meaning of our immunoprecipitation data in which UCHL1 bound to HIF-1alpha and prevented VHL from directly interacting with HIF-1alpha (XREF_FIG) and the interaction between UCHL1 and HIF-1alpha was facilitated under hypoxic conditions (XREF_FIG).
UCHL1 affects UBC
1 |
UCHL1 increases the amount of UBC. 1 / 1
1 |

signor
These data suggest that the physiological role of UCH is to hydrolyze small adducts of ubiquitin and to generate free monomeric ubiquitin from ubiquitin proproteins, but not to deubiquitinate ubiquitin-protein conjugates or disassemble polyubiquitin chains
UCHL1 affects UBA1
| 1
UCHL1 activates UBA1. 1 / 1
| 1

reach
We also found that overexpression of UCHL1 increased the UPS related proteins UBE1, PSMA7, ubiquitinated proteins, and monoubiquitin, and proteasomal activity.
UCHL1 affects Tubulin
| 1
| 1

reach
showed that UCH-L1 decreased the ability of tubulin to form MTs in vitro, and overexpression of UCH-L1 in an SV40 transformed fibroblastic cell line caused the reduction in MT assembly in about 30% of transfected cells.
UCHL1 affects TRPV1
| 1
UCHL1 activates TRPV1. 1 / 1
| 1

reach
No difference in mRNA expression of HRH1, HRH2, TRPV1, or the pan-neuronal marker PGP9.5 was found between IBS and HVs in rectal biopsy specimens, further supporting TRPV1 sensitization rather than up[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
UCHL1 affects TRAF2
| 1
UCHL1 activates TRAF2. 1 / 1
| 1

reach
Speculatively, at the non canonical side signaling could be hampered by abrogation of UCHL1 mediated TRAF2 and/or 5- or E7 mediated IKKalpha functioning.
UCHL1 affects TNFRSF
| 1
UCHL1 activates TNFRSF. 1 / 1
| 1

reach
We and others have previously shown that hrHPV attenuates the pattern recognition receptor induced and TNFR induced NFkappaB pathway activation by upregulating UCHL1, a cellular deubiquitinase/E3 ligase.
UCHL1 affects TH
| 1
UCHL1 inhibits TH. 1 / 1
| 1

reach
Consistently, we found that TBI enhances GFAP and UCHL-1 expression and reduces the number of dopaminergic TH positive neurons in WT compared to GMF-KO mice 72 h post-TBI.
UCHL1 affects TG
| 1
UCHL1 activates TG. 1 / 1
| 1

reach
Finally, we also found that pre-treatment with TAT-HA-Uch-L1 was able to protect against the neuronal cell death, indeed we found that the restoration of Uch-L1 significantly increases the percentage of neuronal density in pre-lesioned Tg treated animals respect to untreated lesioned ones.
UCHL1 affects TBXAS1
| 1
UCHL1 activates TBXAS1. 1 / 1
| 1

eidos
Furthermore , UCHL1 upregulated TS expression , which mitigated PEM-induced DNA damage and cell cycle arrest in NSCLC cells , and also conferred resistance to PEM and other drugs .
UCHL1 affects Synovitis
| 1
| 1

reach
Compared with the control group, the expression of SP and PGP9.5 nerve fibers density and gene levels of them in the synovium tissue were significantly increased in CFA-induced TMJ synovitis rats.
UCHL1 affects SYNPR
| 1
UCHL1 decreases the amount of SYNPR. 1 / 1
| 1

reach
A20 overexpression or UCH-L1 inhibition increased expression of synaptoporin and nephrin but decreased desmin expression and ubiquitin accumulation level in podocytes.
UCHL1 affects SYNPO
| 1
Modified UCHL1 decreases the amount of SYNPO. 1 / 1
| 1

reach
Beyond that, UCH-L1 overexpression lowered the expression of synaptopodin and CD2AP (XREF_FIG).
UCHL1 affects SQSTM1
| 1
UCHL1 increases the amount of SQSTM1. 1 / 1
| 1

reach
Suppression of UCH-L1 activity in a-syn tg mice, however, decreased p62 levels by 19%, and to levels observed in non tg mice (XREF_FIG, a-syn tg, control 1.0 +/-0.0; LDN treated, 0.81 +/-0.07).
UCHL1 affects SNAI1
| 1
Modified UCHL1 decreases the amount of SNAI1. 1 / 1
| 1

reach
As illustrated in our early study [XREF_BIBR], UCH-L1 overexpression could decrease the expression of nephrin, a slit diaphragm protein that is a hallmark for podocyte injury, and increased the expression of Snail, a special transcription factor that is involved in mediating podocyte morphology and function (XREF_FIG).
UCHL1 affects SLC6A5
| 1
UCHL1 activates SLC6A5. 1 / 1
| 1

reach
Thus, UCHL1 activity may indirectly modulate the turnover of neuronal GlyT2.
UCHL1 affects SLC4A1
| 1
UCHL1 activates SLC4A1. 1 / 1
| 1

reach
This is due to the presence of ubiquitin in Lewy pathology (Alves-Rodrigues et al., 1998), a decreased level of proteasomal subunits in nigral brain homogenates (McNaught and Jenner, 2001) and autosom[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
UCHL1 affects SLC1A2
| 1
UCHL1 activates SLC1A2. 1 / 1
| 1

reach
Mechanistically, UCHL1 mediates rapid recycling of NCAM and GLT-1 within early endosomes through its DUB activity, reducing downstream degradation within the lysosome [XREF_BIBR, XREF_BIBR].
UCHL1 affects SCARB2
| 1
UCHL1 increases the amount of SCARB2. 1 / 1
| 1

sparser
We supposed whether decreased CD36 expression induced by UCHL1 is associated with UPS.
UCHL1 affects S100B
| 1
UCHL1 activates S100B. 1 / 1
| 1

reach
There was no significant increase in the serum S100B and UCH-L1 levels in patients with mTBI.
UCHL1 affects RELA
| 1
UCHL1 inhibits RELA. 1 / 1
| 1

reach
As we have demonstrated that over-expression of UCH-L1 suppresses NF-kappaB p65 transcriptional activity in VSMCs [XREF_BIBR], it is conceivable that UCH-L1 inhibits VSMC proliferation via at least partly suppressing NF-kappaB pathway.
UCHL1 affects RCC
| 1
UCHL1 activates RCC. 1 / 1
| 1

reach
In addition the sequencing of bisulfite treated DNA confirmed the distinct methylation status of the UCHL1 promoter in the RCC lesions (data not shown).
UCHL1 affects RAC
| 1
UCHL1 activates RAC. 1 / 1
| 1

sparser
UCHL1 activated Akt and Erk1/2, which process also required enzymatic activity and was necessary for mediating cell migration and invasion.
UCHL1 affects Phosphatase
| 1
UCHL1 decreases the amount of Phosphatase. 1 / 1
| 1

reach
In contrast, we observed a dramatic increase in the phosphatase PHLPP1 levels following depletion of UCH-L1 (XREF_FIG and XREF_SUPPLEMENTARY).
UCHL1 affects PSMA7
| 1
UCHL1 activates PSMA7. 1 / 1
| 1

reach
We also found that overexpression of UCHL1 increased the UPS related proteins UBE1, PSMA7, ubiquitinated proteins, and monoubiquitin, and proteasomal activity.
UCHL1 affects PRKN
| 1
UCHL1 activates PRKN. 1 / 1
| 1

reach
XREF_BIBR, XREF_BIBR Two of these - parkin (the product of PARK2) and UCH-L1 (the product, of PARK5) - are enzymatic components of the UPS for intracellular protein clearance.
UCHL1 affects PMAIP1
| 1
UCHL1 increases the amount of PMAIP1. 1 / 1
| 1

reach
Epigenetic silencing of UCH-L1 in these tumor samples reduced Noxa protein expression.
UCHL1 affects PKAR
| 1
UCHL1 inhibits PKAR. 1 / 1
| 1

reach
Our hypothesis is that Uch-L1 degrades the PKA-R protein, freeing up PKA to activate CREB.
UCHL1 affects PI3K
| 1
UCHL1 inhibits PI3K. 1 / 1
| 1

reach
Our data suggest that PI3K and Akt pathway is possibly involved in apoptosis in breast cancer cells and blocked by UCH-L1.
UCHL1 affects PCNA
| 1
UCHL1 increases the amount of PCNA. 1 / 1
| 1

reach
We also observed that silencing of UCH-L1 decreased the phosphorylation level of Akt and PCNA in the xenograft experiments.
UCHL1 affects PARP1
| 1
UCHL1 inhibits PARP1. 1 / 1
| 1

reach
UCH-L1 knockdown increased the cleavage of caspase-3 and PARP in both r-IAPP- and h-IAPP-transduced cells in comparison to scramble transfected cells.
UCHL1 affects PADI2
| 1
UCHL1 activates PADI2. 1 / 1
| 1

eidos
Interestingly , UCHL1 promotes p53 signaling in nasopharyngeal carcinoma 40 and PADI2 facilitates p53 degradation in breast cancer cells .
UCHL1 affects OSR1
| 1
UCHL1 inhibits OSR1. 1 / 1
| 1

reach
The reporter assay demonstrated that the overexpression and knockdown of UCHL1 significantly increased and decreased ODD-Luc fusion protein levels, respectively (XREF_FIG and XREF_SUPPLEMENTARY).

reach
The CSC-like characteristics, such as the expression of pluripotency markers, chemoresistance, and sphere-forming ability, were promoted by UCH-L1, whereas those were repressed by UCH-L3.

eidos
Interestingly , UCHL1 promotes p53 signaling in nasopharyngeal carcinoma 40 and PADI2 facilitates p53 degradation in breast cancer cells .
UCHL1 affects NOS3
| 1
UCHL1 increases the amount of NOS3. 1 / 1
| 1

reach
Specifically, Uch-L1 decreased the NF-kappaB activity induced by TNF-alpha and increased eNOS expression, which was able to protect atherosclerosis reducing ischemic vascular disease.
UCHL1 affects NOS
| 1
UCHL1 inhibits NOS. 1 / 1
| 1

reach
In addition, UCH-L1 may also reduce NOS II synthesis by attenuation of NF-kappaB activation XREF_BIBR.
UCHL1 affects NFKBIA
| 1
UCHL1 activates NFKBIA. 1 / 1
| 1

reach
Additionally, LDN57444 pretreatment reduced the protein levels of IkappaBalpha, the negative NF-kappaB modulator, while overexpression of UCHL1 maintained IkappaBalpha levels, suggesting that UCHL1 promoted the stability of IkappaBalpha, which may further inhibit NF-kappaB activation in MSCs.
UCHL1 affects NEB
| 1
UCHL1 inhibits NEB. 1 / 1
| 1

reach
Beyond the confirmation that morphology, content of biologically active substances such as serotonin and calcitonin, and innervation are evolutionary well preserved features of NEB, the results reveal some intriguing features of B. vittatus NEB : strict separation of calcitonin and CGRP, reduced need for the de-ubiquitinating enzyme PGP 9.5, lack of luminal contact, and the basket like innervation.
UCHL1 affects NCAM1
| 1
UCHL1 activates NCAM1. 1 / 1
| 1

reach
Mechanistically, UCHL1 mediates rapid recycling of NCAM and GLT-1 within early endosomes through its DUB activity, reducing downstream degradation within the lysosome [XREF_BIBR, XREF_BIBR].

eidos
Consistently , in C2C12 cells , UCHL1 knockdown increased the myotube size , enhanced mTORC1 activity , and reduced mTORC2 activities as compared with control cells .

reach
UCH-L1 Inhibition Decreases the Microtubule Binding Function of Tau Protein.

reach
Interestingly, an induced UCHL1 expression was also demonstrated in multipotent mesenchymal stromal cells (MSCs) upon stimulation with proinflammatory cytokines IFN-gamma plus TNF-alpha, and negatively regulated the immunosuppressive capacity and survival of MSC.
UCHL1 affects MYOG
| 1
UCHL1 inhibits MYOG. 1 / 1
| 1

reach
Meanwhile, UCHL1 gene knockdown upregulated myogenic factors myoD and Myogenin (MyoG).
UCHL1 affects MYOD1
| 1
UCHL1 inhibits MYOD1. 1 / 1
| 1

reach
Meanwhile, UCHL1 gene knockdown upregulated myogenic factors myoD and Myogenin (MyoG).
UCHL1 affects MUC1
| 1
UCHL1 activates MUC1. 1 / 1
| 1

reach
Conclusions : It appears that UCHL1 promotes PEM resistance by upregulating TS in NSCLC cells, which mitigated DNA damage and cell cycle arrest.
UCHL1 affects MTOR
| 1
UCHL1 increases the amount of MTOR. 1 / 1
| 1

reach
However, UCHL1 shRNA 2 and 3 treatments could significantly enhance the levels of P-mTOR in cPKCgamma -/- neurons with OGD treatment.
UCHL1 affects MPZ
| 1
UCHL1 inhibits MPZ. 1 / 1
| 1

reach
BDNF, synapsin I and UCH-L1 mRNA expression decreased significantly after 3, 8 or 48 h MPP + treatment in Lenti-NRSF-FLAG infected cells (P < 0.05), while TH, Synapsin I and UCH-L1 mRNA expression dec[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
UCHL1 affects MMP9
| 1
UCHL1 activates MMP9. 1 / 1
| 1

reach
Overexpression of UCH-L1 in MCF7 cells up-regulated MDR1, CD147, MMP2, and MMP9, which conferred MDR and promoted migration and invasion.
UCHL1 affects MMP2
| 1
UCHL1 activates MMP2. 1 / 1
| 1

reach
Overexpression of UCH-L1 in MCF7 cells up-regulated MDR1, CD147, MMP2, and MMP9, which conferred MDR and promoted migration and invasion.
UCHL1 affects MLST8
| 1
UCHL1 activates MLST8. 1 / 1
| 1

reach
Additionally, OTUD7B, but not UCH-L1, a DUB for RPTOR 24, targeted GbetaL for deubiquitination (XREF_FIG).
UCHL1 affects MEP2
| 1
UCHL1 inhibits MEP2. 1 / 1
| 1

reach
The aim of this study was to assess the presence and relative distribution of tumor necrosis factor alpha (TNF-alpha), protein gene product 9.5 (PGP 9.5), matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) in adhesions.
UCHL1 affects MAP1LC3
| 1
UCHL1 activates MAP1LC3. 1 / 1
| 1

reach
Both inhibitor and shRNA of UCHL1 significantly reduced the ratio of LC3-II and total LC3, which contributed to neuronal survival after ischaemic stroke, but did not alter the level of Cl-caspase-3.
UCHL1 affects Leu-Asn
| 1
| 1

reach
Next, UCH-L1 was downregulated in MRL and lpr mice to assess biological functions of UCH-L1 in LN.
UCHL1 affects LORICRIN
| 1
| 1

reach
In the epidermis, there was an increase in cellular keratin 14, keratin 10, and loricrin, as well as PGP 9.5 in innervating nerve fibers.
UCHL1 affects KRT14
| 1
UCHL1 activates KRT14. 1 / 1
| 1

reach
In the epidermis, there was an increase in cellular keratin 14, keratin 10, and loricrin, as well as PGP 9.5 in innervating nerve fibers.
UCHL1 affects KRT10
| 1
UCHL1 activates KRT10. 1 / 1
| 1

reach
In the epidermis, there was an increase in cellular keratin 14, keratin 10, and loricrin, as well as PGP 9.5 in innervating nerve fibers.
UCHL1 affects KRBOX1
| 1
UCHL1 activates KRBOX1. 1 / 1
| 1

reach
The dramatic inverse correlation between UCHL1 and KRBOX1 expression patterns and the potential role of KRBOX1 as a suppressor of gene transcription intrigued us to investigate whether UCHL1 is a direct target of KRBOX1.
UCHL1 affects Interferon
| 1
| 1

reach
All together, these data clearly demonstrate that UCHL1 can downregulate the PRR mediated activation of both the type I IFN and proinflammatory cytokine and chemokine pathways.
UCHL1 affects IL6
| 1
Modified UCHL1 decreases the amount of IL6. 1 / 1
| 1

reach
It was showed that UCH-L1 over-expression inhibited NF-kappaB activation and decrease IL-6 and IL-8 levels, while knockdown of it enhanced NF-kappaB activation and increase IL-6 and IL-8 levels during TNF-alpha treatment.
UCHL1 affects IGFALS
| 1
UCHL1 activates IGFALS. 1 / 1
| 1

reach
Although UCHL1 is not known to directly cause ALS, UCHL1 null mice showed upper motoneuron vulnerability [XREF_BIBR].
UCHL1 affects IDO1
| 1
UCHL1 decreases the amount of IDO1. 1 / 1
| 1

reach
UCHL1 inhibition promotes the immunosuppressive capacity and IDO expression of human MSCs.
UCHL1 affects HESX1
| 1
Modified UCHL1 increases the amount of HESX1. 1 / 1
| 1

reach
As expected, overexpression of UCHL1 significantly enhanced cardiomyocyte size, the mRNA level of ANF, and the protein levels of EGFR, and phosphorylated EGFR, AKT, and EKR1/2 compared with coinfection with Ad-GFP and siRNA-control after PE stimulation; moreover, this effect was markedly attenuated by coinfection with Ad-GFP or Ad-UCHL1 and siRNA-EGFR.
UCHL1 affects GRIA
| 1
UCHL1 activates GRIA. 1 / 1
| 1

reach
Uch-L1 also modulates the turnover of the glutamate receptors NMDAR and AMPAR, and has effects on neurotransmitter release.
UCHL1 affects GM
| 1
UCHL1 activates GM. 1 / 1
| 1

reach
We found that a deficit in Uchl1 accelerated GM induced ototoxicity by showing a decreased number of SGCs and nerve fibers in organotypic cochlear cultures and HEI-OC1 cells.
UCHL1 affects GAPDH
| 1
UCHL1 bound to TP53 activates GAPDH. 1 / 1
| 1

reach
Relevant to this report, TP53 was reported to directly upregulate GAPDH [XREF_BIBR] and glycolytic pathway [XREF_BIBR - XREF_BIBR], and UCHL1 directly interacts with TP53 and stabilizes p53 through the ubiquitination pathway [XREF_BIBR, XREF_BIBR].
UCHL1 affects GADD45A
| 1
UCHL1 activates GADD45A. 1 / 1
| 1

reach
The expression and methylation state of the GADD45a target UCHL1 were evaluated, revealing a hypermethylation of its promoter in lesional skin compared to controls.
UCHL1 affects FUT1
| 1
UCHL1 activates FUT1. 1 / 1
| 1

sparser
HSC-T6 cells were cultured in the medium in the presence or absence of purified rUCHL1 protein to define the signaling pathway underlying UCHL1-induced activation of HSCs.
UCHL1 affects FAS
| 1
UCHL1 activates FAS. 1 / 1
| 1

reach
The results indicated that probably the extrinsic (Fas, Fas-L, Trail, DR4 and DR5) and intrinsic (cytochrome C) apoptotic pathways, the activation of p53 (phospho-Mdm-2 and phospho-p53) and the Bcl-2 family members (pro apoptotic member Bax, anti-apoptotic members Bcl-2 and Bcl-xL) combined with each other, participating in the process of apoptosis induced by UCH-L1 in MCF7 cells.
UCHL1 affects F
| 1
UCHL1 activates F. 1 / 1
| 1

reach
UCH-L1 Overexpression Induced Changes of F-Actin and Hypermotility in Podocytes.
UCHL1 affects ESR1
| 1
UCHL1 inhibits ESR1. 1 / 1
| 1

reach
Up-regulation of ERalpha caused by UCH-L1 inhibition could significantly enhance the efficacy of tamoxifen and fulvestrant in ERalpha (-) breast cancer both in vivo and in vitro.
UCHL1 affects ERCC1
| 1
UCHL1 increases the amount of ERCC1. 1 / 1
| 1

reach
Consistent with the fact that DDP resistance mainly involves nucleotide excision repair XREF_BIBR, we found that ERCC1 expression was elevated in the two PEM-R cell lines, while UCHL1 silencing or inhibition suppressed ERCC1 expression in the PEM-R cells.
UCHL1 affects EIF4E
| 1
UCHL1 activates EIF4E. 1 / 1
| 1

reach
UCH-L1 associates with and promotes the assembly of eIF4F and stimulates protein synthesis through a mechanism that requires its catalytic activity.
UCHL1 affects Disease
| 1
| 1

reach
Although no UCHL1 inhibitors have demonstrated antitumour activity in vivo, inducible depletion of UCHL1 has been shown to cause disease regression in an orthotopic multiple myeloma mouse model 125 .

bel
However, mice homozygous for both UCH-L1 and UCH-L3 deletions die early due to dysphagia and display degeneration of the nucleus tractus solitarius and area postrema in addition to the degeneration of the gracile tract that is observed in GAD mice that only have a UCH-L1 deletion
UCHL1 affects DLG4
| 1
UCHL1 activates DLG4. 1 / 1
| 1

reach
Inhibition of UCHL1 using LDN-57444 depletes the hippocampus of monomeric ubiquitin and postsynaptic density protein PSD-95.
UCHL1 affects DES
| 1
UCHL1 increases the amount of DES. 1 / 1
| 1

reach
A20 overexpression or UCH-L1 inhibition increased expression of synaptoporin and nephrin but decreased desmin expression and ubiquitin accumulation level in podocytes.
UCHL1 affects Clathrin
| 1
| 1

reach
As shown in XREF_FIG, downregulation of UCH-L1 in SH-SY5Y cells enhanced lipid raft dependent endocytosis, but not clathrin dependent endocytosis.
UCHL1 affects CYCS
| 1
UCHL1 activates CYCS. 1 / 1
| 1

reach
The results indicated that probably the extrinsic (Fas, Fas-L, Trail, DR4 and DR5) and intrinsic (cytochrome C) apoptotic pathways, the activation of p53 (phospho-Mdm-2 and phospho-p53) and the Bcl-2 family members (pro apoptotic member Bax, anti-apoptotic members Bcl-2 and Bcl-xL) combined with each other, participating in the process of apoptosis induced by UCH-L1 in MCF7 cells.
UCHL1 affects COPS5
| 1
UCHL1 activates COPS5. 1 / 1
| 1

reach
Interestingly, UCH-L1 has been observed to interact with Jab1, a regulator of p27 Kip1, suggesting that UCH-L1 may modulate Jab1 in a manner that leads to increased p27 Kip1 degradation and potentiate[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
UCHL1 affects CHAT
| 1
UCHL1 increases the amount of CHAT. 1 / 1
| 1

reach
Our results showed that continuous abdominal massage could not only upregulate the mRNA and protein expressions of nNOS and CHAT but also upregulate the mRNA and protein expression of protein gene product 9.5 (PGP9.5).
UCHL1 affects CFTR
| 1
UCHL1 activates CFTR. 1 / 1
| 1

reach
Co-transfection with mutant ubiquitins and treatment with proteasome inhibitors suggested that UCH-L1 was reducing the proteasomal targeting of CFTR during synthesis by shortening conjugated polyubiquitin chains.
UCHL1 affects CDKN2A
| 1
UCHL1 activates CDKN2A. 1 / 1
| 1

reach
The exact mechanism by which UCHL1 regulates tumor development remains uncertain, although recent data suggest that UCHL1 increases the half-life of p53 and p14 ARF, decreases the half-life of Mdm2, and activates the p53 signaling pathway XREF_BIBR, XREF_BIBR.
UCHL1 affects CDH1
| 1
UCHL1 decreases the amount of CDH1. 1 / 1
| 1

reach
Recently, it was shown that UCH-L1 enhances prostate cancer cell metastasis by increasing the expression of pro EMT genes such as vimentin and matrix metalloproteinases (MMPs) and reducing transcription of the EMT suppressor E-cadherin [XREF_BIBR].
UCHL1 affects CD2AP
| 1
Modified UCHL1 decreases the amount of CD2AP. 1 / 1
| 1

reach
Beyond that, UCH-L1 overexpression lowered the expression of synaptopodin and CD2AP (XREF_FIG).
UCHL1 affects CCNB1
| 1
UCHL1 increases the amount of CCNB1. 1 / 1
| 1

reach
UCHL1 silencing reduced cell proliferation in vitro and in vivo, cyclin B1 protein levels and cell cycle progression.
UCHL1 affects CCL20
| 1
UCHL1 increases the amount of CCL20. 1 / 1
| 1

reach
This suggests that downregulation of UCHL1 increases the gene expression of IL-8 and MIP3alpha in hrHPV+ KCs.
UCHL1 affects BECN1
| 1
UCHL1 inhibits BECN1. 1 / 1
| 1

reach
UCH-L1 overexpression improved survival of hippocampal neurons, reduced accumulation of amyloid-precursor protein, and decreased Beclin 1 and LC3-II in injured rats.
UCHL1 affects BCL2L1
| 1
UCHL1 activates BCL2L1. 1 / 1
| 1

reach
The results indicated that probably the extrinsic (Fas, Fas-L, Trail, DR4 and DR5) and intrinsic (cytochrome C) apoptotic pathways, the activation of p53 (phospho-Mdm-2 and phospho-p53) and the Bcl-2 family members (pro apoptotic member Bax, anti-apoptotic members Bcl-2 and Bcl-xL) combined with each other, participating in the process of apoptosis induced by UCH-L1 in MCF7 cells.
UCHL1 affects BASP1
| 1
UCHL1 inhibits BASP1. 1 / 1
| 1

reach
Therefore, the neuroprotective effect of 3α-DIOL against PAC-induced painful neuropathological symptoms appears to be dependent on its ability to reverse to normal values decreased NF expression level, reduced CV and NAP peak amplitude in PAC-treated rat peripheral nerves.Moreover, our results also revealed that 3α-DIOL modulate differentially the expression of CNPase, NF200 and PGP9.5 genes.
UCHL1 affects B2
| 1
UCHL1 activates B2. 1 / 1
| 1

reach
AS Uchl1 enhances translation of UCHL1 (ubiquitin carboxy-terminal hydrolase L1) through an embedded SINE (short interspersed nuclear element) B2 repeat present in AS Uchl1 [XREF_BIBR].

eidos
28 A study , using a mouse model , showed that lack of UCHL1 results in axonal degeneration and neuronal death .
| 1
| 1

reach
Mechanistically, UCHL1 promotes angiotensin II induced fibrotic responses by way of activating nuclear factor kappa B (NF-kappaB) signaling.
UCHL1 affects Actin
| 1
UCHL1 activates Actin. 1 / 1
| 1

reach
UCHL1 up-regulates beta-catenin signaling and possibly promotes invasion of both Salmonella and Listeria by modulating actin dynamics in the host cell.
UCHL1 affects ATXN3
| 1
UCHL1 inhibits ATXN3. 1 / 1
| 1

sparser
Since mutations in the UCHL-1 gene, reducing UPS activity by 50%, have been reported in autosomal dominant PD, and UCHL-1 inhibition results in the formation of alpha-synuclein aggregates in mesencephalic cultured neurons, the present study was initiated to test UCHL-1 mRNA and protein levels in post-mortem frontal cortex (area 8) of PD and DLB cases, compared with age-matched controls.
UCHL1 affects AS
| 1
UCHL1 increases the amount of AS. 1 / 1
| 1

sparser
AS Uchl1 transcription has a more restricted tissue distribution, as compared with the sense Uchl1 gene.
UCHL1 affects AGT
| 1
UCHL1 activates AGT. 1 / 1
| 1

reach
Inhibition of UCHL1 by LDN-57444 attenuates Ang II Induced atrial fibrillation in mice.
UCHL1 affects ADM
| 1
UCHL1 inhibits ADM. 1 / 1
| 1

reach
The IC 50 values of BEL-7402 cells and BEL-7402 cells with UCHL1 knockdown of ADM and ADM+VER in ADM and ADM+VER groups were examined using CCK-8 assay.
UCHL1 affects ACTN4
| 1
UCHL1 activates ACTN4. 1 / 1
| 1

reach
Our data suggest that UCHL1 upregulation in ACTN4 associated FSGS fuels the proteasome and that UCHL1 deletion may impair proteolysis and thereby preserve K256E and wt-alpha-actinin -4 heterodimers, maintaining podocyte cytoskeletal integrity and protecting the glomerular filtration barrier.
UCHL1 affects ABCB1
| 1
UCHL1 activates ABCB1. 1 / 1
| 1

reach
Overexpression of UCH-L1 in MCF7 cells up-regulated MDR1, CD147, MMP2, and MMP9, which conferred MDR and promoted migration and invasion.

reach
Upregulation of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Mediates the Reversal Effect of Verapamil on Chemo-Resistance to Adriamycin of Hepatocellular Carcinoma.

reach
The dialyzed ubiquitin conjugates (2-15 mul) were taken up in 50 mul of buffer containing 50 mM Tris [pH 7.4], 5 mM DTT, and 50 mug/ml ovalbumin and then treated with either UCH-L1 or an equal volume [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
| 1

reach
Finally, renal nerve dysfunction in Uchl1 -/- mice is suggested given increased renal nerve arborization, decreased urinary norepinephrine and impaired vascular reactivity.
| 1

reach
Since Uch-L1 enhances the down-stream signaling pathways of cAMP by acting on PKA, this provides another rationale for the targeting of Uch-L1 in SCI treatment.
UBA1 affects UCHL1
| 1
UBA1 inhibits UCHL1. 1 / 1
| 1

reach
Pharmacological inhibition of Uba1, levels of which are robustly reduced in SMA, was sufficient to induce accumulation of UCHL1 in primary neuronal cultures.
Tobacco Smoke Pollution increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
TRAPPC9 affects UCHL1
| 1
Modified TRAPPC9 increases the amount of UCHL1. 1 / 1
| 1

reach
Taken together, these results showed that lentivirus mediated NIBP shRNA efficiently knocked down NIBP expression and inhibited cytokine induced NFkappaB activation and neuronal differentiation in ENC, whereas NIBP overexpression promoted constitutive and inducible expression of PGP9.5.
THAP1 affects UCHL1
1 |
THAP1 increases the amount of UCHL1. 1 / 1
1 |

bel
Genes up-regulated after ectopic expression of THAP1 in primary EC
TGFB affects UCHL1
| 1
TGFB increases the amount of UCHL1. 1 / 1
| 1

reach
PGP9.5 expression in cultured normal fibroblasts was increased by transforming growth factor beta stimulation, indicating the phenotypic alteration to activated fibroblast.
TES affects UCHL1
| 1
TES activates UCHL1. 1 / 1
| 1

reach
We then demonstrate that the embedded TEs modulate AS Uchl1 RNA nuclear localization to an extent moderately influenced by ILF3.
TAC1 affects UCHL1
| 1
TAC1 activates UCHL1. 1 / 1
| 1

reach
Substance P combined with epidermal stem cells promoted PGP9.5 and type III collagen immunoreactivity in granulation tissue of diabetic rats.
Smoke affects UCHL1
1 |
Smoke increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
STAT3 affects UCHL1
| 1
STAT3 activates UCHL1. 1 / 1
| 1

reach
Therefore, SP1, STAT3, and c-JUN are likely candidates to contribute to LANA- and LMP1 induced activation of the uch-l1 promoter and will be the subject of future studies.
ST3GAL4 affects UCHL1
| 1
ST3GAL4 activates UCHL1. 1 / 1
| 1

reach
STZ induced a progressive depletion of UCHL1 protein from beta cells, hours before insulin itself becomes depleted.
SPARC affects UCHL1
| 1
SPARC inhibits UCHL1. 1 / 1
| 1

reach
Among the reversed genes, Nr4a3, Sncg, Uchl1, and Tppp3 were involved in axon development and regeneration and were downregulated by ON, indicating the beneficial effect of needling at GB20.
SP1 affects UCHL1
| 1
SP1 activates UCHL1. 1 / 1
| 1

reach
Therefore, SP1, STAT3, and c-JUN are likely candidates to contribute to LANA- and LMP1 induced activation of the uch-l1 promoter and will be the subject of future studies.
SOX2 affects UCHL1
| 1
SOX2 activates UCHL1. 1 / 1
| 1

reach
Over-expressing Oct4 and Sox2 induced production of neural marker PGP9.5, as well as transformation of hUCB-MCs into micro-glial and endothelial lines in ALS spinal cords.
SLC14A1 affects UCHL1
| 1
| 1

reach
The microarray analysis showed that UT-B deletion caused alteration of MCM 2-4, Dcaf11, 45S pre rRNA, Uch-L1 and Bnip3.
SF1 affects UCHL1
1 |
SF1 decreases the amount of UCHL1. 1 / 1
1 |

biopax:msigdb
No evidence text available
SB 203580 affects UCHL1
| 1
| 1

reach
SB203580 treatment significantly decreased PGP9.5, Trk A, SP, and CGRP positive IENFD in db/db mice at 8 wk of age (XREF_FIG).

ctd
No evidence text available
1 |
Resiniferatoxin decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
RTX affects UCHL1
| 1
RTX inhibits UCHL1. 1 / 1
| 1

reach
Intravesical instillation of RTX also decreased the number of PGP 9.5 and TRPV1 immunoreactive nerve fibers in the human bladder with higher intensity of staining in patients with spinal neurogenic detrusor overactivity (Brady et al., 2003).
RPL29 affects UCHL1
| 1
RPL29 decreases the amount of UCHL1. 1 / 1
| 1

reach
UCH-L1 protein levels were decreased by 42 +/- 9% in islets of HIP compared with wild-type rats (P < 0.01) (XREF_FIG B).
RENBP affects UCHL1
| 1
RENBP increases the amount of UCHL1. 1 / 1
| 1

reach
Our data show that GSPB2 preincubation markedly inhibited AGE induced proliferation and migration of HASMCs in a dose dependent manner and upregulated the protein level of UCH-L1.
REN affects UCHL1
| 1
REN increases the amount of UCHL1. 1 / 1
| 1

reach
In a study on UCH-L1 and alphaII-spectrin levels in experimental rat models of IS and non traumatic hemorrhagic stroke, Ren et al. [13] detected significantly increased serum and CSF levels of UCH-L1 [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

drugbank
No evidence text available

reach
However, our study is the first to assess PGP 9.5 and GAP-43 nerve fiber density and gene expression in proximal and distal skin samples of a large group of patients with peripheral neuropathies of di[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
Palm Oil affects UCHL1
1 |
Palm Oil increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
PTEN affects UCHL1
| 1
PTEN activates UCHL1. 1 / 1
| 1

reach
In certain cases, the etiology of this disease is closely related to certain gene mutations which include synuclein, alpha (SNCA), Parkin RBR E3 ubiquitin protein ligase (PARK2), Parkinson's disease protein 7 precursor (PARK7), PTEN-induced putative kinase 1 (PINK1), ubiquitin carboxy-terminal hydrolase L1 (PARK5), and leucine-rich repeat kinase 2 (LRRK2) (41).
| PMC
PRR11 affects UCHL1
| 1
PRR11 increases the amount of UCHL1. 1 / 1
| 1

reach
Silencing PRR11 inhibited the expression of UCHL1, EGR1, and SNAT1 proteins, with immunoassays revealing a significant correlation among the levels of these four proteins.
PRDX3 affects UCHL1
| 1
PRDX3 activates UCHL1. 1 / 1
| 1

reach
PRDX3 (downregulated in young and old GBM analyses) also increases IKK activation [XREF_BIBR], and knock-down studies of UCHL1 (also downregulated in young and old GBM analyses), show an increase in NFkB function via IKK activation [XREF_BIBR].
POU5F1 affects UCHL1
| 1
POU5F1 activates UCHL1. 1 / 1
| 1

reach
Over-expressing Oct4 and Sox2 induced production of neural marker PGP9.5, as well as transformation of hUCB-MCs into micro-glial and endothelial lines in ALS spinal cords.
PKA affects UCHL1
1 |
Active PKA increases the amount of UCHL1. 1 / 1
1 |

bel
Activated PKA induces transcription of ApUCH (UCH-L1 in mammals), a deubiquitinating enzyzme, which has been found to be critical for the induction of long-term facilitation (Hegde et al. 1997).
PGA1 affects UCHL1
| 1
PGA1 inhibits UCHL1. 1 / 1
| 1

reach
Neither PGJ2 nor PGA1, D2, and E2 were found to inhibit UCH-L1 and UCH-L3.
PACC1 affects UCHL1
| 1
PACC1 decreases the amount of UCHL1. 1 / 1
| 1

reach
Interestingly, under neuropathological situations when NF200, PGP9.5 and CNPase levels were repressed by PAC treatment, 3α-DIOL was able to restore to normal the levels of all of these 3 key proteins controlling peripheral nerve activities and intraepidermal innervation sensory functions.
NFIL3 affects UCHL1
1 |
NFIL3 decreases the amount of UCHL1. 1 / 1
1 |

biopax:msigdb
No evidence text available
NFE2L2 affects UCHL1
1 |
NFE2L2 decreases the amount of UCHL1. 1 / 1
1 |

biopax:msigdb
No evidence text available
NFE2L1 affects UCHL1
1 |
NFE2L1 decreases the amount of UCHL1. 1 / 1
1 |

biopax:msigdb
No evidence text available
| 1
| 1

sparser
Reporter assays revealed that LANA and RBP-Jκ separately activated the uchl-1 promoter to modest, yet significant (p < 0.05), levels.
NCAM1 affects UCHL1
| 1
NCAM1 activates UCHL1. 1 / 1
| 1

reach
Nevertheless, lysosomal degradation of NCAM was reduced after overexpression of UCHL1 supporting a role of UCHL1 in NCAM functions after its internalization.

reach
Specifically, NMDA treatment of cultured hippocampal neurons resulted in increased activation of UCH-L1 and increased levels of monomeric ubiquitin [XREF_BIBR].
MYC affects UCHL1
1 |
MYC decreases the amount of UCHL1. 1 / 1
1 |

biopax:msigdb
No evidence text available
MUC1 affects UCHL1
| 1
MUC1 activates UCHL1. 1 / 1
| 1

reach
In addition, the PEM induced G1 arrest was aggravated in UCHL1 depleted PEM-R cells.
MOS affects UCHL1
| 1
MOS activates UCHL1. 1 / 1
| 1

reach
Two days after injection, two independent MOs that target UCHL1 showed a similar phenotype of curly tail with 53% of 150 embryos in the UCHL1MO1 group and 79% of 112 embryos in UCHL1MO2 group, while the group without injection (Uninjected) and the standard control MO (control MO) injection group did not show obvious curly tail zebrafish embryos (XREF_FIG B, C).
MAX affects UCHL1
1 |
MAX decreases the amount of UCHL1. 1 / 1
1 |

biopax:msigdb
No evidence text available
MAPT affects UCHL1
| 1
MAPT activates UCHL1. 1 / 1
| 1

reach
Tau induces mitochondrial degradation, synaptic deterioration, and cellular death by recruiting UCHL1 in vitro.
LY-411575 affects UCHL1
| 1
| 1

reach
Besides, LY411575 treatment also increased the percentage of PGP9.5 + cells by 2.5 +/- 0.6 fold (p < 0.05, Figure XREF_FIG F-G), while 616452 drastically decreased the ratio of PGP9.5 + cells by 61 +/- 19% compared to NWR control (p < 0.05, Figure XREF_FIG F-G).
LTF affects UCHL1
| 1
LTF increases the amount of UCHL1. 1 / 1
| 1

reach
In summary, these findings provide new evidence that dietary Lf supplementation up-regulated gene expression of BDNF and UCHL1, decreased the colon microbiota of E. coli, improved gut maturation and reduced early weaning diarrhea in piglets.
LEF1 affects UCHL1
1 |
LEF1 decreases the amount of UCHL1. 1 / 1
1 |

biopax:msigdb
No evidence text available
1 |
L-methionine increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
L-dopa affects UCHL1
1 |
L-dopa increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
ITCH affects UCHL1
| 1
ITCH activates UCHL1. 1 / 1
| 1

reach
Keratinocytes and PGP 9.5 + LCs closely cooperate via direct contact with itch mediating PGP 9.5 +, CGRP + neurons [XREF_BIBR].
IGFALS affects UCHL1
| 1
IGFALS activates UCHL1. 1 / 1
| 1

reach
Moreover, we also warrant the evidence that ALS patients with a short symptom duration display both CSF and serum increased UCHL1 concentrations.
IFNG affects UCHL1
| 1
IFNG increases the amount of UCHL1. 1 / 1
| 1

reach
In this study, we identified that UCHL1 expression was upregulated in MSCs by stimulation of the proinflammatory cytokines IFN-gamma plus TNF-alpha.
HSPA8 affects UCHL1
| 1
HSPA8 inhibits UCHL1. 1 / 1
| 1

reach
Blocking UCH-L1 deubiquitinating activity with the LDN-57444 inhibitor or with the overexpression of the C90S UCH-L1 DUB dead mutant did not have a significant effect on LMP1 loading to the exosomes when the protein levels of LMP1 were normalized to the exosomal markers Flotillin and HSC-70.
HSPA5 affects UCHL1
| 1
HSPA5 activates UCHL1. 1 / 1
| 1

reach
Knockdown of UCHL1 upregulated GRP78 in CFs with TGF-beta1 stimulation and inhibition of GRP78 diminished the antifibrotic effect of UCHL1 knockdown.
HDAC affects UCHL1
| 1
HDAC inhibits UCHL1. 1 / 1
| 1

reach
XREF_BIBR HDAC inhibition results in transcriptional upregulation of UCH-L1 and stabilization of Noxa protein in tumor cells, thus identifying an additional Noxa-regulatory circuit that is epigenetically controlled.
Glu-Ser affects UCHL1
| 1
Glu-Ser increases the amount of UCHL1. 1 / 1
| 1

reach
As high expression of PGP 9.5 was only found in neural tumors; PGP 9.5 expression by ES provides further evidence for a neural origin of this tumor, whereas TH expression is highly specific for neuroblastomas.
GRIN2A affects UCHL1
| 1
GRIN2A activates UCHL1. 1 / 1
| 1

sparser
Furthermore, NMDA receptor-dependent activation of UCH-L1 may potentially have a significant effect on synaptic transmission by controlling ubiquitin levels in neurons.
GAS2 affects UCHL1
| 1
GAS2 inhibits UCHL1. 1 / 1
| 1

reach
Overexpression of GAS2 could reverse the inhibitory effects of silenced UCHL1 on migratory ability in glioma cells.
Flavonoids affects UCHL1
1 |
Flavonoids increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
FUT2 affects UCHL1
| 1
FUT2 decreases the amount of UCHL1. 1 / 1
| 1

reach
Investigating further, we confirmed that SE induces post- translational loss of UCHL1 through depletion of a lncRNA, and highlighted the contribution of UCHL1 to the regulation of excitability.
FLOT affects UCHL1
| 1
FLOT inhibits UCHL1. 1 / 1
| 1

reach
Blocking UCH-L1 deubiquitinating activity with the LDN-57444 inhibitor or with the overexpression of the C90S UCH-L1 DUB dead mutant did not have a significant effect on LMP1 loading to the exosomes when the protein levels of LMP1 were normalized to the exosomal markers Flotillin and HSC-70.
FADH2 affects UCHL1
| 1
FADH2 activates UCHL1. 1 / 1
| 1

reach
However, as documented in Table 3, research laid the foundation for U.S. Food and Drug Administration (FDA) accelerated approval of measures of UCH-L1 and GFAP for acute diagnosis of TBI not associated with CT abnormalities versus moderate TBI associated with CT abnormalities.
Endotoxins affects UCHL1
1 |
Endotoxins increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
EPO affects UCHL1
| 1
EPO increases the amount of UCHL1. 1 / 1
| 1

reach
That is, EPO treatment significantly enhanced the expression of PGP 9.5 in the regenerated sciatic nerve, and locally controlled release by PLGA significantly reinforced the therapeutic effects of EPO.
ELF4 affects UCHL1
| 1
ELF4 inhibits UCHL1. 1 / 1
| 1

reach
As shown in Figure XREF_FIG C, induction of necroptosis in WT MEF by TNF/zVAD/CHX caused the appearance of the ~ 35-kDa band within 4h of treatment and again reduced the levels of the 25-kDa UCH-L1 form (most clearly visible after 8h).
EGFR affects UCHL1
| 1
EGFR increases the amount of UCHL1. 1 / 1
| 1

reach
Using quantitative real-time polymerase chain reaction and western blot analyses, we found accompanying over-expression of UCH-L1, EGFR was up-regulated in both MCF7 and ADR and MCF7 cells.
EBNA1 affects UCHL1
| 1
EBNA1 increases the amount of UCHL1. 1 / 1
| 1

reach
Both EBNA1 and the EBERs have been shown to play roles in malignant transformation, and because we propose that during transformation oncogenic viruses activate the uch-l1 promoter; it is possible and probable that EBNA1 and the EBERs may also induce UCH-L1 expression either directly or indirectly.
E2 affects UCHL1
| 1
E2 inhibits UCHL1. 1 / 1
| 1

reach
Neither PGJ2 nor PGA1, D2, and E2 were found to inhibit UCH-L1 and UCH-L3.
1 |
Dietary Fats increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
DST affects UCHL1
| 1
Mutated DST inhibits UCHL1. 1 / 1
| 1

reach
In addition, immunohistochemical analysis demonstrated that the dystonin mutation reduced the number of PGP 9.5 and calbindin D28k containing nerve fibers in fungiform papillae.
DSP affects UCHL1
| 1
DSP activates UCHL1. 1 / 1
| 1

reach
We next tested whether the protein protein cross-linker DSP would increase the retention of UCHL1 and TRF1 to the nuclear scaffold of DU 145 cells.
1 |
D-glucopyranose increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
Crack Cocaine increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
COPS5 affects UCHL1
| 1
Modified COPS5 increases the amount of UCHL1. 1 / 1
| 1

reach
In fact, it has been reported that COPS5 (also known as JAB1) was upregulated in HCC, and loss of COPS5 could inhibit the growth of HCC cells by restoring the expression of p57.33,34 Jun Yu etal found that UCHL1 was expressed in all normal tissues and immortalized normal epithelial cell lines but was low or silenced in 77% (10/13) of HCC cell lines.
CIB1 affects UCHL1
| 1
CIB1 activates UCHL1. 1 / 1
| 1

reach
The CIBP model induced up-regulation of ubiquitin and UCHL1 in the spines, as well as glial activation.
CDKN1B affects UCHL1
| 1
CDKN1B inhibits UCHL1. 1 / 1
| 1

reach
Results of multiple Western blot analysis showed that pro apoptotic factors, Fas, Fas-L, Trail, DR4, DR5, Bax, cytochrome C, active caspase-3 and phospho-p53 levels were remarkably higher (XREF_FIG), anti-apoptotic factors, phospho-Mdm-2, Bcl-2 and Bcl-xL levels were significantly lower (XREF_FIG), cyclin dependent kinase inhibitor p21 level was elevated, while p27 level was reduced (XREF_FIG) in UCH-L1 transfectants than in MCF7 cells and their empty loading control transfectants.
CDC5L affects UCHL1
1 |
CDC5L decreases the amount of UCHL1. 1 / 1
1 |

biopax:msigdb
No evidence text available
CD55 affects UCHL1
| 1
CD55 increases the amount of UCHL1. 1 / 1
| 1

reach
Given that Gene 33 deletion dramatically up-regulates UCHL1, Cr (VI) tends to promote UCHL1 expression, and that elevated UCHL1 is known to up-regulated in lung cancer, we propose that UCHL1 plays an important role in the early stage of lung epithelial cell transformation and lung tumorigenesis.
CCNB1 affects UCHL1
| 1
CCNB1 activates UCHL1. 1 / 1
| 1

reach
Our findings suggest that cyclin B1 is a novel target of UCHL1 and targeting UCHL1 is a potential therapeutic strategy for USC.
CCI affects UCHL1
| 1
CCI decreases the amount of UCHL1. 1 / 1
| 1

reach
Hence, CCI attenuated the expression of PGP9.5 in pawn skin, and this detrimental effect was restored by hAFMSCs.Human mesenchymal stem cells are able to reduce pro-inflammatory gene and protein expression in neuropathic mice [28].
CAT affects UCHL1
| 1
CAT activates UCHL1. 1 / 1
| 1

reach
50,51 Analysis of the UCHL1 gene promoter by CAT assay and electrophoretic mobility shift assay have shown that the PSN element has a functional role regulating the expression of UCHL1 gene contributi[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
1 |
BEP protocol increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
BDNF affects UCHL1
| 1
BDNF activates UCHL1. 1 / 1
| 1

reach
Furthermore, BDNF increased the activity of the deubiquitinating enzyme UchL1 in synaptoneurosomes and upregulated free ubiquitin.
Antirheumatic Agents increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
| 1

reach
These and other lines of evidence support a role for dysfunction of the ubiquitin-proteosome pathway in the pathogenesis of AD supporting the importance of the UCH-L1 protein.
AR affects UCHL1
| 1
AR inhibits UCHL1. 1 / 1
| 1

reach
However, although we could not observe any impact of stimulation with several different compounds on the Uch-L1-alpha 2A AR-interaction in transfected cells, some of these alpha 2 AR ligands may influ[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
AGT affects UCHL1
| 1
AGT increases the amount of UCHL1. 1 / 1
| 1

reach
However, the molecular mechanism by which Ang II, PE, or TAC up-regulates UCHL1 expression remains to be determined.
AADAC affects UCHL1
| 1
AADAC activates UCHL1. 1 / 1
| 1

reach
To confirm that UCHL1 promoter DNA hypermethylation is responsible for the silencing of UCHL1, a selected number of UCHL1 - and UCHL1 + RCC cell lines were treated with different concentrations of DAC (1, 5, 10 muM) for 5 days.
6-propyl-2-thiouracil increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
4-phenylbutyric acid increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
1 |
4-methylcatechol decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
4-hydroxynon-2-enal increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available
2-phenylethylamine decreases the amount of UCHL1. 1 / 1
| 1

reach
Western blot analysis revealed that PEA (200, 400, 800 μg/mL) acted in a concentration-dependent manner to reduce λ-carrageenin-induced PGP 9.5 expression (Figure 3B).

sparser
Treatment with Δ 12 -PGJ 2 in cells also inhibited UCH-L1 and UCH-L3 without alteration of proteasomal activity, indicating that prostaglandins can be suitable for neural disorder therapy [ 95 ] .
| PMC
1 |

ctd
No evidence text available

reach
15d-PGJ2 has the ability to covalently modify and subsequently inhibit the hydrolase activity of UCH-L1 [94].
| PMC
1-naphthyl isothiocyanate increases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available
1 |
(S)-nicotine decreases the amount of UCHL1. 1 / 1
1 |

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available

ctd
No evidence text available